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ABSTRACT
The purpose of this study was to develop an incremental
field exercise test of disability to use in the assessment
of functional capacity in patients with chronic airways
limitation (CAL). The test was modified from the 20m
shuttle running test, employed to predict the maximal
oxygen uptake of sporting individuals. The protocol devised
for the patients was adapted from the running speeds
proposed by Leger and Lambert (1982). The shuttle walking
test requires patients to walk up and down a 10m course at
speeds dictated by a series of audio signals played from a
tape cassette, increasing each minute to a symptom limited
maximum performance. Examination of the reproducibility of
the test revealed strong test/retest reliability, after
just one practice walk. The mean between trial difference
(test 2 vs test 3) was -2m,(n=10), (95% CI -21.9 to 17.9m).
The shuttle walking test was validated against the
traditional measurement of peak oxygen uptake (Vo2pmk)
measured conventionally during an incremental maximal
treadmill test with Douglas bags (n=19). The results from
this exercise test were compared against the patients'
performance (distance achieved) on the shuttle walking test
(after one practice walk) and revealed a strong
relationship between the two variables (r=0.88).
The validity and the resistance to breathing, of a
portable oxygen consumption meter was examined. Validation,
again in comparison to Douglas bag measurements, involved
four cohorts (two healthy and two patient groups). After
some modifications to the equipment, measurements of lib2 by
the two different methods were not significantly different.
The patients' response to the shuttle walking test was
examined (n=10). The heart rate, ventilation and 7Orck2
increased gradually in response to the increasing intensity
of the shuttle walking test. Again Vo 2wa measurements
related strongly to the patients performance (r=0.81).
A further study employing a treadmill test and shuttle
walking test confirmed that the latter provided a
comparable metabolic and physiological challenge to the
patients as the conventional treadmill test.
Comparison with the 6 minute walking test (6MWT), one of
the most commonly employed field exercise tests in this
patient population) revealed that the heart rate response
was significantly higher in the shuttle walking test than
the 6 MWT and graded, a response not observed in the 6MWT.
The shuttle test reflected the true extent of the patients
disability more accurately than the 6MWT.
The shuttle walking test provides a simple, reproducible
exercise test of disability in patients with CAL that
relates well to Vb2puk . The external pacing of the test
allows more valid intra- and inter- subject comparison than
has previously been possible with field tests alone.
ACKNOWLEDGEMENTS
I would like to express my thanks to Dr Adrianne Hardman
and Dr Michael Morgan. Firstly, for providing me with the
opportunity to develop the idea of the shuttle walking test
and study exercise physiology in patients with chronic
airways limitation and secondly, for the valuable advice
and encouragement during both the writing of this thesis
and the experimental work reported within it.
For the development of the shuttle walking tape cassette
I would like to thank David Johnson of the Audio-Visual
department at Loughborough University.
I would like to thank the staff of the Cardio-respiratory
department at Glenfield General Hospital for allowing me to
use their exercise equipment and their valuable assistance
in creating a prototype mouthpiece for the Oxylog. In
addition I would like to extend my thanks to Medical
Physics Dept, Leicester Royal Infirmary for assistance in
measuring the resistance to ventilation in the equipment
employed in this project.
Finally I would like to thank the experimental subjects
from the Department of Sports Science and Physical
Education for their time, effort, and of course to the
patients who willingly participated in the study making the
research so enjoyable.
PUBLICATIONS
Unless otherwise acknowledged or referenced to the
published literature the work reported in this thesis is
that of the author. Parts of this work have been reported
in the following publications:
1. A progressive shuttle walking test of functional
capacity in patients with chronic airways obstruction.
Scott SM Walters DA Singh SJ Morgan MDL Hardman AE.
Thorax 1990,45,781a.
2. A comparison of patients performance on the shuttle
walking test and the six minute walking test. Singh SJ
Morgan MDL Hardman AE. Thorax 1992,47,236p.
3. A comparison of patients performance on the shuttle
walking test and maximal oxygen uptake in patients with
chronic airways limitation. Singh SJ Hardman AE Bardsley
PA Morgan MDL. Am Rev Resp Dis 1992,145:4,765a.
4. The development of the shuttle walking test of
disability in patients with chronic airways obstruction.
Singh SJ Morgan MDL Scott SC Walters D Hardman AE.
Thorax 1992,47:1019-1024.
5. Patients performance on the shuttle walking test and the
six minute walking test: a comparison. Singh SJ Morgan MDL
Hardman AE. Clinical Rehabilitation 1992;6:348.
6. The ventilatory response of patients with COPD to the
shuttle walking test. Singh SJ Rowe C Hardman AE Morgan
MDL..Proceedings of the 2nd international conference on
advances in pulmonary rehabilitation and management of
chronic respiratory failure, Venice. 1992.
7. Does the shuttle walking test provoke a symptom limited
maximal performance. Thorax 1993,48:446a.
111
TABLE OF CONTENTS
Page
1. INTRODUCTION	 1
1.1 Organisation of thesis	 4
2. REVIEW OF THE LITERATURE
2.1 The pathology of CAL	 6
2.2 The assessment of patients with CAL
	 16
2.3 Exercise tests for the assessment of functional
capacity in patients with CAL
	 28
2.4 The normal ventilatory response to exercise 	 41
2.5 Response to exercise in patients with CAL 	 50
2.6 The measurement of 17E and 170 2 in patient with
CAL	 59
2.7 The measurement of blood lactate concentration
and indices of metabolic acidosis in patients
with CAL	 66
3. GENERAL METHODS
3.1 Equipment	 72
3.2 Expired gas collection (Douglas bags) 	 75
3.3 Expired gas analysis	 75
3.4 Subject recruitment and consent	 76
3.5 Statistical methods	 76
4. DEVELOPMENT OF A 10 METRE SHUTTLE WALKING TEST OF
FUNCTIONAL CAPACITY IN PATIENTS WITH CHRONIC
AIRFLOW LIMITATION
4.1 Introduction 	 78
4.2 Method	 79
4.3 Results	 85
4.4 Discussion	 103
iv
5. EXAMINATION OF THE VALIDITY OF THE SHUTTLE WALKING
TEST AS A MEASURE OF FUNCTIONAL CAPACITY BY COMPARISON
WITH SYMPTOM LIMITED MAXIMUM OXYGEN UPTAKE
5.1 Introduction
	 110
5.2 Method	 110
5.3 Results	 113
5.4 Discussion	 131
6. EXAMINATION OF THE PORTABLE OXYGEN CONSUMPTION METER
6.1 Introduction	 143
6.2 Description	 143
6.3 The Squirrel	 145
6.4 Routine use of the Oxylog	 146
6.5 Examination of the validity of the oxylog
(healthy subjects)
6.5.1 Introduction	 147
6.5.2 Method	 147
6.5.3 Results	 148
6.5.4 Discussion	 163
6.6 Examination of the validity of the Oxylog in
patients with CAL (sub-maximal)
6.6.1 Introduction	 167
6.6.2 Method
	 167
6.6.3 Results	 168
6.6.4 Discussion
	 177
6.7 Examination of the usefulness of the Oxylog
incorporating a mouthpiece (healthy subjects)
6.7.1 Introduction	 179
6.7.2 Method
	 179
6.7.3 Results	 180
6.7.4 Discussion	 188
6.8 Examination of the validity of the Oxylog (&
mouthpiece) during maximal exercise testing in
patients with CAL
6.8.1 Introduction	 191
6.8.2 Method	 191
6.8.3 Results	 192
6.8.4 Discussion	 196
6.9 Investigation into the resistance to inspiration
of the Oxylog and the Douglas bag
6.9.1 Introduction	 199
6.9.2 Method	 200
6.9.3 Results	 200
6.9.4 Discussion	 205
7. THE PHYSIOLOGICAL RESPONSES TO THE SHUTTLE WALKING
TEST
7.1 Introduction	 210
7.2 Method	 210
7.3 Results
	
213
7.4 Discussion	 231
8. EXAMINATION OF CAPILLARY BLOOD LACTATE CONCENTRATIONS
IN RESPONSE TO THE SHUTTLE WALKING TEST AND A
CONVENTIONAL SYMPTOM LIMITED TREADMILL TEST
8.1 Introduction	 237
8.2 Method	 238
8.3 Results	 241
8.4 Discussion	 267
9. A COMPARISON OF PATIENTS' PERFORMANCE ON THE SHUTTLE
WALKING TEST AND THE SIX MINUTE WALKING TEST
9.1 Introduction	 276
9.2 Method	 276
vi
9.3 Results	 277
9.4 Discussion	 296
10. GENERAL DISCUSSION
	 301
REFERENCES	 313
APPENDICES
A. The shuttle walking test instructions 	 332
B.i. Borg breathlessness scale	 334
B.ii.Borg perceived exertion scale 	 335
C. Chronic respiratory disease questionnaire 	 336
D. Calibration procedures 	 344
E. Gas analysis	 345
F. Blood lactate assay	 347
vii
LIST OF FIGURES
page
804.1 The shuttle walking test.
4.2 The cumulative number of shuttles completed at
the end of each level.
4.3 Mean (SEM) maximal distance (m) walked on
trials 1, 2 and 3.
4.4 Mean (SEM) maximal heart rate (beat.min4)
recorded for trials 1, 2 and 3.
83
89
93
4.5 Mean maximal heart rate expressed as a
percentage of predicted maximum plotted against
the distance walked (m), trial 3. 	 95
4.6 The heart rate response (beat.min4 ) to the
shuttle walking test for two representative
patients.	 96
5.1 Predicted /02mu (ml.min4 .kg4) plotted
against the measured 1T02 during the treadmill
test (n= 22).	 118
5.2 Predicted maximal 'Q'E (1.min4 ) plotted against the
measured /CTE during the treadmill test (n= 22). 	 120
5.3 Heart rate response (beat.min 4 ) during the
treadmill test of three representative patients. 	 124
5.4 Ventilatory response (1.min4) during the
treadmill test of three representative patients. 	 125
5.5 Oxygen uptake (ml.min4 .kg4 ) response measured
during the treadmill test of three representative
patients.
	
126
5.6 1:702peak (iul.min4 .kg4) measured on the treadmill
test against performance [distance walked, (m))
on the shuttle walking test. (n=19). 	 127
5.7 '0'02peak (ml.min4 .kg4) measured on the treadmill
test against performance [distance walked, (in))
on the shuttle walking test. (n=19) with the 95%
confidence intervals for the relationship. 	 128
6.1 The relationship between the mean (SEM) i7o2
(ml.min4 .kg4) measurements with the Oxylog
and Douglas bag at each stage of the exercise
test.
	
153
viii
6.2 The relationship between the mean (SEM) V/
(1.min4 ) measurements with the Oxylog and
Douglas bag at each stage of the exercise test. 	 154
6.3 Mean (SEM) heart rate (beat.min4) at each
stage of exercise with the Oxylog and Douglas
bag.	 160
6.4 Mean (SEM) Borg exertion score reported at
each stage of exercise with the Oxylog and
Douglas bag.	 162
6.5 Mean (SEM) V02 (ml.min4 .kg4) measurements at
the two stages of exercise with the Oxylog and
Douglas bag.	 172
6.6 Mean (SEM) '(Ti (1.min4) measurements at the two
stages of exercise with the Oxylog and Douglas
bag.	 173
6.7 Mean (SEM) values of Vo2 (ml.min4.kg4)
at each stage for the Oxylog and Douglas bag. 	 185
6.8 Mean (SEM) values of VI(1.min4) at each
stage for the Oxylog and Douglas bag. 	 187
6.9 The resistance (cm.H20) to inspiration (range
10 - 100 1.min4) of the Salford valve and the
Oxylog inspiratory valve.	 203
6.10 The resistance (cm.H20) to inspiration (range
10 - 100 1.min4) of the Salford valve
and the Oxylog connected with the
Hans Rudolph valve. 	 204
7.1 Relationship between the distance(m) walked on
the lactate and Oxylog trials. 	 216
7.2 Oxygen consumption response (nl.min4.kg4)
to the shuttle walking test in two
representative patients.	 221
7.3 Ventilatory response (1.min4) to the shuttle
walking test in two representative patients.	 222
7.4 Mean (SEM) ventilatory response (1.min4) to
consecutive levels of the shuttle walking test.	 223
7.5 Mean (SEM) oxygen requirements (ml.min4.kg4)
to consecutive levels of the shuttle walking
test.	 224
7.6 Predicted iIE max (1.min4) plotted against
measured VI max using the Oxylog for the
individual patients.	 225
ix
227
228
229
230
251
252
254
256
261
262
7.7 Maximal i/o2 (ml.min4 .kg4) measured with the
Oxylog against performance [distance walked, (in)]
on the shuttle walking 'test. (n10)
7.8 Predicted 17o2	(ml.min4.kg4) plotted against
measured t021ea using the Oxylog for the
individual patients.
7.9 Mean (SEM) pre and post exercise capillary
blood lactate concentration (mmo1.1-1).
7.10 Peak values of V02 (ml.min4 .kg4 ) measured
from the Oxylog during the shuttle walking test
and those values from the Douglas bag experiment
(Chapter 5).
8.1 Pre and post treadmill test blood capillary
lactate concentration in the patient group
(n=10).
8.2 Pre and post treadmill test blood capillary
lactate concentration in the control group
(n=10).
8.3 iTco2/i/o2 slope with the identification of
the ventilatory threshold in 6/10 patients.
8.4 1co2/Io2 slope for the control group with
the identification of the ventilatory
threshold. (n=10).
8.5 Pre and post shuttle test blood capillary
lactate concentration in the patient group
(n=10).
8.6 Comparison of the post exercise capillary
blood lactate concentration in the patient
group after the treadmill and shuttle walking
test. (n=10).
8.7 The relationship between the symptom limited
Vo2pc,d, and the distance completed on the
shuttle walking test. ( n=10).	 264
9.1 Mean(SEM) distances (m) walked on the shuttle
walking tests and the six minute walking tests.	 280
9.2 The relationship between the distance (m)
walked on the first and second six minute
walking test.	 283
9.3 The relationship between the distance (m) walked
on the first and third six minute walking test. 	 284
9.4 The relationship between the distance (m) walked
on the second and third six minute walking test.	 285
9.5 The relationship between the distances (m)
walked on the two shuttle walking tests. 	 286
9.6 The relationship between the distances (m) walked
on the second shuttle walking test and the third
six minute walking test.	 287
9.7 The mean (SEM) maximal heart rate (beat.min4)
attained on the shuttle walking test and the
six minute walking test. 	 289
9.8 The heart rate response (beat.min 4) to the
shuttle walking test and the six minute
walking test of two representative patients. 	 292
9.9 Mean (SEM) maximal Borg score post exercise
for the shuttle walking test and the six
minute walking test.	 295
xi
LIST OF TABLES
page
4.1 The shuttle walking test protocol. 	 82
4.2 Some physical characteristics [mean (SD)] of the
patients, n=10.	 86
4.3 Mean distance (m) completed on the 10m shuttle
walking test.	 88
4.4 Mean and standard deviation for between trial
difference (m) and 95% confidence intervals (m)
together with Pearson Product Moment Correlation
coefficients (r) describing the relationship
between distance walked on the 3 trials.
	 90
4.5 Mean and standard deviation maximal heart rate
(beat.min4 ) during the 10m shuttle walking test. 	 91
4.6 Mean and standard deviation maximal heart rate
(beat.min4) expressed as a percentage of predicted
maximal heart rate [210 - (0.65 x age)].	 92
4.7 Pearson Product Moment correlation evaluating
the relationship between the distance walked and
percentage of predicted maximal heart rate
attained.	 94
4.8 The relationship between three lung function
variables and patients' performance (Pearson
Product Moment correlation) for the three trials.
	 97
4.9 Post exercise Borg breathlessness scale scores
for the three trials. 	 98
4.10 Mean (SD) difference and the 95% confidence
interval between the Borg rating for trials 1,
2 and 3 and the Spearman Rank Order Correlation
coefficient evaluating the between trial
relationship of these ratings.	 99
4.11 Relationship between the CRDQ responses and the
patients' spirometry results shown by the
Spearman Rank Order Correlation coefficient
(Pearson Product Moment Correlation). 	 101
4.12 Spearman Rank order Correlation coefficients
(Pearson Product Moment) between the four
components of the chronic respiratory disease
questionnaire and the distance walked on the
three trials.	 102
5.1 Some physical characteristics of the patients,
Mean (SD). n=22 ( 17 male, 5 female). 	 114
xii
5.2 Mean and standard deviation distance walked
(m) on the two shuttle walking tests and the
mean difference (m) and 95% confidence interval. 	 116
5.3 Mean (SD) treadmill performance and ventilatory
results from the treadmill test, n =22.	 117
5.4 Patients heart rate (beat.min4) at comparable
speeds on the treadmill (0%) and on the shuttle
walking test.	 121
5.5 Some physiological variables [mean (SD)] of the
two sub-groups divided by their FEV1 values.	 130
6.1 Some physical characteristics of the group
(mean and SD). n=10.	 149
4 males, 6 females
6.2 Mean (SD) values measured in normals for V02
(STPD) ml.min4 .kg4 . n=10.	 151
6.3 Mean (SD) values measured in normals for
(STPD) 1.min4 . n=10.	 152
6.4 The mean differences and the 95% confidence
intervals of the Douglas bag and Oxylog
measurements at each stage for 17o 2 (ml.miril.kg-1)
and the Pearson Product Moment correlation.
	 155
6.5 The mean (SD) differences and the 95%
confidence intervals of the Douglas bag and Oxylog
measurements at each stage for di (1.min4) and the
Pearson Product Moment correlation. 	 156
6.6 Mean and standard deviation of R values measured
at each stage during the Douglas bag measurements. 158
6.7 Mean (SD) heart rate (beat.min4) recorded at
each stage of exercise with the Oxylog and
Douglas bag.
	
159
6.8 Mean (SD) Borg exertion scale recorded at each
stage of the exercise test with the Oxylog and
Douglas bag.
	
161
6.9 Some physical characteristics of the patient
group [mean (range)]. n=5.	 169
4 males, 1 females.
6.10 Mean (range) t02 (ml.min-l .kg-1 ) measurements at
the two stages of exercise with the Oxylog and
Douglas bag.	 170
182
183
184
186
193
6.11 Mean (range) 171 (1.min-1 ) measurements at the two
stages of exercise with the Oxylog and Douglas
bag.	 171
6.12 Mean (range) heart rate (beat.min -1 ) measurements
at the two stages of exercise with the Oxylog
and Douglas bag.	 174
6.13 Mean (range) Borg breathlessness scores recorded
at the two stages of exercise with the Oxylog
and Douglas bag.	 176
6.14 Some physical characteristics of the group
[mean and standard deviation)]. n=8.	 181
3 males, 5 females
6.15 Mean (SD) values measured in normals for t02
(STPD) ml.min-1 .kg-1 . n=8.
6.16 Mean (SD) values measured in normals for '(Ti
(STPD)	 . n=8.
6.17 Mean (SD) differences and the 95% confidence
intervals of the Douglas bag and Oxylog
measurements at each stage for 17o2
(ml.min-l .kg-1 ) and the Spearman rank order
correlation.
6.18 The mean (SD) differences and the 95% confidence
intervals of the Douglas bag and Oxylog
measurements at each stage for /i(l.min-1)
and the Spearman Rank Order correlation.
6.19 Some physical characteristics of the patient
group, mean (range). n=6.
3 males, 3 females.
6.20 Mean(range) maximal measurements of to2
(ml.min-l .kg-1 ) and VI(1.min-1 ) for the
Oxylog and Douglas bag at the patient's maximum. 	 194
6.21 Mean differences, standard deviations and the 95%
confidence intervals of the maximal Douglas bag
and Oxylog measurements values for tO2
(iul.min'.kg 1 and VI (1.min-1 ) and the
Spearman Rank Order correlation. 	 195
6.22 Resistance (cmH20) of the inspiratory ports of
the Salford, Oxylog and Hans Rudolph valves. 	 201
7.1 Some physical characteristics of the patient
group, mean (SD), n=10. (6 males, 4 females). 	 214
7.2 Mean (SD) Borg breathless score at rest and
post-exercise.	 217
xiv
7.3 Mean (SD) resting values of ventilation (1.min4)
and ft2 (ml.min4.kg4).	 218
7.4 Mean (SD) maximal values of ventilation (1.min4)
and "(702 (ml.min4.kg4).	 220
8.1 Some physical characteristics of the patients,
Mean (SD). n=10 (6 male,4 female). 	 242
8.2 Some physical characteristics of the control
group, Mean (SD). n=10 (6 male, 4 female). 	 243
8.3 Mean difference and 95% confidence interval
between the physical characteristics of the
patient and control groups. 	 245
8.4 Mean (SD) resting results prior to the
treadmill test, for both patients and the
control group. (Both n=10).	 246
8.5 Mean difference and 95% confidence interval
of the resting results prior to the treadmill
test between the patients and control group. 	 247
(Both n=10).
8.6 Mean (SD) treadmill performance and
ventilatory results from the treadmill test,
for the patients and control groups. (both
groups n=10).	 248
8.7 Mean difference and 95% confidence interval
for the maximal results of the treadmill test
between the patients and control group.	 249
(Both n=10).
8.8 Reported Borg breathlessness score at rest and
immediately post exercise for the shuttle and
treadmill test (mean, SD) (n=10).	 265
8.9 Mean difference, 95% confidence interval and
Spearman correlation between the reported Borg
breathlessness score of the shuttle versus the
treadmill exercise test.	 266
9.1 Some physical characteristics of the group
(Mean, SD), n=15. 10 males, 5 females 	 278
9.2 Mean (SD) and range of distances (m) walked
on the shuttle walking test and the six minute
walking test.	 281
9.3 Mean (SD) differences (m) and 95% confidence
intervals (m) and correlation coefficients in
the distances walked between the two field
exercise test.	 282
XV
9.4 The mean (SD) maximal heart rate (beat.min4)
attained and corresponding mean percentage
values on the shuttle walking tests and the six
minute walking tests.	 290
9.5 The relationship between the distance (m)
walked on the shuttle walking test and the six
minute walking test and the percentage of
maximal heart rate attained, [(210-0.65) x
age].	 291
9.6 Pearson Product Moment correlations between
the distance (m) walked on the shuttle walking
test or the six minute walking test with the
spirometry results.	 294
1. INTRODUCTION
Objective measures of disability are important in the
assessment and clinical management of patients with chronic
airways limitation (CAL). It is well documented that lung
function values, the most commonly used being the forced
expiratory volume in 1 second (FEVO and forced vital
capacity (FVC) do not relate well to a patient's functional
capacity. Consequently exercise tests are employed to
evaluate more precisely a patient's level of disability and
can subsequently be employed to assess a patients response
to treatment.
Two modes of testing exist, formal laboratory assessment
or perhaps more commonly field exercise tests. Laboratory
assessment requires the patients to perform a treadmill or
cycle ergometer test with detailed gas analysis
measurements requiring the patient to wear either a face
mask or mouthpiece and nose clips. This form of testing is
not widely available, being confined to large teaching
hospitals were the technical support exists. Added to which
the equipment (treadmills and gas analysis equipment) is
expensive and the procedures involved quite intimidating to
the patient. As a consequence of these limitations field
exercise tests were developed as a cheap, simple but
effective alternative assessment of disability. Field tests
of walking ability are most frequently employed and usually
comprise a self paced test where the patient is required to
walk as far as possible in either twelve or six minutes
(McGavin et al 1976, Butland et al 1982). These protocols
re difficult to standardise and may be overly influenced by
motivation and encouragement (Guyatt et al 1987). In
addition their very simplicity limits the information which
can be obtained from them about the physiological and
symptomatic changes that occur during exercise (Beaumont et
al 1985).
The most accurate measure of exercise capacity is to
1
directly measure maximal oxygen uptake ( .102 ,u) (Astrand &
Rodahl 1986). In patients with respiratory disorders the Vo2
is limited due to ventilatory abnormalities and
consequently the maximal Vo2 that a patient attains is often
described as the symptom limited Von= or 1.7o2pea. A ton= is
traditionally defined as the point at which, despite an
increase in the gradient of the treadmill there is no
accompanying increase in oxygen uptake (less than 150m1
02/min), ie a plateau effect. This point is rarely seen in
patients with CAL, primarily attributable to different
mechanisms causing the cessation of exercise in healthy
subjects compared to patients with CAL. In patients with
CAL the limitation to exercise is due to the inability of
the lungs to meet the demand for increasing ventilation. In
healthy trained subjects the limit to continued exercise is
the cardio-vascular system.
There is a paucity of data relating existing field test
performance to 17% 1,4, in patients and consequently their
validity in assessing exercise tolerance is questioned.
McGavin et al (1976) proposed the original 12 minute
walking test to assess patients with CAL. The authors
identified a moderate relationship between the two
variables, ie distance walked versus 'O2. Subsequent work
examining the relationship between these two variables for
this test or any subsequent field exercise test is sparse.
There is also a scarcity of data regarding the cardio-
respiratory response to these field tests. Moreover, the
data that has been presented focuses on the end points or
maximal values rather than the overall response to exercise
in these patients (Swinburn et al 1985).
Considerably more data are available examining patients'
exercise tolerance in the laboratory environment, observing
the ventilatory and physiological responses to exercise.
Again authors tend to concentrate on maximal values rather
than the response to various intensities of exercise
(Matthews et al 1989) .
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The purpose of the series of studies presented in this
thesis, was to develop an incremental externally paced
field walking test to assess functional capacity in
patients with CAL. The principle for the test, a 10m
shuttle walking test, is based upon the 20m shuttle running
test (Léger and Lambert 1982). The aim would be to offer
this test as a more objective and standardised alternative
to the currently available field exercise tests rather than
to replace the more detailed measurements obtained by
formal laboratory assessment.
3
1.1 Organisation of the thesis
There are six experimental chapters included in this
thesis. The first study involves the development of a
shuttle walking test protocol with suitable walking speeds
and incremental increase in the speed that would allow
range of patients to be stressed to a symptom limited
maximum performance. The proposed protocol was initially
assessed for reproducibility.
The second study addresses the validity of the shuttle
walking test against a traditional, maximal oxygen uptake.
To explore this patients were required to perform a symptom
limited incremental treadmill walking test and their to2
was directly measured. In comparing patients performance on
the shuttle walking test against the Douglas bag
measurements of ''o, it was possible to reveal if the
shuttle walking test was in fact a valid indicator of
functional capacity.
One of the subsequent aims of the project was to examine
patients' respiratory response during the shuttle walking
test. In order to do this it was necessary to examine the
reliability of a portable oxygen consumption and
ventilation meter, the 'Oxylog'. The Oxylog carried in a
backpack enabled ambulatory measurements of ventilation and
oxygen uptake during exercise in the field to be made.
Chapter six scrutinises the usefulness of the Oxylog in a
cohort of healthy volunteers and a two separate patient
groups. The final section of this chapter examines the
resistance to breathing of the Oxylog equipment compared to
the conventional Douglas bags.
The following study examines the physiological responses
to the shuttle walking test employing the Oxylog. This made
it possible to investigate patients' respiratory responses
throughout the shuttle walking test. Blood lactate
concentration measurements were employed to assess the
metabolic response to exercise in this patient group.
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During this study the opportunity was taken to make the
corresponding resting measurements.
The penultimate study investigates further, the patients'
metabolic response to exercise, again using blood lactate
measurements. For this study the performance of a group of
patients with an age matched control group was compared.
This allowed the examination of patients' response to
exercise and explore the relationship with the control
group.
The final study compares patients' response and
performance on the self paced six minute walking test
(Butland et al 1982) with their performance on the
externally paced shuttle walking test.
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2.0 REVIEW OF THE LITERATURE
This review is divided into seven sections. The first
section defines and describes the pathological state of CAL
and its associated clinical manifestations. The second
section outlines some of the commonly employed tools of
assessment (both objective and subjective) used in an
attempt to quantify the degree of disability in the
patient.
The third section discusses the usefulness of the
exercise testing and its clinical relevance. The section is
concerned primarily with the development of the argument
supporting the proposal of another field exercise test,
documenting the development of the currently available
field exercise tests and the problems associated with them.
The final three sections examine the response to exercise
firstly in the healthy individual and secondly in the
patient with CAL. The normal response is important to
understand when examining the abnormal response of patients
with CAL. The response to exercise in patients with CAL
focuses on the limitations imposed by the respiratory
system, and examines published data on the measured values
of exercise tolerance. The final section of this review
examines the measurements of blood lactate concentrations
and metabolic acidosis in this patient group.
2.1 DEFINITION AND PATHOLOGY OF CAL
The aim of this project was to develop a simple exercise
test to be used in the assessment of patients with
respiratory conditions. The spectrum of diseases affecting
the chest is enormous and can be divided into two broad
categories ie, those affecting the conducting airways and
secondly those affecting the lung parenchyma. This project
was confined to evaluate the suitability of the shuttle
walking test in patients with pathology affecting the
conducting airways, ie, chronic airways limitation. Within
this broad diagnostic category however lies a vast spectrum
of patients.
6
Definition
The definitions commonly used today are based upon those
agreed in 1959 (Ciba symposium). In 1965 the Lancet
(Editorial) published a statement outlining the definition
and classification of chronic bronchitis which brought
together work from this 1959 symposium and from the
previous decade attempting to define this respiratory
condition; ' Simple chronic bronchitis is defined as
chronic or recurrent increase in the volume of mucoid
bronchial secretion sufficient to cause expectoration.
(This definition is in essential agreement with other
published definitions but is simpler and shorter)'. This
definition is based upon clinical and functional
abnormalities and proceeds to outline diagnostic criteria.
This work also described subclassifications of chronic
bronchitis-
a. Simple chronic bronchitis (as described above)
b. Chronic or recurrent mucopurulent bronchitis
c. Chronic obstructive bronchitis, chronic bronchitis
associated with persistent irreversible widespread
narrowing of the airways (Lancet 1965, Pride 1990a).
The working party of 1965 did not attempt to define
asthma or emphysema. The definition of emphysema has tended
to be based more upon pathological terms describing the
anatomical abnormality unlike the definition of chronic
bronchitis based upon patients symptoms and history -
'Emphysema is defined pathologically as a condition
characterised by destruction and dilation of air spaces
distal to the terminal bronchioles'. Both emphysema and
chronic bronchitis may occur in the same patient (Petty
1990).
Recently there has been a trend towards a collective
label for these lung conditions, in part due to trans-
atlantic anomalies. The diagnosis of chronic airways
limitation (alternatively, chronic obstructive pulmonary
disease (COPD) or chronic airways obstruction) embraces
emphysema and chronic bronchitis,
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A disorder characterised by abnormal tests of
expiratory flow that do not change markedly over periods of
several months observations' [American Thoracic Society
(NTS) 1987].
This describes the dominant functional defect, a slowing of
the lung emptying on forced expiration. The pathology of
CAL can be explained in terms of the disease processes or
in terms of the resulting mechanisms of the particular
lesions such, as loss of elastic recoil and airway
narrowing. Petty (1990) suggests that by the time the
patient has advanced and irreversible airways obstruction,
particularly at an older age, there is little point in
seeking a more specific diagnosis than COPD.
2.1.1 Pathogenesis of CAL
The cause of chronic bronchitis and emphysema is not
clearly understood but certain relevant factors have been
identified in epidemiological studies (Cole & Mackay 1990).
CAL is most likely to be observed in smokers ( CAL is
diagnosed in 4% of non-smokers (Pride 1990a)), the
cigarette smoke having a number of toxic effects including
immediate increase in airways resistance, inhibition of
ciliary action and release of proteolytic enzymes from
neutrophils (Cole & Mackay 1990, Wanner 1990). Other risk
factors include environmental pollution, particularly prior
to the Clean Air Act (1952-68), working environments ie,
dust, smoke or industrial fumes, gender and deficiency of
the enzyme alpha 1-antitrypsin. Overall males appear to be
at an increased risk. Alpha 1-antitrypsin is a proteolytic
enzyme inhibitor believed to protect the lung from the
powerful effects of elastase released from neutrophil
leucocytes (Cole & Mackay 1990) and appears to be
associated with the development of emphysema particularly
in the 30-40 age group (Hopkin 1991).
Chronic bronchitis
This disease is characterised by excessive mucus
production of the bronchial tree. This hypersecretion
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causes coughing and excessive sputum production. Excessive
expectoration is defined as occurring on most days during
at least three consecutive months for more than two
successive years (Lancet 1965). The functional importance
of mucus hypersecretion is unclear it shows no clear
relationship to persistent airway narrowing (Lamb 1990).
The pathological changes that occur are characterised by
the hypertrophy of the mucous glands in the large bronchi
and evidence of chronic inflammatory changes in the small
airways (West 1987). The mucous gland enlargement is due
to hyperplasia and hypertrophy accompanied by an increased
proportion of mucous (goblet) to serous cells and can be
quantified using the 'Reid' index , the ratio of gland
thickness to wall thickness (Thurlbeck 1991a). In normal
lungs this ratio is normally less than 0.4 (West 1987) but
in chronic bronchitis it may exceed 0.7.
A decrease in the number of ciliated cells and the mean
ciliary length in the larger airways may also contribute to
the accumulation of mucus in the conducting airways (Wanner
1990). The presence of smooth muscle hypertrophy in the
large airways is a controversial issue. Thurlbeck (1991a)
suggests that the role of smooth muscle hypertrophy and its
contribution to airflow obstruction is unclear, but adds
that it is unclear if this is a typical presentation.
Jeffery (1991) proposed that the percentage of the
bronchial wall occupied by smooth muscle fell within the
normal range. Reid (1960) stated that inflammatory changes
were not characteristic of chronic bronchitis.
The changes in the small airways (less than 2mm diameter)
are thought to be the most important in mild airflow
obstruction and not associated with any physical impairment
(ATS 1987) and may represent pre-clinical or early CAL
(Wright et al 1984). Considerable obstructive changes can
occur here without appreciable changes in airways
resistance (Pride & Macklem 1986). The characteristic
pathology here is one of inflammation, the changes are
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relatively subtle and appears as an infiltrate containing
mainly lymphocytes and macrophages (Thurlbeck 1991a), which
ultimately leads to airway narrowing. The presence of the
inflammatory exudate itself can result in the displacement
of the surfactant layer of these peripheral airways and
destabilise the airway allowing it to close too easily and
not reopen effortlessly. Alternatively the inflammatory
process may release mediators that cause the smooth muscle
walls to contract, regardless of the mechanism the effect
is to cause fibrosis and narrowing of the small airways
(Thurlbeck 1990a). Severe CAL is identified by marked
narrowing of these small airways although inflammation at
this stage may not be the primary cause, there appears to
be an increase in goblet cells and the small airways may be
more distorted leading to a large increase in airflow
obstruction.
Emphysema
Emphysema is characterised by abnormal permanent
enlargement of the airspaces distal to the terminal
bronchiole, accompanied by destruction of their walls and
without obvious fibrosis (ATS 1986). It is sub-divided into
further clinical groups according to their effect on the
acinus, (emphysema itself is forms a sub-category of the
diagnosis 'respiratory space enlargement')-
a. centrilobular
b. panacinar
c. distal acinar
It should be noted that enlargement of the acinus and
loss of alveolar wall are normal features of increasing age
(Thurlbeck 1991a). The emphysematous lung shows loss of
alveolar wall and destruction of part of the capillary beds
(West 1987). The small airways are narrow and tortuous and
reduced in number and those that do exist have thin
atrophied walls.
a. Centrilobular emphysema
1 0
The destruction is limited to the central part of the
lobe the more peripheral alveolar ducts and alveoli remain
undamaged (West 1987). It is related to cigarette smoking
and inflammation induced (Thurlbeck 1990b). It is the most
common presentation of emphysema and is more common and
more severe in the upper lobes but spreads down the lung as
the disease progresses (West 1987). The respiratory
bronchioles and corresponding alveoli contain excess
macrophages which are highly active and excrete high levels
of proteases. The effect of proteolytic enzymes is
heightened in smokers by the partial inhibition of alpha
1-antitrypsin [this globular protein inhibits the excessive
action of neutrophils and macrophage elastase which
cigarette smoking promotes (Hopkin1991)], which results in
the digestion of elastic tissue.
b. Panacinar emphysema
The acinus is more or less uniformly involved, identical
lesions may be found in different situations and again may
also result from the inflammation caused by smoking. There
is one distinct group of patients which is particularly
susceptible to the effect of cigarette smoking. They have
a deficiency of alpha 1-anti-trypsin (Hopkin 1991). It may
occur maximally in the bases of lungs in patients with
centrilobar emphysema (ATS 1987), in association with the
enzyme deficiency (Lamb 1990) and as an incidental finding
in older patients.
c. Distal acinar emphysema
The alveolar sacs and ducts are predominately affected.
It is usually accompanied by fibrosis and inflammation and
is probably infective in origin (Thurlbeck 1991) and is
uncommon (Thurlbeck 1990b). Because of its location it is
often sited adjacent to lobular septa or the pleura and
consequently associated with pneumothoraces (Thurlbeck
1991b).
2.1.2 Pathophysiology
CAL is a functional disturbance caused by pathological
changes in the lung. Airflow is determined either by the
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pressure applied or the resistance encountered. Applying
this to the lung, the pressure is derived from the elastic
recoil of the lungs, the chief defect in emphysema, and the
resistance encountered is in the form of airway narrowing
(Thurlbeck 1990a). In the normal lung the major site of
resistance lies in the large conducting airways and a small
reduction of the diameter would lead to a noticeable
increase in airways resistance. Hogg et al (1968) drew
attention to the changes occurring in the small airways
suggesting that their initially smaller diameter makes them
more vulnerable to significant narrowing or even closure.
This narrowing due to intrinsic disease and loss of elastic
recoil leads to an increased resistance in flow in the more
peripheral units, noticed at low driving pressures and flow
and appears to be the major site of fixed airway narrowing
in CAL.
In the emphysematous lung there is a loss of elastic
recoil and therefore a reduction in the expiratory
pressures and increased resistance as a loss of support for
the surrounding lung tissue which then encroaches upon the
lumen of the airway (Pare et al 1991). Emphysema can also
lead to air trapping and associated with the loss of
elastic recoil results in an increase in total lung
capacity. These increases in functional residual capacity
(FRC),the gas remaining after tidal breathing and total
lung capacity (TLC) places the inspiratory muscles at a
mechanical disadvantage due to their increase in resting
length (Pride 1990b). FRC in normals is about 50% of the
predicted TLC whilst in patients with CAL it may increase
to possibly as much as 80% of TLC which may in turn
increase by 10-20% (Rochester 1984).
The loss of alveoli results in decreased gas transfer
(Kumar & Clark 1987) and the lung becomes an inefficient
gas exchange organ. Ventilation perfusion (V/Q) mismatching
consequently occurs . In chronic bronchitis there are areas
with a low V/Q value ( 1.0 represents an ideal match) ie,
less than 1.0, the airways in this situation are
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compromised by mucus, inflammation or bronchospasm. In
predominately emphysematous patients the V/Q ratio is
higher as destruction of the alveolar walls and the
capillary beds results in a greater loss of perfusion than
ventilation (Dantzker 1987). Perfusion can also be limited
by active vasoconstriction in areas of severe hypoxia
(Aitkenhead & Smith 1990). Usually this V/Q mismatching
leads to an increase in the PaCO 2 and a fall in the Pa02.
Carbon dioxide is the predominant stimulus to respiration
in the healthy individual (Ganong 1987) and in CAL the
PaCO2 is chronically elevated and the sensitivity of the
central chemoreceptors is dampened and hypoxaemia becomes
the chief stimulus to respiration. The carotid bodies mount
their major action in response to hypoxia. In patients with
CAL this chronic hypoxia can cause the carotid bodies to
hypertrophy to ten times their original size (Flenley
1990).
The increase in airways resistance and increased FRC
obviously leads to an increase in the work of breathing
which limits the oxygen available for peripheral activity
(Cole & Mackay 1990). Total respiratory muscle consumption
may be 10-20 times normal values (Rochester 1984) (normal
value - ventilation at 6 1.min 4 02 uptake would be up to 6
ml Astrand & Rodahl 1986). The pressure change required to
maintain tidal breathing is increased and the decreased
resting length of the respiratory muscles confers a
mechanical disadvantage. Fortunately the inspiratory
muscles are able to adapt to chronic hyperinflation (Pride
1990b).. Due to the alteration in lung pathology and
respiratory muscle activity the pattern of breathing in
patients with CAL is altered from the norm. A higher
negative inspiratory pressure is required to overcome these
limitations and may require the recruitment of accessory
muscles of respiration. This may result in relatively less
movement of the abdomen. The inspiratory time is also
shortened in some patients allowing a greater proportion of
the total breath duration for expiration. Although the
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limits to respiration in CAL are predominately expiratory
it is the inspiratory muscles that compensate to a greater
degree. The inspiratory muscles are also subject to
increased activation to maintain a normal minute
ventilation. This compensates for the inefficiency of
gaseous exchange and increased dead space.
2.1.3 Symptoms of CAL
The principal symptoms are cough, sputum, breathlessness
and wheezing. There may be associated chest discomfort but
rarely pain (Howard 1990). Symptoms can be worsened by non-
specific factors eq. cold and the weather (Kumar & Clark
1987). Breathlessness is the most common reason that
patients seek medical advice and is usually first noticed
on activities such as climbing the stairs or walking
uphill. Severely incapacitated patients may notice
increased breathlessness when they lie flat due to the
limitation of diaphragmatic movement in this position (Cole
& Mackay 1990). Carbon dioxide retention may give rise to
disturbed sleep and early morning headaches and a further
increase can cause drowsiness and confusion (Partridge
1982).
2.1.4 Physical signs
CAL tends to affect the middle aged and elderly person
(ATS 1986), commonly with a history of smoking (Kumar &
Clark 1987). On examination the patient may present with a
normal, kyphotic or barrel shaped chest (increase in the
antero-posterior diameter due to the hyperinflation of the
lungs). Airflow obstruction is indicated by excessive use
of accessory muscles of respiration, pursing the lips
during expiration and by alteration of the respiratory
rhythm increasing the time of the cycle for expiration and
abnormal breath sounds.
On auscultation in these patients the chest may sound
wheezy with decreased breath sounds (ATS 1986). Wheeze is
more common at the bases and is an indication of excessive
mucus secretion in the airways. Flenley (1990) suggests
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that decreased breath sounds is an unreliable indicator of
hyperinflation as is hyperresonance on percussion as the
disease effects both sides of the chest and the value of
comparison between the two sides is lost. Partridge (1982)
proposes that auscultation in these patients is performed
largely to exclude co-existing disease.
Central cyanosis may be detected by examination of the
tongue and inside the lips (Croft & Douglas 1989) but is
difficult to detect until the saturation falls below 85%
(Flenley 1990). It may be the case that some patients only
desaturate on exercise. Examination of the hands may reveal
peripheral cyanosis which always accompanies central
cyanosis. If the patient has a chronically high PaCO 2 the
veins may be dilated and if the arms are stretched out a
flapping tremor may be observed (Cummings & Semple 1973).
Two patterns of CAL can be distinguished clinically the
'pink puffer' and the 'blue bloaters'. Most patients
display some features of both manifestations. It was
originally felt that the 'pink puffers' suffered
predominately from emphysema and therefore a pathological
difference existed between the two groups (Burrows 1966).
It is now believed that generalised emphysema may occur in
'blue bloaters'. Flenley (1990) suggests that the
differences, although based upon clinical assessment, may
be due to inherent differences in the ventilatory response
to hypoxia. The 'blue bloaters' have a congenitally poor
response to hypoxia, whereas the 'pink puffer' has a very
brisk response.
The 'pink puffers' tend to present late in life around 70
years old (Howard 1990) following a history of increasing
dyspnoea, the patient is always breathless with a
hyperinflated chest and characteristically thin but is not
usually cyanosed (Kumar & Clark 1987). Arterial blood gases
show mild hypoxia (Flenley 1990). The 'pink puffer' has an
excessive respiratory drive causing intractable dyspnoea
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(Howard 1990) which becomes severe after only mild exercise
(Cochrane 1984). The 'blue bloater' presents commonly at
around 60 years of age (male to female ratio 5:1) and is
usually obese with a history of smoking. The patient may
not be particularly breathless, has severe central
cyanosis, is oedematous and hypoventilates with little
respiratory effort (Flenley 1990). As a consequence these
patients have arterial blood gases which demonstrate
hypercapnia. In some 'blue bloaters' the normal stimulus to
respiration (increased CO 2) is replaced by a hypoxic drive,
it is thought that this may be due not to insensitivity to
the increased levels but to the inability of the lung to
increase the rate of ventilation. The 'blue bloater' often
has cor pulmonale, a term defined as right heart
hypertrophy associated with parenchymal lung disease
(unlike the 'pink puffer') (Howard 1990).
Many patient with CAL cannot be categorised into one of
these groups but demonstrate some features from each. The
two groups tend to represent opposite ends of the spectrum.
2 . 2 THE ASSESSMENT OF PATIENTS WITH CAL
Lung function tests are used to identify or exclude
respiratory disorders and to quantify the impairment (Spiro
& Roberts 1991) . The simplest test of lung function is a
forced expiration requiring minimal equipment and
calculations but it also provides considerable information
(West 1987). The forced expiratory volume is the volume of
gas that can be exhaled in one second (FEVO after a full
inspiration. This measurement and the forced vital capacity
(FVC) can be measured by spirometry. The FEV 2 depends on
several factors including the size and elastic properties
of the lung, the diameter of the airways and collapsibility
of the airways walls (Gibson 1990). In CAL the reduction in
the spirometry values is due a combination of obstructive
changes in the small airways and destructive changes in the
acinus (Pride 1990b). Consequently, loss of lung recoil
associated in particular with emphysema reduces the
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distending force on all the airways and, in conjunction
with intrinsic narrowing enhances dynamic airways
compression, resulting in expiratory flow limitation
occurring at lower pressures and flow rates. The FEV//FVC
ratio is again lower than the 70-80% predicted normal value
(Spiro & Roberts 1991). In health it is the upper airways
that contribute to airways resistance whereas in CAL it
tends to be the small airways that make the major
contribution to airways resistance (Pride &Macklem 1986).
The FEV/ values are mainly influenced by the large airways
of the lung and in the early stages of CAL the disease in
the small airways may not influence the FEV1 values, in
fact quite considerable obstruction can be present before
a drop in lung function is observed (Pride 1990b). If the
patient has severe obstruction there may be changes in the
central airways that contribute to expiratory flow
limitations when combined with dynamic compression during
the FENT / manoeuvre, and may even occur on tidal breathing
(Pride 1990b). When the patient develops abnormal
breathlessness on exertion standard tests of lung function
including the FENT/ values are abnormal. Many other
parameters can be calculated from the spirometry but there
is no evidence that they provide any more useful
information than the FENT/ and the FVC (ATS 1986). Repeat
spirometric readings are useful in the assessment of
airways reversibility and after the administration of drug
therapies to assess their effectiveness (ATS 1986).
The peak expiratory flow (PEF) is also a widely used lung
function test It measures the maximum expiratory flow rate
over the first 100 milli-seconds (Gibson 1984). Patients
with CAL demonstrate a persistently lowered PEF, this test
is dependent on the patient's effort. Spiro & Roberts
(1991) suggests that the FEV1 and FVC are relatively
independent of effort.
Flow volume curves are useful in detecting mild changes
in airway function. The inspiratory and expiratory flow
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rates are plotted against volume. Pride (1990b) proposes
that the peripheral narrowing occurring in CAL should
become apparent in the final stages of the expiratory
flow/volume curve towards residual volume (RV), the gas
remaining in the lungs after maximal expiration. This has
not been conclusively demonstrated in clinical practice. In
chronic bronchitis the expiratory flow rate is decreased
throughout the expiratory curve. In emphysema the flow is
reduced because of the airways' tendency to close which
results in a dramatic reduction in flow (Spiro 1991).
Spirometry does not allow the measurement of RV or the
FRC or TLC. These can be measured using a body
plethysmograph or helium dilution techniques. Both
techniques demonstrate an increase in RV, FRC and TLC in
patients with CAL (Clausen 1990). Plethysmography appears
to reveal a larger increase in FRC and TLC than helium
dilution techniques. Pride (1990b) suggests that the former
may overestimate lung volumes as the technique measures
trapped gas whereas the latter only measures the gas that
communicates with the airways. Changes in the elastic
properties of the lung allow the lung to achieve greater
lung volumes despite a normal chest wall (Spiro & Roberts
1991). This occurs particularly in patients with emphysema
where the elastic support of the lungs is lost and the
airways close at abnormally high volumes (West 1987).
Elevated FRC may play an important role in the development
of respiratory muscle weakness, fatigue and dyspnoea
(Clausen 1990). The RV is a result of the force generated
by the expiratory muscles and the opposing tendency of the
thorax to recoil outwards at low lung volumes. In CAL
airway narrowing and/or the loss of elastic recoil,
allowing dynamic compression allows gas trapping and an
increase in the RV, commonly an early feature of CAL.
CAL is frequently associated with a reduction in the
diffusing capacity for carbon monoxide (DLco) (ATS 1986).
The value of this depends on the ventilation/perfusion
match and provides an estimate of the surface area
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available for gas exchange. The transfer factor is
dependent upon gas passing from the alveoli to the
capillaries and in turn this is dependent upon the gas
reaching the alveoli. In any patient with airflow
limitation this will be reduced and is compensated for by
using an inert gas (helium) to facilitate the measurement
of alveolar volume. The division of the alveolar volume
into the transfer factor gives the transfer coefficient
(Kco). The Kco is normal in patients with mainly
irreversible airflow limitation but is reduced in patients
with predominately emphysema (Partridge 1982). Clausen
(1990) cites evidence to suggest that the measurement of
DLco correlates well to the pathological assessment of
emphysema. The American Thoracic Society suggest that the
measurement of DLco in conjunction with the measurement of
lung volumes may be useful in the initial assessment of
those patients suspected of having CAL, but for follow-ups
FEVI and FVC is adequate.
Other commonly used laboratory based methods of
assessment and diagnosis of this patient group include
blood gas analysis, chest x-rays and sometimes sputum
analysis.
An impairment in the efficiency of the lungs to deliver
oxygen or eliminate carbon dioxide becomes apparent when
analyzing a sample of arterial blood. Patients with CAL
demonstrate hypoxaemia and with increasing severity of the
disease, hypercapnia. Pride (1990b) states that there is
considerable potential for the arterial blood gases to vary
independent of the severity of the airways obstruction.
This variation depends upon primarily on the V/Q mismatch
and also alveolar hypoventilation. In this situation the
alveolar oxygen partial pressure drops due to the
development of raised partial pressure of arterial (Pa) and
alveolar(PA) carbon dioxide (CO2). Flenley (1990) suggests
that blood gas analysis confirms the diagnosis of 'pink
puffers' and 'blue bloaters'. The former demonstrating mild
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hypoxaemia (8.0 - 10.0 KPa) and a low or normal arterial
PCO2 (4.0 - 5.3 KPa), the latter tending to have a low Pa02
(5.3 - 8.0 KPa) and high PaCO2 (6.0 - 8.6 KPa). Normal
values for the partial pressure of arterial oxygen and
carbon dioxide are 12.6 and 5.3 KPa respectively
(Aitkenhead & Smith 1990).
There is a thought to be a link between the reduction in
the FEV1 and declining Pa02 . The PaCO2 is thought to remain
within normal limits until the FEV1 falls below 1.2 - 1.5
litres (Lane 1968). The blood analysis may also reveal
secondary polycythaemia, particularly in the patients
categorised as 'blue bloaters'.
A chest x-ray is an important investigation in the
overall management of patients with CAL although they do
not always show distinct features. They are often used to
exclude other diagnoses of airways limitation. The most
common features of this patient group are seen in the 'pink
puffers'. These patients tend to have hyperinflation of the
lungs associated with a low flattened diaphragm and bullous
lesions are quite common (ATS 1986). Irregular patchy
shadowing may occur inpatients with CAL representing areas
of fibrosis and possible bronchopneumonia (Cole & Mackay
1990). The characteristic x-ray of the 'blue bloater' with
cor pulmonale will show an enlarged heart and prominent
vascular markings at both hila. Hyperinflation is not as
obvious in this group as those patients with predominately
emphysema (Flenley 1990). However these x-ray findings do
not correlate well with patients' symptoms and the severity
of the airflow limitation (ATS 1986, Clausen 1990).
All the above tests rely on objective findings assessed
by the medical practitioner. To judge how the patient is
affected both physically and psychologically by his
respiratory disease, questionnaires are frequently
employed. An alternative subjective assessment of the
airways limitation is to ask the patient about their
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perceived breathlessness.
Breathlessness/dyspnoea can be defined as 'an awareness
of the act of breathing, usually occurring when ventilation
or the effort required to ventilate the lungs is
excessive' (Howell 1990), or alternatively 'occurring when
the demand for ventilation exceeds the patient's ability to
respond' (West 1987). The feeling of breathlessness can
manifest itself to the patient in a variety of ways, ie the
patient could complain of 'chest tightness', 'an inability
to fill the lungs' or simply 'difficulty in breathing'. The
feeling is a personal sensation which is strongly
influenced by the individual's psychological state at the
time of assessment and not a physical phenomenon that can
be quantified objectively, (Sweer & Zwillich 1990). There
is no one simple explanation of the cause of dyspnoea,
however a number of contributing factors have been
suggested. Altose (1985) proposed a variety of signals that
may be responsible for mediating the sensation of
breathlessness including the chemoreceptors in the blood
and brain, mechanoreceptors in the thorax and outgoing CNS
respiratory motor commands.
An increase in the ventilatory drive is produced by
hypoxaemia, hypercapnia, acidaemia and exercise inpatients
with CAL. Leblanc et al (1986) suggested that respiratory
effort may be linked to dyspnoea, and he demonstrated that
in general the sensation of dyspnoea increased when
ventilation reached a high percentage of the maximum
voluntary ventilation. The length-tension relationship of
the respiratory muscles is thought to influence dyspnoea.
The muscle spindles lie parallel to the muscle bundles and
signal whether or not the expected change in muscle length
has taken place following a central motor command to the
respiratory muscles. If breathing is limited due to
increased resistance or the lungs are hyperinflated as in
CAL the expected amount of shortening may not occur for a
given motor command, consequently the sensation of dyspnoea
may be generated due to this
	 'length-tension
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inappropriateness' (Howell 1990, Sweer & Zwillich 1990).
This has been disputed by Freedman et al (1987) who noted
that the reflexly stimulated increases in ventilation to
the point of breathlessness was not matched by the same
sensation when the increase in ventilation were volitional.
Adams & Guz (1991) suggests that this may indicate
breathlessness depends upon a degree of reflex stimulation
of the respiratory muscles.
Hypoxaemia and hypercapnia evoke the sensation of
dyspnoea but produce shortness of breath due to the
stimulation of the carotid bodies in hypoxic patients and
via direct stimulation of the brain stem in patients with
a high PaCO2 . Swinburn et al (1984) demonstrated the effect
of hypoxia on breathlessness in patients with CAL. He found
that the administration of 02 during exercise prevented the
previous falls in oxygen saturation and also an improvement
in the breathlessness.
In patients with CAL the sensation of breathlessness is
multi-factorial. The predominant factor is thought to be
related to the hyperinflation of the lungs (Howell 1990)
and the influence this has upon the respiratory muscles
(Sweer & Zwillich 1990). Lung hyperinflation results in the
diaphragm being flatter than normal and therefore forced to
operate within a non-optimal portion of the length-tension
curve. In the normal lung the optimal position for
diaphragm contraction is at FRC but in CAL the muscle is
shortened and requires a greater motor input to evoke a
satisfactory shortening (Rochester 1991). The actual
configuration of the diaphragm is altered, normally the
diaphragm increases in both the transverse and anterio-
posterior diameters of the chest when contracting, but in
the hyperinflated chest the lower ribs may in fact be drawn
in (Howell 1990). [It is thought that when a patient leans
forwards in an attempt to relieve the dyspnoea the
diaphragm is pushed proximally into a more efficient
position (Cielsa 1989)]. The hyperinflated lung also
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disadvantages the inspiratory muscles as they too have a
reduced resting length as compared to normal which reduces
the maximum tension they can develop (Folgering et al
1991).
Altose (1985) states that the sensation of breathlessness
can be represented as a function of the conscious awareness
of the outgoing motor commands to the muscles of
respiration as the afferent signals are responsible for the
evaluation of muscle tension but the efferent signal is
responsible for the sense of effort.
The assessment of dyspnoea is difficult because it is
something that the patient feels and is affected by both
emotional and environmental factors and cannot be measured
accurately. One of the earliest approaches was to relate
exercise ventilation to a maximal voluntary ventilation.
This ratio V' E/MVV was termed the 'dyspnoea index'. More
recently this relationship has been used to describe the
ventilatory reserve during exercise rather than dyspnoea
(Clarke 1991). An easily applied scale is required that can
reveal the functional impairment experienced as a result of
the breathlessness (Sweer et al 1990). There are a handful
of commonly used scales that are applied in a clinical
environment to assess the severity of the sensation and its
limitations, alternatively an exercise test can be used to
formally assess the degree to which dyspnoea limits
function. The commonly used scales that can be easily
administered in clinics include the Medical Research
Council (MRC) breathlessness scale (1966) and the Oxygen
cost diagram (McGavin et al 1978).
The first scale requires the patient to choose a verbal
description that describes their sensation of
breathlessness and the associated functional limitations
ie, indicate the point were breathlessness would be
present. The descriptions are divided into categories, for
example (using the MRC scale) the patient may choose from
one of three options (eg, '3. have to stop for breath when
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walking at own pace on level ground'). The Oxygen cost
diagram requires the patient to mark on a line the level
which corresponds to the point where their breathlessness
would not allow them to continue. Along side this line is
a list of daily activities. McGavin et al (1978) found that
the distance that patients were able to walk on the 12-
minute walking test correlated well with the point marked
on the Oxygen cost diagram. An alternative to this
'categorical' assessment is to use a visual analogue scale
(VAS). A 10 cm line labelled from 0 to 10 is commonly used
and the patient marks along the line the intensity if the
sensation. For this method the stimulus-response is treated
in a linear fashion (Jones 1988) and the patient assigns a
numerical value to a sensation.
The modified Borg scale (1982) is commonly used to assess
patients perceived breathlessness in response to clinical
exercise testing. The adjectives range from 'nothing at
all' to 'maximal' and are assigned a value ranging from 0
to 10. The scale presents a combined category and ratio
scale and has been suggested possess interval properties
(Appendix B) allowing analysis using parametric statistical
tests. This however may not be an entirely valid assumption
and the use of non-parametric statistical tests may be more
valid. This discrepancy has lead to the divergence of
analysis of results; Belman et al (1991) Silverman et al
(1988) and Wolkove et al (1989) applied rank transformation
to their Borg data whilst Killian (1985) applied tests
appropriate to interval data. However, if patients were
asked to adjust their level of exercise so that their
perceived rate of breathlessness was halved, the level of
exercise may not coincide with the level chosen. Borg
(1982) proposed that the scale allows a inter-individual
comparison to be made. The category scale increases
linearly as exercise intensity increases and is closely
correlated to physiological responses that also increase
linearly such as heart rate (ACSM 1991). This was
demonstrated by Muza et al (1990) on patients with CAL.
They compared the VAS(30 cm) with the unmodified Borg scale
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(numbers ranged from 6-20 and described the sense of effort
associated with breathing) during incremental exercise in
patients with CAL, the results showed that both test scores
increased linearly with oxygen consumption. They also
suggested that the VAS was more sensitive than the Borg,
possibly a reflection on the categories of the Borg scale
and the fact that the line was 30 cm for the VAS.
The reproducibility of the Borg scale was assessed in
patients with CAL by Belman et al (1991). They found that
the Borg rating decreased progressively with repeated
testing at sub-maximal levels. Silverman et al (1988)
concluded that the Borg scale was highly reproducible in
patients with stable CAL. For this project the patients
were required to repeat maximal exercise tests which
decreased the variability of the Borg score seen during
repeated sub-maximal tests (Belman et al 1991). Wolkove et
al (1989) investigated the relationship between the scoring
on the Borg scale and the spirometry results before and
after bronchodilators for a large number of patients with
CAL. They concluded that the Borg scale related poorly to
the spirometry. The Borg scale did however identify a
reduced sensation of dyspnoea post-treatment not shown in
the FEVI values.
Breathlessness can also be assessed from an alternative
perspective, the employment of quality of life measures.
These can indicate the impact that the patients
breathlessness and other manifestations of respiratory
disorders have upon their daily life, and therefore relate
to the quality of life. Questionnaires were developed to
aid the overall evaluation of functional status and to
reveal any hidden links between directly measured
pathophysiological parameters and a patients quality of
life. It is well recognised that disability does not relate
well to conventional lung function tests (McGavin et al
1978).
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The first quality of life measure designed for the
specific assessment of patients with chronic respiratory
disorders was the Chronic Respiratory Disease Questionnaire
(CRDQ)(Guyatt et al 1987)(Appendix C). This questionnaire
based upon previously identified areas (Guyatt et al 1987)
examines four aspects of patients lives; dyspnoea, fatigue,
emotion and mastery (the feeling of control over the
disease). The questionnaire consists of 19 questions.
Dyspnoea is evaluated by asking the patient to identify the
five most important activities which they do frequently and
are limited by dyspnoea. These can be volunteered
independently or taken from a list. These activities are
identified on the first administration and used for
repeating the CRDQ. The responses for all the questions are
based upon a seven point Likert scale. The questionnaire is
both reproducible and responsive. The responsiveness of the
CRDQ was confirmed by examining patients taking part in a
rehabilitation programme. For the validity study patients'
results on the CRDQ were compared with several other
measures, including FEV 1 , the six minute walking test and
the Oxygen cost diagram (McGavin et al 1987). In general
moderate correlations were found between the changes in the
CRDQ and changes in the other measures. It was found that
there was a moderate relationship between the dyspnoea
score and the six minute walking test but the six minute
walking test was less well correlated with the 'emotion'
score. Guyatt et al (1987) concluded that the CRDQ was
highly reproducible and responsive enough to detect changes
in the quality of life in small sample groups. It should be
noted that the data generated from this study was examined
using parametric statistical analysis, primarily, according
to the authors because this was the most familiar form of
analysis to the readers.
In 1989 Guyatt et al used the CRDQ and other outcome
measures (including Oxygen cost diagram) to assess the
effectiveness of bronchodilators in CAL. The CRDQ dyspnoea
score presented the highest correlation values for the
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change in the measures and the changes in the variables
(spirometry, six minute walking test and a breathlessness
VAS post walking test).
Jones (1991) highlights some of the problems associated
with the CRDQ. He proposes that by allowing an individual
to choose activities which make them feel short of breath
the questionnaire is not standardised and does not allow a
score to be calculated.
Weir et al (1991) identified a problem when using the
CRDQ in patients with cystic fibrosis. They found that this
group of patient identified fewer activities that induced
breathlessness and had to alter the scores to allow a
comparison to be made between these patients and patients
with CAL. However when using the CRDQ to assess patients
with CAL it is sensitive to change, reproducible in stable
patients, allows for statistical comparisons to be made on
repeat questioning and is easy to administer (Morgan 1991).
The St Georges Respiratory Questionnaire (SGRQ) has
recently been introduced to assess both CAL and asthma
patients (Jones et al 1991). It is proposed that this test
is more standardised than previous questionnaires and
consists of seventy-six items divided into three sections
(symptoms, activity and impacts). The questionnaire it was
reported, correlated well to other reference values
[including spirometry, FEV, r=0.22 and the six minute
walking test r=0.36 (Jones et al 1990)] and was related to
more general measures of health eg. The Sickness Impact
Profile (Bergner et al 1981), although the former appeared
to be more sensitive to a wider range of diseases (Jones
1991).
27
2.3 EXERCISE TESTS FOR THE ASSESSMENT OF FUNCTIONAL
CAPACITY IN PATIENTS WITH CAL.
2.3.1 Introduction
The assessment of exercise tolerance in patients with CAL
provides an objective index of their disability and reveals
functional abnormalities not present in measurements made
at rest. However, laboratory assessment is not always
available. In addition, formal laboratory testing requires
skilled technicians, is expensive in terms of the equipment
required (eg. treadmills, cycle ergometer and gas analysis
equipment) and can be quite intimidating to the patient. As
a consequence of these limitations field tests were
developed as a cheap, simple and effective alternative
method of assessing disability. Field tests are frequently
employed by physiotherapists in the assessment of a number
respiratory conditions including CAL.
Exercise testing in patients with CAL is an important
tool in the assessment of functional capacity. A well
recognised problem is that spirometric values from these
patients do not match their ability to exercise. It would
seem reasonable to suggest that a patient's static lung
function test results should relate well to their exercise
tolerance, but this is not the case and most studies reveal
a poor relationship between the two (McGavin et al 1978,
Swinburn et al 1985). Simple exercise tests are therefore
employed to reveal the true extent of disability and assess
a patient's ability to perform day to day activities.
Secondly an exercise test can objectively characterise the
true extent of a patient's disability. Patients accounts of
their own functional capacity is notoriously under/over
exaggerated and an exercise test can help to distinguish
dyspnoea associated with anxiety from cardio-respiratory
disease (Spiro 1977). Health service workers also need to
assess a patient's response to treatment
(drugs/physiotherapy) and in the case of exercise
rehabilitation for these patients it has been shown that
lung function values alter very little (Simpson et al 1992)
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and in these situation it is more appropriate to use an
exercise test to gauge a patient's response to treatment.
Research examining 'traditional' chest physiotherapy for
these patients has also documented very little change in
these reference values (Gallon 1991, Sutton et al 1985).
However a change may be apparent by exercise testing and
consequently more credibility assigned to these 'custom &
practice' modalities of treatment. Many drug interventions
may also appear to have an enhanced effect if the
researches combined the traditional lung function values
with exercise testing. An exercise test can also indicate
the limitations to exercise, ie respiratory or
cardiovascular and therefore be of use in the differential
diagnosis of a patients condition. Despite field testing
being considered a relatively crude form of testing it is
possible to differentiate between cardiac, respiratory or
peripheral limitations (eg muscle fatigue) to exercise.
However a more specific diagnosis can be made with
laboratory testing.
2.3.2 Requirements of a simple exercise test
An exercise test should be simple for both the operator
and patient to use and based upon an activity familiar to
the patient. For this reason walking tests are preferred to
cycle ergometry and step tests. To assess patients'
disability the exercise test should stress the cardio-
respiratory system to a symptom limited maximum (see
below).
Any protocol used must also be reproducible and,
consequently, capable of providing meaningful results. At
least one practice test is required, often more (Mungall &
Hainsworth 1979), to familiarise the patient to the test
and minimise any training or learning effect. For a test to
be reproducible the protocol and conduct should be both
standardised and consistent.
Both walking and step tests represent a form of exercise
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testing that can be performed outside of the laboratory
environment. The former is often the preferred mode of
testing being an activity familiar to the patient.
Nevertheless step testing is frequently used to assess
cardiac function. A number of step test protocols are
employed which the changes of work rate can be made by
altering the step height and the frequency (Nagle et al
1965). The disadvantages associated with step tests relate
mainly to the fact that the amount of work done is
difficult to measure and is dependent on the patient's
weight (Wilmore 1984). Jones (1988) suggests that it is
also difficult to measure the power because of the
difficulty in gauging the work done in stepping down. The
patients for whom stepping is an unfamiliar activity the
limitation to exercise may be caused by local muscular
fatigue rather than due to a symptom of their respiratory
disorder. A small area of space is required to perform the
test may make it preferable to a walking test in some
situations. A variety of opinions exist as to whether it is
relatively easy to make physiological measurements (eg HR)
as the patient is confined to a small area or alternatively
because of the considerable vertical displacement the
results have to be viewed with caution (Wilmore 1984).
Swinburn et al (1985) assessed the usefulness of step
testing in patients with CAL and he found a 96% improvement
in performance from test one to test four. He also found
that the maximum ventilation (Vs) and oxygen consumption Vo2
were significantly greater in the paced fixed height step
test than in the self paced walking test (12 NWT - see
below).
2.3.3 Development of the field walking test
One of the first field tests proposed that was not a step
test was developed by Cooper (1968). The twelve minute
running test was used to assess the fitness of male air
force officers. Performance on the field test had a strong
relationship with laboratory determined maximal oxygen
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consumption (7o2 ) data (correlation coefficient of
r=0.897) considered to be the traditional indicator of
cardio-vascular fitness. An individuals' maximal aerobic
power plays a decisive role in his/her physical performance
(Astrand & Rodahl 1986) and is regarded as the best
physiological measurement of endurance performance. McGavin
et al (1976) suggested that a downgrading of this test to
a twelve minute walking test (12 MWT) would be appropriate
in the assessment of patients with CAL. The reproducibility
of the test was assessed on twelve in-patients over a three
day period. This test, conducted along a hospital corridor,
advises patients to " Cover as much ground as you can in
twelve minutes. Keep going continuously if possible, but
don't be concerned if you have to slow down to stop and
rest. The aim is to feel that at the end of the test you
could not have covered any more ground in the time." A
doctor accompanied the patient acting as a time keeper and
gave encouragement as necessary. Taking into account the
variation in spirometry (the test was not conducted during
a period of clinical stability) McGavin and colleagues
(1976) found that there was a significant difference
between test 1 and 2 but a further increase on test 3 was
not significant. The mean percentage improvement in
distance walked for test 1 vs 2 was not documented but the
mean change for test 2 vs 3 was 7.33%. The 12 NWT exhibited
only moderate relationship with the peak oxygen uptake (th
peak ) (r=0.52) (McGavin et al 1976). Therefore only 25% of
the variation recorded in the walking distance was
explained by the variation in the to 2peak . The latter was
measured during a progressive exercise test performed on an
electrically braked cycle ergometer, and the t02peak reached
during this form of exercise can be up to 10% lower than
that obtained during treadmill walking (Astrand & Rodahl
1986). This need not decrease the strength of the
relationship if the difference between the cycle '(To 	 and
treadmill t02peak is systematic, but it may not always be. In
conclusion, it was suggested that the 12 minute walking
test must be carried out twice before the distances
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recorded are reproducible (McGavin et al 1976).
A six minute walk (6 MWT) was presented by Butland et al
(1982). The group initially studied the usefulness of 2, 6
and 12 minute walks in patients with CAL. The tests were
conducted in a similar manner to the 12 NWT except that
encouragement was standardised. Two practice 12 MWT's walks
were required before entry into the study. They found that
performance on the 6 MWT related well the performance on
the 12 MWT distance (r=0.95). Although the implication is
the 6 minute walk is reproducible no direct evaluation of
the reproducibility of the 6 MWT was performed in this
study. These 6 and 12 minute walking tests are the most
commonly used self paced walking field tests for the
assessment of various drug and therapeutic interventions.
There have been a few additions to these two most popular
walking tests to measure disability in patients with CAL.
One is the 100 in walk proposed by Morrice and Smithies
(1984). The authors felt that the 'traditional' corridor
tests could be too challenging for the more severely
affected patient. Patients were therefore required to walk
300 in in total, by walking successive 50 in lengths of
corridor. The authors found that the time taken to complete
the third 100 m correlated well with the 12 minute walk
distance. The mean distance that the patients walked for
the 12 NWT was 778 m, it could be that for some of the
patients this 300 in walk may confer little time benefit
over the 6 MWT. Davidson et al (1988) suggested an
endurance walk, for this the subject is instructed to walk
as far as possible (at a pace as though late for an
appointment) and to stop when unable to go any further. The
endurance time and distance covered is recorded. Recording
two variables can cause some difficulty when trying to make
inter-subject comparison. This test was introduced as part
of a study examining the affect of supplemental oxygen on
exercise ability in patients with CAL. They also used the
6 MWT as an outcome measure (after 3 practice walks). Their
results showed that the endurance walk (distance and time)
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revealed a greater effect of the treatment than the 6 MWT
(17% vs 59% improvement of distance) although the number of
practice walks performed for the endurance walk is not
documented.
The most recent development in this area is the use of
the 20m shuttle running test to examine the incidence of
exercise induced asthma and concurrently reveal levels
physical fitness in school children (Freeman et al 1990).
This field test is based upon the 20m shuttle running test
(Leger and Lambert 1982) now widely used to assess the
functional capacity of sportsmen and women. There was a
strong relationship between the athletes' shuttle running
performance and t02 (r=0.84) (Leger and Lambert 1982).
This test represents a new direction in field testing. The
speed of running is externally paced and progressive, being
dictated by audio-signals played on a tape recorder. As the
speed of running is dictated by the tape, the influence of
encouragement and motivation is limited.
2.3.4 Problems associated with field walking tests
There has been extensive work using the six and twelve
minute walking test as a research tool in the assessment of
various therapeutic interventions. However its reliability
does remain in question. The details of the protocols are•
not standardised and the lack of uniform instructions for
the operator or the patient results in a variety of test
procedures being adopted. This lack of standardisation is
apparent in several aspects in the conduct of the test, for
example the variables a) whether the doctor/physiotherapist
walks alongside the patient throughout the test, which it
could argued is in itself a form of pacing and b) what if
any form of encouragement is offered. An obvious practical
dilemma is locating a corridor of adequate length to
perform the 6 or 12 minute walk that is free from obstacles
and the outside influence by visitors or other hospital
personnel.
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Reproducibility also presents a problem for these self
paced tests, as a measurement that is totally unrepeatable
clearly has no validity (Chinn 1991). It has been suggested
that 1, 2, or 3 practice walks may be necessary to
counteract any learning or training effect (Knox et al
1988, Mungall & Hainsworth 1979 Swinburn et al 1985). Knox
et al (1988) identified a 33% increase in the 12 MWT
distance over walks 1 to 12 performed over three
consecutive days, half of this increase occurred during the
first three walks. An 8.5% increase was observed in repeat
testing that occurred over a four week period. In the
conclusion it is suggested that five practice walks are
required before the learning effect appears to plateau when
testing at short intervals and four practice walks are
required if the testing interval i6 greater.
Swinburn et al (1985) identified a similar magnitude of
improvement of 16% for the first four tests performed
during consecutive days and although a placebo was
administered between test three and four no effect on the
exercise was detected. This work suggested that three
practice 12 MWT are necessary before the effect of any
intervention can be measured and even then it may be
important to consider the effects of repeat testing.
Mungall and Hainsworth (1979) also identified a
significant increase in the 12 MWT distance in 13 patients
with CAL tested six times at intervals of two or three
weeks (no numerical value was assigned to the increase). At
the same time a variety of standard respiratory tests were
completed and these values did not alter significantly.
Again it was conclude that three practice walks were
required to obtain reproducible values.
If reproducibility of the test is in the order of 5-10%
improvement with repeat testing, then it would only be
possible to identify treatment effects that produce more
than a 5-10% increase in performance. Consequently
researchers may fail to identify real effects or
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alternatively wrongly assign a treatment effect. Quite
variable results have been recorded for the 12 MWT distance
in the above and other clinical trials despite the patient
groups being similar in their physical characteristics
(Swerts et al 1990, Beaumont et al 1985, McGavin et al
1976).
Guyatt et al (1984) demonstrated that the effect of
encouragement during the walk could significantly increase
performance. He randomised 43 patients with either CAL or
chronic heart failure or both to receive or not receive
encouragement as they performed a series of 2 and 6 MWTs.
The effect of encouragement constituted a 30.5 in increase
in walking distance for the 6 MWT over tests three to six.
The effect of repeat testing appeared also greater in the
group receiving encouragement and the patients with CAL
showed a greater improvement with repeat testing than did
the cardiac patients. The administration of encouragement
could in fact account for the 'positive' treatment effect
in studies that used the 6 or 12 MWT as an outcome measure
(Cockcroft et al 1981, Sinclair & Ingram 1980, Pardy et al
1981, Leitch et al 1981, Belman & Mittman 1980).
Consequently when reviewing original research the protocol
should be carefully scrutinised for standardisation and the
verbal encouragement controlled. As an example, Pardy et al
(1981) studied the effect of inspiratory muscle training
and 'physiotherapy' in patients with CAL. The patients were
required to perform just one practice 12 MWT prior to the
intervention and no indication is provided regarding the
conduct of the test. After inspiratory muscle training the
12 NWT distance increases by 59 in (10.4%). This apparent
treatment effect could also be accounted for by either the
effect of repeat testing as the learning curve will not
have plateaued after just one attempt or due to the
positive effect of encouragement. Physiotherapy appeared to
have a 4 in (3.6%) improvement in walking distance which is
an insignificant improvement.
Swinburn et al (1985) suggest that the habitual nature of
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walking may prevent a self-paced walking test from
demonstrating fully the possible beneficial effects of any
treatment. In the same way that the operator can influence
the outcome, so can the patient's mood, often affected by
how he feels he should perform. As mentioned above, there
is only a moderate relationship between 'Oro2p,k and walking
performance measured on these tests, in patients with CAL
(McGavin et al 1976).
Day to day activities are mostly of an irregular nature
with a steady state rarely being achieved. Most clinical
problems and their associated symptoms lead to a premature
limitation of exercise tolerance which is most likely to be
revealed or identified during an increasing work rate test
(Spiro 1977). An incremental test suitable for a wide range
of patients and valid results are obtained regardless of
how much exercise stress the patient is able to tolerate.
Therefore an incremental test can provide an objective
assessment for a range of patients, from those with severe
CAL to those whose function is minimally effected. Because
the pace is externally controlled the effect of motivation
and encouragement is minimised.
External pacing also allows for valid inter-subject
comparison. Patients who have completed 500 metres in an
incremental field walking test have experienced an
equivalent 'work rate'/stress. This however cannot be
concluded from patients completing similar distance in the
6 or 12 MWT and any comparison made as to their respective
functional capacity would be invalid. A standardised
incremental walking test would allow for a more objective
comparison of any intervention to be made. An improvement
in a patient's exercise capacity is immediately apparent
when a patient repeats an incremental test and easily
recorded but the same improvement is often not as obvious
in a self paced test. For example a patient on his first
recorded walk (not including practice walks) may walk 500
metres. After a course of physiotherapy/drugs the repeated
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walking test may again record 500 metres but the patient
approach to the two walking tests could have been quite
different. In the first test they may have sauntered along
the course but for the second walk they could have walked
considerably quicker for the first 4 minutes and slowed
down for the last 2 making the overall distances
comparable. To the operator it would have been apparent
that the patient's ability to exercise at a higher capacity
had improved but not at all obvious to a second person
assessing the patient's results. The 12 and 6 MWTs can be
time quite consuming as they require at least two practice
walks.
2.3.5. Laboratory assessment
Laboratory assessment is both expensive in terms of the
equipment required and quite intimidating to the patient
and as a result of these limitations field exercise tests
were developed. Field tests are easy to administer but have
the disadvantage that usually the pulse, ECG and
respiratory rate can only be measured after exercise or
with telemetry devices. It is impossible or very difficult
to measure /E, t02 or Nlco2 (carbon dioxide). If this breadth
of information is required it is usually necessary to
perform a laboratory based test. This is usually performed
using either a treadmill or a cycle ergometer.
In the mid-eighties a compromise between the self-paced
field test and laboratory assessment was proposed, a self
paced treadmill test (Beaumont et al 1985). The patients,
as in the 12 MWT were allowed to control the speed of
treadmill walking and during this test various
physiological parameters were monitored. The distances
covered for treadmill test two vs test three was not
significantly different, nor was the distance between the
corridor and treadmill test. However this distance did
become significantly different for the treadmill test when
measurements of gas exchange were made that required the
patients to breathe through a mouthpiece. In conclusion it
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was suggested that patients may prefer this type of testing
over progressive treadmill tests which may be frightening
to them and being able to quantifying the rest periods may
be of use in assessing the limits to everyday activity.
Contrary to the results of Beaumont et al (1985) Swerts et
al (1990) identified that patients walked significantly
further during the corridor test than during a self paced
treadmill test (no equipment worn) although the maximal
heart rate and breathlessness score were not significantly
different. This suggests that the patients experienced a
similar level of stress for the two protocols and were more
familiar with the corridor walk.
There exists a wealth of incremental treadmill protocols
that are varied in their speed, inclination or both to
assess the breathless patient. They allow detailed cardio-
respiratory measurements to be performed. The majority have
their origins in the assessment of cardio-vascular
disorders. The most widely used is the Bruce protocol (ACSM
1991). The protocol involves a change of speed and
inclination every 3 minutes. These increases of exercise
intensity are relatively large and consequently the test is
usually quite brief. A disadvantage of this approach is the
high oxygen cost of the initial stage and each increment
(Jones 1988). The ACSM suggest a 10-20% error in the
estimation of 7o2p,,k due to the large increments of the test
exceeding the o2 uptake mechanisms in most patients. The
Balke protocol keeps the speed constant and the gradient is
increased from zero by equal steps of 2.5% every minute. A
modified Balke protocol (Balke 1959, Jones 1988) format
again adopts a constant walking speed with increases of 2-
3% every 2-3 minutes. This test is appropriate for the more
severely disabled patient. The ACSM (1991) suggest that
this protocol is more suitable to assess to2peak in patients
because of the gradual rise in exercise intensity.
Very recently Myers et al (1992) recommend that the most
appropriate treadmill test is indeed one that is
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individualised to each patient. McKelvie and Jones (1989)
propose that treadmill testing is the most appropriate form
of exercise testing if a rehabilitation program constitutes
fully or in part an exercise regimen based upon walking.
The treadmill offers a familiar activity to the patient
,perhaps unlike cycle ergometry. Jones (1988) suggests that
some measurements are more easily taken during a cycle
test. Blood pressure and blood sampling is easier for the
operator and breathing through a mouthpiece is easier for
the patient whilst on a cycle. This is because of the
relative stability of the upper body. Practical
disadvantages to the treadmill are the size, weight and
cost of the equipment and some are quite noisy. The major
difference between the two modes of testing is with the
N7o7„,„• In untrained subjects it is usually higher on the
treadmill than on the cycle ergometer. On average this
difference is 5-10% (ACSM 1991). The majority of these
studies applies to a normal population and may not apply
equally well to a patient population (McKelvie and Jones
1989). This difference is possibly related to the
peripheral fatigue of the exercising thigh muscle. However
some patients find it difficult to walk without holding on
to the handrail and this reduces 0 2 uptake (ACSM 1991).
Cycle ergometry has certain advantages over treadmill
testing. The former is relatively inexpensive and quiet and
the work rate is easy to control. Because the body weight
is supported the work rate is definable although for some
individuals the seat may prove uncomfortable and difficult
to maintain. Hansen (1984) suggests that some women and a
few men have difficulty in cycling smoothly. In 1985
Cockcroft et al studied arterial desaturation in 9 patients
with CAL during treadmill and bicycle exercise. A greater
fall was identified during the self paced treadmill walk
than the cycle test. The 1.1o2peak was in fact higher on the
bicycle than the treadmill in contrast to studies on
f normals'(Hansen 1984). They remarked that care must be
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taken when testing patients on a cycle and examining the
arterial desaturation as it may underestimate the
desaturation that occurs with walking.
2.3.6. Sub-maximal versus maximal exercise testing
In the use of both field and laboratory exercise tests
opinion varies as to whether they should be maximal or sub-
maximal. A test should be incremental as fixed level
exercise protocols add little information to that gained
from the resting measurements (Jones 1988). Wilmore (1984)
proposes that sub-maximal (which may be single or multi-
stage) testing with end points determined on predicted
maximal heart rates is not considered desirable as the
standard deviation of predicted maximal heart rate can be
+/-10 beat.min4 . Bruce (1984) supports this view and
highlights that predetermined end points (HR, 02
requirements or work load) are based upon average values
for the 'normal' person. Lung disease can limit exercise at
heart rates less than 130 beat.min 4 and therefore
estimation of the 17o2ma at these low levels may not
possible. Once one of these end points has been reached it
then relies on the patient reporting whether the exercise
represented a high, medium or low fraction of his capacity.
Ideally the exercise protocol should therefore stress the
patient's respiratory system progressively to a symptom
limited maximum performance.
Maximal testing with self determined symptomatic end
points allows individual patients to attain a maximal
performance that is more reproducible than the response to
sub-maximal work load and from these maximal values a
comparison can be made to expected normal values to define
the limitation to exercise and assess the patients 'true'
functional capacity. Spiro (1977) identified that
motivation is important and will vary considerably amongst
patients. Furthermore, an incremental exercise protocol
stresses the cardiovascular system gradually, unlike the
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sub-maximal tests where the stress may be maximal from the
start so an incremental test may be safer for the patient.
2.4 THE NORMAL VENTILATORY RESPONSE TO EXERCISE
It is appropriate to consider the determinants of the
ventilatory response to muscular activity as this provides
a reference point for considering the patterns of abnormal
responses and to identify the site(s) of the system's
limitations.
The performance of exercise requires a co-ordinated
response from the respiratory and cardiovascular system to
transport oxygen from the atmosphere to the contracting
muscles and dispose of carbon dioxide. The normal response
is precisely regulated in response to the metabolic
requirements of the system. The ability to take in and
utilize oxygen depends upon firstly the efficiency of the
respiratory system, ie pulmonary ventilation, diffusion of
the oxygen from the lung alveoli to the pulmonary
capillaries. Secondly, cardiac performance ,ie
redistribution of blood flow to the skeletal muscle and
finally the extraction and utilisation of the oxygen by
the contracting muscle (ACSI41991). However this discussion
will be confined to the response made by the respiratory
system to exercise.
2.4.1 The ventilatory response to exercise
The normal response to exercise is an increase in
ventilation (VI) from the resting 6.0 1.min4 to 100-150
1.min4 (in extreme cases up to 200 1.min4). The increase is
to maintain the physiochemical environment of the
contracting muscle cells (Whipp & Ward 1991) ie, to
transfer 02 and clear CO2 at rates appropriate to their
consumption and production. This increase in tE with
progressive exercise is achieved initially by an increase
in the tidal volume (VT) with a modest increase in the
frequency (these changes occur before there has been any
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alteration in the CO 2 production (Jones 1991)). The changes
occur virtually simultaneously with the onset of exercise
and it has been suggested that the increase in trE is
associated with the increase in pulmonary blood flow (Whipp
& Ward 1991), possibly activated by mechanisms originating
in the right ventricle. The rapid changes in In had
traditionally been considered to be secondary to the
activity of exercising limbs. Subsequent increases in VE
(after 20s) are proposed to be a response to peripheral and
central chemoreceptors by the altered blood gas
composition. As the intensity of the exercise increases a
maximum VT is reached and any increase in 'E is a result of
an increase in the respiratory rate (at maximum exercise
this may reach 50 breath. min' (Pardy 1984)). VE increases
in a linear relationship with 02
 consumption and CO2 output
to approximately 50-60% of the maximal oxygen uptake (1N)2
)(Jones 1988). The maximally attained tidal volume
represents 50-60% of the vital capacity (Gibson 1990). It
is thought that any further increase in the V T is limited
mechanically due to the decreased compliance of the lungs
which in turn is thought to be reduced because of the
increased volume of blood in the lungs causing the tissues
to stiffen (Gibson 1990). With this increase in exercise
intensity is a fall in the end expiratory volume to below
the FRC, this force generated by the expiratory muscles
considerably reduces the pressure generated by the
inspiratory muscles for a given VT (Jones 1991). The ratio
of inspiration/expiratory time remains fairly constant from
rest to exercise (Ti/Ttot 0.35-0.4) as does the ratio of
inspiratory and expiratory flow (inspiration is
approximately 1.5 times expiratory flow) (Grimby 1971).
Grimby et al (1976) indicated that during exercise the
diaphragm generated most of the driving force of the
inspiratory effort and remained within an acceptable range
of the length-tension curve.
The physiological dead space (VD) increases with exercise
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although not as much as the increase in the VT,
consequently the VD/VT ratio which is normally 25-35% at
rest falls to values between 5-20% (Jones 1988). The
implications of these changes in absolute values and the
ratio is unclear (Jones 1991). It is thought that the
airways resistance is reduced with exercise allowing an
increase in the tidal volume. The increase in the VD
potentially worsens gas exchange (V/Q ratio). Whipp and
Ward (1991) suggest that the VD/VT ratio influences the
effectiveness with which VE can clear a given volume of CO2
per minute, also taking into account the alveolar and
arterial pCO2 . A decrease in the latter and a rise in the
VD/VT ratio requires a greater ventilatory response per unit
of CO2
 exchange and vice versa. In the ideal lung the mean
alveolar and arterial pCO 2 is equal and both are determined
by the appropriateness of the alveolar response to the CO2
outpUt of the lungs (Whipp & Pardy 1986). This alveolar
ventilation is influenced by both the level of CO2 output
and the PaCO 2, for example a high #co2 during exercise
requires a large . ventilatory response to regulate the
PaCO2. An increase in the alveolar ventilation - perfusion
ratio further increases the need for the alveolar•
ventilation to increase. However the total ventilatory
response is influenced by the 1co, PaCO 2 and the VD/VT
ratio.
In a steady state and non steady state phases of moderate
exercise the increase in ventilation is closely matched to
the increases in the /m 2 . The coupling of the tco 2 to the
VE response allows regulation of the PaCO2 and the 1-14' in the
steady state and results in only a small increase in the
non-steady state. Consequently it is more appropriate to
consider the relationship between tE and #co2 rather that
considering the effect of the 102 upon tE (Whipp & Ward
1991). However, most types of exercise requiring dynamic
work the increase in the 1o2 is linearly related to the
power output (Jones et al 1985). Wasserman (1967)
demonstrated that changes in tE at steady state work rates
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have a stronger relationship with alterations in Vto2 than
1702 . Non steady state .7'E responses are linear to the 17co2but
not the 1o2 . The linear tE//co2 relationship has a slope of
approximately 25 1.min4 VE per 1.min4 CO2 in healthy
individuals (Wasserman & Whipp 1975). The linear
relationship is preserved despite different test protocols
until a point of sustained lactic acidosis is reached.
This relationship between rising 7co 2 and E during exercise
is recognised but the linking mechanisms are unclear
(Astrand & Rodahl 1986). It is proposed that the stimuli to
increased ventilation is a combination of chemical (acidity
and CO2) and neurogenic signals (Gibson 1990).
CO2 output at a given 17o2 can be altered by a variety of
metabolic factors. This ratio of CO 2 metabolically
generated to 02 consumption is labelled the respiratory
quotient (RQ). The RQ value alters depending upon substrate
utilisation, oxidative metabolism of free fatty acids is
associated with a 30% reduction in Tco2 (RQ = 0.7) as
compared to the tco 2 resulting from the aerobic metabolism
of glucose or glycogen (RQ = 1.0) (Wasserman and Whipp
1975). The implication is that the rate of ventilation
during exercise can be influenced quite markedly by the
fuel source that is used. At rest the RQ value is
approximately 0.8 this tend to rise with exercise to 1.0.
This is however influenced by the duration and type of
exercise performed. The mobilisation of fatty acid stores
can take up to 20 minutes but after this point the longer
exercise continues at low /moderate intensity the lower the
CO2
 output will be.
At the lungs the ratio of CO2/02
 exchange is termed the
respiratory exchange ratio (RER or R). R can differ from
the RQ value particularly during exercise when CO2 can be
stored in the exercising muscle (Whipp & Ward 1991). Brown
and Wasserman (1981) predicts that a substrate mixture
dominated by fatty acid oxidation would be less stressful
to the respiratory system during exercise as opposed to a
44
mixture dominated by carbohydrate oxidation. For prolonged
exercise at a constant work rate the R value decreases. The
result is a slightly increased cost for the work performed
and a reduced CO2 load to be cleared (Whipp & Wasserman
1988). The R value is also altered by the release of
certain hormones that have their effect on fuel metabolism.
The hormonal changes during exercise encourage lipolysis,
there is a reduction in the level of insulin with elevation
of catecholamines which favours the increased mobilisation
of free fatty acids (Calles-Escandon 1984).
2.4.2 Maximal oxygen uptake
The ability to deliver 02 to contracting skeletal muscle
is vital to the performance of exercise. Maximal oxygen
uptake (1o2 ) is an important index of the capacity for
sustained work performance (ACSM 1991). Th2m,„, has been
described as a measure of the functional capacity of the
body (Snell & Mitchell 1984), Astrand & Rodahl (1986)
describe 17o2 more precisely as the 'highest oxygen uptake
the individual can attain during exercise engaging large
muscle groups while breathing air at sea level'. This gives
an indication of the individual's aerobic power and can be
identified by no further increase in the 02 uptake despite
an increased work load. One way in which this can be
confirmed by a blood lactate concentration exceeding 8-9
mmo1.14 (Astrand & Rodahl 1986).
The determinants of 17o2 can be divided into four main
categories; the respiratory system, the central and
peripheral circulation and the muscle metabolism (Snell &
Mitchell 1984). These factors in turn can be influenced by
certain physical attributes to affect the overall
performance in a healthy population. Stature affects the
size of the heart, lungs and muscle. Age affects the
maximal heart rate and the haemoglobin content of the
blood. Exercise training can increase the effectiveness of
the determinants of 'oxygen transport/delivery'. Endurance
training improves the cardio-respiratory response to
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exercise resulting in a higher 1o2 , based upon a higher
stroke volume and an increase in the arteriovenous 02
difference. This type of training also evokes major changes
in muscle oxidative capacity (Jones 1988) (beyond the scope
of this review). Gender influences to2 . Astrand & Rodahl
(1986) suggest that the difference although at first
appears to be significant in fact becomes insignificant
when individual weight is expressed as kilo/fat-free body
mass. The effects of inactivity are quite dramatic causing
the Vo2 to fall. The detrimental effects can be observed
in the muscle and cardio-vascular system (Jones 1988).
2.4.3 Metabolic acidosis
Pyruvate is the end point of glycolysis and the
subsequent fate of pyruvate depends on the conditions of
the cell. The purpose of glycolysis is to produce ATP and
substrates for the tricarboxylic (TCA) cycle for oxidation.
Pyruvate formation is also associated with the reduction of
nicotinamide adenine dinucleotide (NAD + ) to NADH. To
maintain glycolysis, NADH must be reoxidised (to NAD).
This can occur either through oxidation in the mitochondria
or through the action of lactate dehydrogenase (LDH)(Katz
and Sahlin 1990). At mild to moderate levels of exercise
the increase in glycolysis is balanced by an increase in
the oxidation of pyruvate with no increase in the
production of lactate. Lactate accumulation becomes
apparent when an increased proportion of pyruvate is
reduced to lactate, and the latter released from the
contracting skeletal muscle. This usually occurs at high
exercise intensity and is indicative of accelerated
glycolysis. This increase in the lactate production is
observed at approximately 50-70% of 1.702 , ie well before
the aerobic capacity is fully utilised (Katz and Sahlin
1990).
The classic explanation is that the 02 supply to the
contracting muscles is inadequate and part of the energy
requirements must be provided by increasing the amount of
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ATP derived anaerobically (although the mechanism for the
increased production is not fully understood). At this
point predominately anaerobic metabolism occurs with the
excessive production of lactic acid beyond its level of
uptake with the consequent accumulation of lactic acid in
the plasma. The work rate or /o2 at which this occurs is
commonly named the anaerobic threshold (AT) (Stainsby and
Brooks 1990, Jones 1991). Originally, the concept of an
anaerobic threshold was introduced to identify the point at
which the ventilatory changes associated with incremental
exercise matched the metabolic acidosis (Wasserman et al
1973). It should be noted that the production of lactate
and its entry into the blood continuously occurs even at
low levels of exercise despite the muscle being well
oxygenated, however it is simultaneously removed from the
blood. The anaerobic threshold is identified by the
increase in plasma levels of lactate and secondly as was
suggested by Wasserman (1984), identified as the point
where the linear relationship between VE and 'co2 deviates
and there is an increase in the CO2 production. The source
of the increased /co2 during heavy exercise is firstly
metabolic, secondly as a result of the bicarbonate
buffering and finally can be a result of hyperventilation
(Wasserman 1984). This buffering of the H + accounts for the
disproportionate increase of /co2 compared to the 1:To2 when
the blood lactate increases.
Whipp and Wasserman (1988) propose that an exercise test
with one minute increments allows the identification of a
period of 'isocapnic buffering', ie a change in "OrE
proportional to the changes in the 1.7co2 in the same
proportions as below the threshold despite two sources of
N/co2 . Once this has been identified it allows the
investigator to exclude other causes of an increase in the
ventilatory drive eg pain. This stage is transient and is
followed by a respiratory compensation for this non
respiratory acidosis. The rise in the VE/Sco2 relationship
as the work rate increases, and the pH and PaCO 2 drop is
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initiated by the carotid bodies stimulating the increase in
VE beyond the increase in the 'co2.
The intensity of exercise at which lactate accumulation
increases is 50-70% of the maximal oxygen uptake (1:702)
(Katz and Sahlin 1990, ACSM 1991). The measurement of the
anaerobic threshold is unaffected by the protocol employed
but like the measurement of "V02 it is affected by the mode
of testing (Wasserman 1984). The threshold is however
altered by factors such as good physical fitness and
cardio-vascular performance (Kanarek et al 1979). The
anaerobic threshold has often been documented using the
alternative terminology 'onset of blood lactate
accumulation f (OBLA). The terms are not synonymous, the
latter refers to a reference value of blood lactate
concentration, eg 2.5 or 4 mmo1.14 . It is assumed that a
threshold level of blood lactate concentration
(corresponding to a predominately anaerobic metabolism) and
the deviation of the linear ITE/17co2 relationship are highly
correlated (Astrand & Rodahl 1986). However peak capillary
blood lactate concentrations of 8 mmo1.1 4 support the
assumption that a healthy individual's aerobic power has
been taxed to its maximum (Astrand & Rodahl 1986).
The description of an anaerobic threshold is not
universally accepted. It is felt that the theory does not
match the practical findings eg some muscle fibres employ
anaerobic metabolism despite adequate 02 delivery.
Wasserman (1984, 1992) provides a list of evidence
supporting the concept of the anaerobic/lactate threshold
and its dependency upon the adequacy of 0 2 delivery,
defining the anaerobic threshold as the point below which
work is performed totally oxidatively and above which the
metabolism is at least partially anaerobic.
2.4.4 The limitation to exercise tolerance
The limit to exercise in healthy individuals is not the
respiratory system. The work of the respiratory muscle is
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to overcome the elastic resistance and flow resistance
forces. The energy requirements of breathing are 0.5-1.0 ml
02 .14 ventilation, obviously with increased work the cost
increases up to 10% of the total 0 2 uptake. Astrand &
Rodahl (1986) dismiss this as not being a limiting factor
to exercise because firstly after the 17o 2
 has been reached
the exercise continues. Secondly, at maximal exercise it is
possible to increase ventilation voluntarily, ie the
respiratory muscles are not exhausted during spontaneous
respiration. This is demonstrated by a comparison of
maximum ventilation during exercise with the maximum
voluntary ventilation (MVV) at rest, the former is between
half and three-quarters of the maximum ventilatory capacity
and therefore unlikely to be the initiating factor for the
termination of exercise. Thirdly, with strenuous exercise
tE depends on the volume of CO 2
 produced. The measurement
of the alveolar gas tensions indicate that gas exchange is
effective.
The respiratory muscles may indirectly limit exercise by
demanding a high percentage increase in their 02
requirements and therefore deprive the exercising muscle of
increased 02 supply. It is not usual for this to occur in
normal individuals and increase in ventilation beyond a
critical point can be met by anaerobic metabolism. The
identification of fatigue is more difficult in respiratory
muscles than skeletal muscles (Jones 1991), making it
difficult to identify fatigue and how it imposes limits to
exercise. Electromyographic changes have been identified,
as have alterations in breathing patterns (paradoxical
movement of the abdomen and rib cage). Work has been
completed to argue that these observations do not
necessarily indicate respiratory muscle fatigue (Tobin et
al 1987). Whipp and Ward (1991) suggest that in highly
trained athletes who can exercise with their tE at 90% of
their MVV respiratory muscle fatigue is likely to develop.
Di Prampero (1992) reviews the current literature examining
the limitations to .7co.2 	 in healthy individuals at sea
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level. The article identifies four resistances to maximal
02 flow. Firstly the flow of 0 2 from the atmosphere to the
arterial blood, secondly transport by the circulation,
thirdly the peripheral transfer of 0 2 to the mitochondria
and finally the efficacy of the mitochondria. He cites a
number of authors considering this last factor in
conjunction with the 02 kinetics at the lung and tissue
level as a limitation to exercise. However, the stroke
volume attains its maximum volume at relatively low work
rates. As a result of this any increase in cardiac output
is manifested through an increase in the heart rate. At
maximum exercise the normal individual is very close to the
predicted maximal heart rate and tolerance to exercise is
dictated by the maximum cardiac output that can be
achieved (Gibson 1990).
2.5 RESPONSE TO EXERCISE IN PATIENTS WITH CAL
Exercise tolerance in patients with CAL is reduced. A
number of reasons why patients experience this reduction
have been reported (Brown and Wasserman 1981), ranging from
compromised gas exchange to cardiac limitations. However
the consensus of opinion suggests the major limitation is
related to the abnormal mechanical characteristics of the
respiratory system, ie an inability to increase ventilation
(Jones 1966). The recognition of a ventilatory limit to
exercise in patients with CAL was further supported by
Jones and colleagues (1971) in work identifying that at
maximal levels of exercise in patients with CAL the heart
rate response is frequently below that predicted from the
age (Jones et al 1971) and the patients complain of
dyspnoea, reflecting a lack of stress on the cardio-
vascular system. Further evidence of a ventilatory limit to
exercise is revealed when ventilatory mechanisms are
compared in the normal and in patients with CAL. A
sedentary male may reach a maximum of 140 litres in sharp
contrast to a patients values. Values for patients maximum
ventilation have been recorded as low as 26.9 1.min4
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(Swinburn et al 1985) although other workers have reported
higher values for 1.7E in groups of patients with differing
FEVI values (Dillard et al 1985, Brown et al 1985, Kirsch et
al 1989). Jones et al (1971) suggest that a relationship
exists between the severity of the obstruction as measured
by the FEVI and the maximum ventilation. A patient with an
FEV1 of 2 litres would have a maximum 11E of 60 litres. This
value would fall to 45 litres with an FEVI of 1 litre. An
alternative comparison with the norm can be made with
regard to the MVV; in normal subjects the maximal exercise
ventilation is usually around 70% of the MVV (Whipp and
Pardy 1984) whilst in patients with CAL this value is
commonly 100% (Jones et al 1971).
Blood lactate concentrations during exercise in patients
are typically low, Wasserman and Whipp (1975) suggest that
the values rarely rise above 3-4 mmo1.1 4 and in some cases
may not rise above the resting levels (Jones et al 1985).
If a metabolic acidosis does occur it is usually at a lower
work rate than for normal subjects (Jones et al 1971).
Jones et al (1985) propose that in pulmonary disorders
associated with a serious decrease in ventilatory capacity,
patients may be limited by this factor before lactate
accumulation occurs. Lactic acid begins to accumulate in
blood at about 55% of a healthy untrained aerobic
metabolism (McArdle et al 1991). Exercise performance is
frequently calibrated against HR therefore a patient
exercising at a high percentage of his maximum predicted HR
should be anticipated to produce a lactic acidosis.
It is now clear that patients with CAL can develop
metabolic acidosis with exercise (Kanarek et al 1979,
Severa et al 1983, Sue et al 1988). The presence or absence
of a metabolic acidosis during exercise may have important
implications for the choice of exercise levels within a
training programme (Sue et al 1988). The identification of
an anaerobic threshold in this group of patients can be
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used as an aid to the diagnosis of exercise intolerance.
Wasserman (1984) suggests that the AT is normal in patients
with CAL whilst the 17° 2 is reduced. One explanation for the
absence of an anaerobic threshold is the severe ventilatory
limitation prevents the threshold from being recognised or
alternatively the respiratory system imposes such a
limitation that the threshold levels are not reached
(Kanarek et al 1979). Wasserman and Whipp (1975) suggest
that this may be due to arterial hypoxaemia or a detraining
effect.
The maximal oxygen uptake measured at maximal exercise in
these patients is lower than seen in a normal age matched
population (Loke et al 1984, Mihn et al 1979). Because of
this ventilatory limit to exercise the peak /o 2 measured is
often referred to as a symptom limited /o 2 (Selman 1986)
or /o2peak . Gallagher (1990) questions the exact mechanisms of
this reduced response to exercise and proposes an
alteration in the pulmonary mechanics, an increase in the
oxygen cost of breathing and poor exercise technique a
possible reasons (ie poor treadmill technique). Astrand and
Rodahl (1986) quote 2.55 1.min4 as a typical 17o2peak in a 55-
59 year population. On the other hand Swinburn et al (1985)
document a /02k of just 0.8 1.min4 in a group of patients
with severe CAL. The value of /o2k is occasionally reported
as an oxygen pulse, ie the /o2pak is divided by the heart
rate, and is a product of stroke volume and the arterio-
venous 02 difference. The oxygen pulse is reduced at maximal
exercise in patients with CAL (Kanarek et al 1979). Some
authors have found that the ratio of heart rate to the .To2
is normal. An alternative finding is for the heart rate to
be higher in patients at a set work rate when compared to
normals and the /o2 to be reduced giving a reduced heart
rate//o2 slope. The interpretation of the oxygen pulse in
this group of patients is not unanimous. Some authors (Mihn
et al 1979) believe that it is an indication of a reduced
stroke volume and therefore concurrent cardiac
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abnormalities. Other workers (Nery et al 1983) suggest that
the low values are consistent with a ventilatory limit to
exercise reflecting that the cardio-vascular system has not
been stressed.
Recently attention has been directed towards studying
latent cardiac abnormalities affecting exercise performance
in patients with CAL. Wagner (1992) proposes that mixed
venous p02 is reduced at rest in these patients and could
fall even with gentle exercise. The reason suggested for
this is the relative increase in /02 requirements to the
cardiac output. Factors identified as limiting the cardiac
output were co-existing ischaemic heart disease (most CAL
patients are old and have smoked) and pulmonary
hypertension (associated with structural abnormalities of
the lung compounded by hypoxic vasoconstriction). It has
also been documented that right ventricular function is
decreased in this group of patients (Matthay et al 1992).
Right ventricular afterload is increased for the reasons
described above, the response of the right ventricle is to
dilate and hypertrophy to maintain cardiac output, however
the increased pulmonary vasculature reduces the right
ventricular ejection fraction and there is a resulting
tachycardia to maintain cardiac output (Rogers & Howard
1992).
It can be concluded that the mechanisms limiting
exercise performance in patients with CAL is not fully
understood. Although the main rate limiting factors may
include ventilation, circulation, V/Q inequality, muscular
and psychological, a consensus of opinion exists believing
that most patients have a ventilatory limit to exercise.
2.5.1 The ventilatory response to exercise
If a patient with CAL is required to perform an
incremental exercise test a point is rapidly reached when
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the spontaneously generated expiratory airflow reaches the
maximum values attainable by forced volitional effort
(Whipp and Pardy 1984). This was demonstrated by Stubbing
et al (1980). In a study of 6 patients with CAL it was
identified by using body plethysmography that at rest all
but 1 patient reached their maximum expiratory flow volume
curve (MEFV), but no patient exceeded it. On exercising all
the patients reached their MEFV curve, indicating that this
inability to increase flow rates is a major constraint on
maximum 17E. In the same piece of work it was identified that
these patients exhibit significant increases in their FRC
and RV. In contrast to normal subjects (Dodds et al 1984),
the FRC is increased with exercise particularly those with
severe CAL (Younes 1991). The reasons for this are thought
to be as a result of the breathing pattern adopted by the
subject (due to the reduced expiratory flow rates) and
secondly it is actively elevated by activity of the
inspiratory muscles to allow a greater expiratory flow at
higher lung volumes (Younes 1991). This increase in the FRC
allows higher expiratory flow rates to be reached for the
same driving pressure (due to the shift of the exercising
flow/volume curve within the MEFV curve). The result is a
delay in the onset of mechanical limitation to exercise.
However this is complicated by the exacerbation of dynamic
airways compression associated with the increased driving
pressures required to generate the maximum expiratory flow.
The generation of pressures in excess of a critical point
would result in increased respiratory work but not in
expiratory flow. Leaver and Pride (1971) suggest that this
point is not exceeded in patients with CAL and adequate
pressures are generated to induce maximum expiratory
airflow but not to cause unnecessary airway and alveolar
compression.
A second detrimental effect of increasing the FRC is to
mechanically disadvantage the inspiratory muscles as they
are placed at an inefficient part of their force length
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relationship and to produce a given force at this position
requires an increase of muscle excitation. Consequently, it
would be anticipated that the inspiratory muscles would
fatigue more rapidly (Rochester et al 1979). This volume
increase associated with an increase in the volume of the
thorax if too large can lead to a further decline in the
efficiency of the inspiratory muscles. Consequently the
changes in the FRC become self limiting, requiring higher
and higher pressures to be generated in the inspiratory
muscles resulting in fatigue. The dynamic hyperinflation is
also likely to account for the rapid increases in 02
consumption when IE rises. Dodds et al (1984) suggests that
the hyperinflated lung with a flattened diaphragm requires
greater activity of the inspiratory inter-costal muscles
and again predisposes to fatigue and this combined with
respiratory muscle dysfunction leads towards limitation of
exercise performance. Sharp et al (1968) demonstrated that
the maximal inspiratory muscle pressure measured at FRC was
significantly lower in patients with CAL than in normal
subjects (31 vs 78 cm H20) and this weakness contributes to
exercise limitation. With these limitations the patient
with CAL must increase his 1.7E in response to exercise by
using the following strategy. The FRC would increase, VT
must decrease and the respiratory rate must increase. This
approach overcomes the problems imposed by the MEFV curve.
To increase VI. the FRC would need to decrease which in turn
would decrease the maximal flow on expiration and therefore
decrease i7E. Consequently the above approach is adopted to
support moderate exercise (Beck et al 1991).
During an incremental exercise test patients exhibit a
higher ventilation than normal at a prescribed metabolic
rate/power output/17o2 (Jones et al 1985) and usually
although not always, an increase in the slope of the tE/i7m2
relationship, which increases with the intensity of the
exercise (Whipp et al 1984). This rise is thought to be
mainly due to the large increase in dead space ventilation
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which occurs as a result of the high frequency of breathing
as the work rate increases (Wasserman and Whipp 1975).
Total ventilation is conventionally divided into alveolar
and dead space components. The former is usually defined in
terms of the arterial pCO2 . Alveolar under-ventilation
frequently occurs in patients with CAL but it is seldom to
such a degree as to reduce the total 1TE response to
exercise. Jones, Killian and Stubbing (1985) propose that
these patients usually have an increased PaCO2 during
exercise, unlike normal subjects. Dead space ventilation is
expressed as the proportional difference between PaCO 2 and
PECO2.
The VD/VT ratio is defined using the Bohr-Enghoff equation
as,
VD/VT = PaCO2 - PECO2 / PaCO2
(Jones et al 1985) and is regarded as an index of the
efficiency with which 1 clears CO2 from the alveoli. In CAL
patients the VD/VT ratio is often high in exercise due to a
limitation upon the increase of V T and poor gas exchange
efficiency. A high VD/VT ratio leads to a high ventilation
for a given CO2 and therefore predisposes to dyspnoea. In
some patients alveolar under ventilation lessens this
effect but are consequently exposed to the effect of an
increased PaCO2 . A patient's ratio during exercise may reach
0.5, the normal exercising value is 0.05 - 0.2 and is
lowest in those individuals with a high V T and low breathing
frequency.
For patients to maintain a PaCO2 within the normal range,
1TE at a given V'co2 must increase. This need to increase the
1TE will ultimately encroach upon the ventilatory capacity
and contribute to the dyspnoea and the termination of
exercise. Younes (1991) suggests that this ability to
increase the frequency of breathing is limited to 20/min in
moderate disease and even lower in more severe disease, at
these critical values there is no increase in the /E and the
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VT falls. There appears to be no consensus as to how
patients with CAL increase their VT . Dodd et al (1984) in
his study of patients with severe CAL (and marked
hyperinflation) revealed that the driving force for the
increase in volume arose from the intercostal and accessory
muscles for inspiration and the abdominal muscles increased
expiration. Conversely, Pardy et al (1981) studying the
effect of physiotherapy versus the effect of inspiratory
muscle training in patients with CAL identified that the
primary increase in NTE was due to the diaphragm.
An alternative strategy used in patients with CAL to
increase ventilation besides the disproportionate increase
in frequency (Younes 1991), is to increase the time allowed
for the expiratory phase of the breathing cycle. This
requires the inspiratory flow to increase and a shortened
Ti. In mild to moderate CAL the respiratory cycle (Ti/Ttot)
is not reduced, but in more severe disease the value falls
to 0.35 to 0.4 (Dodd et al 1984). It has been suggested
that these values may fall as low as 0.3 (normal 0.4-0.5).
Younes (1991) proposes that patients with severe CAL do
vary in their Ti/Ttot and frequency in response to
exercise.
The work of breathing has two main components, firstly
the work against lung elasticity and secondly the work
performed in generating airflow, both of which are
disturbed in patients with CAL (Beck et al 1991). In CAL
the lung elasticity is reduced and the airways resistance
is increased which leads to increases in the work of
breathing (at rest the power output of the respiratory
muscles is 10-12 times that of normals (McGregor & Becklake
1961). The result of these demands is that the work rate
and the 02 consumption of the respiratory muscles is
increased and it has been proposed that respiratory muscle
fatigue may contribute to the termination of exercise. The
magnitude of this increase is uncertain due to the
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difficulties associated with measurements of respiratory
muscle work, increases up to 35-40% of the total 02
consumption have been quoted (Loke et al 1984) and this
obviously leaves little 02 for the exercising muscle. Dodd
et al (1984) suggest that the expiratory muscles are also
inefficient in their energy consumption, it is believed
that these muscles generate high positive pleural pressures
beyond which maximum flow is generated.
Jones (1966) examined pulmonary gas exchange in patients
with CAL who were divided into two categories, emphysema
and chronic bronchitis. The main differences revealed were
that the chronic bronchitis patients were able to exercise
to a significantly higher workload and had a significantly
lower arterial P02 at rest that did not fall with exercise,
unlike the patients with emphysema where a significant fall
in their arterial saturation was observed. The cause of
this difference is related to the poor V/Q ratio that is
accentuated with exercise. Minh et al (1979) exercised 17
patients with CAL and divided them into two groups based
upon whether desaturation occurred. The patients who
desaturated appeared to have a higher FRC, RV and TLC but
a lower FEVI and MVV compared to the group of patients with
CAL who did not markedly desaturate with exercise and
contributed this alteration of saturation levels to the V/Q
mismatch. Dantzer (1986) also showed that in his group of
7 patients with severe CAL (mean FEVI 0.56) the V/Q ratio
did not alter significantly despite the sharp fall in the
arterial blood gases. Loke et al (1984) proposes that
emphysematous patients tend to desaturate on symptom
limited exercise whilst in chronic bronchitic patients the
response is influenced by the degree of obstruction.
Saturation monitoring is useful in exercise testing to
assess the severity of the gas exchange impairment
associated with the loss of alveolar surface area and
capillary beds (Jones 1988).
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2.6 THE MEASUREMENT OF Th AND S02 IN PATIENTS WITH CAL
The measurements of 17E and /o2
 at both rest and exercise in
patients with CAL is relatively well documented. The
measurement of /0 21mg, in patients with CAL is synonymous with
a symptom limited /02 . Jones (1988) suggests this value is
a close approximation of a true /o 2 , it is however a true
/o2  for these patients. The primary difference between a
/o2pak and a true /o2 is the nature of the limitation.
Assessment of the degree of exhaustion is difficult as
patients often terminate the test before the maximal heart
rate is attained, the basis of effort evaluation in
normals. It is documented that the measurement of /02p,k is
reproducible in these patients (Severa et al 1983).
Brown et al (1985) examined the reproducibility of '(To,
employing three different incremental cycle ergometer
exercise protocols (not described). The group (n=11, mean
FEV1
 1.5 1) had remarkably similar mean /o 2puk and 1.7E for
the 3 tests (1.31, 1.31 and 1.32 1.min4 /o2p,a, and 52.8, 50.2
and 53.7 1.min4 /E ), despite the different modes of
testing. Despite the mean values being similar these
results do not indicate that there was good agreement
between the tests. The authors however did indicate that a
degree of variability may be anticipated in this category
of patients due to firstly the problem that a true 1:/o k is
hardly ever measured. Similarly the degree of patient
effort is difficult to determine. The authors suggest that
even stable patients vary in their lung mechanisms
resulting in variability of their /o2.
Belman et al (1991) concurrently measured the
reproducibility of exercising measurements whilst assessing
the reproducibility of the Borg breathlessness scale.
Eleven patients (mean FEV I 1.18 1) performed one incremental
test and four subsequent tests at 95% /02p,,k . The 1:1E, HR and
7o2 p,* stabilised after 1 or 2 attempts. The mean /0 4, was
1.07 1.min4 (ITE and HR data not presented).
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An early study (Jones et al 1971) divided 50 patients
into various categories (FEV" diagnosis) for analysis.
All subjects performed an incremental and steady state
cycle test and a step test. The results identifying FEV/
categories revealed decrease in tE , from 56 1.min4 in the
less affected group (FEV / > 1.6 1) to 38 1.min4 in the most
disabled group (FEV 1
 < 0.8 1). The mean maximal heart rate
ranged from 132 - 151 beat.min 4 in the 4 study groups. Spiro
et al (1975), like Jones et al (1971) categorised the
patients into 2 groups, depending on their FEV 1 value (mean
values 1.45 1 and 0.62 1), but also recruited a group of
normal subjects. All individuals performed a maximal
incremental cycle test. The values of tE	 and i7o2pak were
lower than the normals in both clinical groups and lower
for the patients with the lower FEV 1 OE was 54.4, 48.6
and 30.0 1.min4 , /o2peak was 2.0, 1.5 and 1.0 1.min4 in the
normal and patient groups, mean FENT/
 1.45 and 0.62 1
respectively). The fE pea of patients exceeded their
predicted fE	 (FEV1 x 35). For the more severely affected
patient this represented 146% of their predicted /E	 and
for the less affected patient 99%.
Following on from the work of Spiro et al (1975),
Matthews et al (1989) and Nery et al (1983) directly
compared the performance of patients and age matched
controls. Patient groups were not divided into clinical
categories. Matthews et al (1989) evaluated the response to
a series of cycle ergometer exercise protocols (incremental
and individually prescribed steady state) for both normals
and patients (FVC 4.49 & 3.40 1 and FEV1 3.34 & 1.68 1
respectively). He found that the resting 1702 was similar
(0.33 and 0.34 1.min4 respectively), unlike the resting tE
which was significantly higher in the patients, 11.3 1.min4
vs 13.6 1.min4 , as was the resting HR (78 vs 85 beat.min4 in
the control and patient group respectively). Results of the
symptom limited test reveal a significant lower fE pea (79
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1.min4
 vs 58 1.min4 ) (but a higher level of VE at comparable
work rates) and 1.702 (2.08 vs 1.61 1.min4 ). The maximal
values for the patients were recorded at a significantly
lower work rate. In contrast to other studies (Nery et al
1983, Belman 1986) the maximal heart rate was not
significantly different for the two groups, (156 normals vs
148). However in agreement with Spiro et al (1975) and
Jones & Berman (1984) the heart rate values represented a
higher heart rate than the normals for a prescribed "(7o2.
Nery et al (1983) studied the different exercise
responses between normals, cardiac and respiratory patients
(CAL n=6 mean FEV1 1.1 1), employing an incremental cycle
test. The resting N.7o2 was similar for the 3 groups (CAL
patients 4.7 ml.min4 .kg4 ) while the Io2pea was 18.3 ml.min-
l .kg4 for the CAL patients and 30.7 ml.min4 .ke for the
control group. 1.7E was again lower than normals 44.5 vs
80.9 1.min4 , however at an equivalent metabolic rate the CAL
patients had a significantly higher 1.7E, supporting the
reports by Spiro et al (1975) and Matthews et al (1989)
that a higher is required to complete the same work level
as normals. The maximal heart rate was 141 beat.min4
(normals 154 beat.min4 p<0.05). The mean maximal oxygen
pulse (ml.beat4 ) was significantly lower than the normal
(8.3 vs 13.5 ml.beat4). The authors concluded that these
patients were not experiencing a cardio-vascular limitation
to exercise proposing that the low 0 2
 pulse, indicated a low
stroke volume and lower heart rate, reflects the
termination of exercise before the cardio-vascular system
is stressed.
In opposition to this opinion is the work of Minh et al
(1979). In study of 18 patients with CAL (mean FEV I
 1.85 1)
they measured a max VE of 49 1.min4 , a ro2I, 1.18 1.min4 and
a maximal heart rate of 137 beat.min 4 . This was assessed by
an individually prescribed incremental treadmill test.
However, unlike the cycle tests this test lasted for 16-20
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minutes, and the authors document that 3 patients
complained of leg pain at the end of exercise and 8 of
general fatigue. The 102 is not very different from the
values reported above despite the different modes of
testing [it is acknowledged (Hansen 1984) that treadmill
testing provokes a higher <T02  cycle ergometry]. The
values translate into an 02 pulse of 8.56 ml.beat 4 . Although
this value is comparable to that of Nery et al (1983), Minh
et al (1979) interprets the low value as an indicator of a
low stroke volume (SV) which occurs secondary to the loss
of the pulmonary capillary bed. Matthews et al (1989)
support the theory of Mihn et al (1979) but propose
alternative cardiac abnormalities that may contribute to
the higher HR at a given level of exercise when compared to
normals.
Kirsch et al (1989) employed a universal cycle ergometer
protocol to assess 6 patients. The mean FEV / was 1.28 1, the
mean resting 1o2 0.28 1.min4 and mean 1/ at rest was 15.8
1.min4 . These values represent a slight increase from the
normal values at rest ( 10 2 2-300 ml.min4 and 1E 10-12 1.min-
1 ). This group of patients had a mean tE of 43 1.min4 the
mean to2puk was 1.04 1.min4 . The significantly different
result of this trial compared to those quoted above is the
heart rate data. The mean maximal heart rate was just 101
beat.min4
 despite the age and FENT/ values being similar.
In a group of more severely affected patients (n= 50 mean
FEV1
 1.02 1) ZuWallack et al (1991) measured the mean 1E
to be 26.8 1.min4
 and the mean 1o2peak 890 ml.min4 , equivalent
to 13.7 ml.min4 .kg4 . These patients performed an incremental
treadmill test that was set on estimated physical
impairment. The low tE	 is consistent with the severe
airflow obstruction indicated in the FEV 1 value.
Similarly low values were quoted by Swinburn et al (1985)
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who examined the effect of 3 different types of exercise on
/02 and SE. The patients (n=17) with severe CAL (mean FEV,
0.8 1) performed an incremental cycle test, a paced step
test and a self paced corridor walk test. The mean 11o2peak
values were 0.8, 1.0 and 0.85 1.min4
 respectively
(significantly greater for the step test). The
corresponding values for the 1z were 26.9, 31.3 and 27.4
1.min4 . The values for the self paced test indicate that
these patient did not volitionally reach a 1.7o2p,,k.
Lanigan (1990) studied the resting N.70 2 of normals and
patients and standardised the results for body surface
area. The mean '7o2 was 0.18 1.min4 higher in patients which
when standardised for body surface area represents a 10.9%
increase in patients. This was significantly higher,
however these patients did have severe airways disease
(mean FEV, of 0.78 1). A fundamental difference in this
trial compared to other trials is the method of gas
analysis. The patients were assessed with an open canopy
technique. The patient's head and chest is enclosed in a
clear chamber that has a fresh gas flow and an exhaust
system. This form of measurement was an attempt to overcome
the problems identified by Askanazi et al (1980). These
authors observed a 30% increase in the minute volume if a
face mask was worn and a 14% increase if a nose-clip and
mouthpiece used. The effect of apparatus on clinical
measurement was documented by Beaumont and Cockcroft
(1985). Whilst developing a self-paced 12-minute treadmill
walking test they found that patients' performance
(distance walked) was significantly reduced when using a
mouthpiece.
Despite this apparent lack of agreement when directly
measuring 11o2puk and SE in these patients there have been
many attempts to develop predictive formulae of patients'
maximal exercise capacity. If reliable these equations
could replace expensive and invasive exercise tolerance
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tests in some individuals (Carlson et al 1991).
Dillard et al (1985) proposed a two variable formula
incorporating the peak inspiratory flow rate (PIFR) and the
FENT/ to estimate maximum which in turn is used as a
predictor of the severity of the disease. The mean
measured on an incremental cycle ergometer test (n=30, mean
FEV1 1.75 1) was 67.2(29)1.min4 . Dillard presented the
formula VE ma, = 21.34 FEV I + 6.28 PIFR + 3.94 (r= 0.967 for
the predicted vs measured 1E relationship).
In a subsequent piece of work again considering the
importance of the inspiratory muscles contribution to i/E
, Dillard et al (1989) proposed that 1:7o2puk could be
predicted from an equation including static lung function
values. The patients (n=20 mean FEV I
 1.72 1) had a mean
max of 67 1.min4 and a mean to2pmk of 1.8 1.min4 . The FEV,
had a moderate relationship with the to2pak (r=0.76). The
peak inspiratory pressure (PIP), unlike the peak expiratory
pressure (PEP) correlated well with i1o 2pea
 (r=0.82 and 0.14
respectively). The 1i	 in both studies by Dillard and
colleagues is considerably higher than has been previously
reported for this category of patients but the lung
function values were also greater for this group.
In a recent study Carlson et al (1991) assessed the
usefulness of predictive equations of t To2 , in 2 groups of
patients. The 2 groups had mean FEV I values of 1.44 and 1.40
1. The directly measured i7o2puk values were 1.25 and 1.23
1.min4 . The authors concluded that they were able to predict
exercise .7o2}; using measurements of the diffusing capacity
of carbon monoxide, maximum voluntary ventilation, peak
exercise VD/VT and resting .(TE (r=0.90).
Carter et al (1987) examined the usefulness of a number
of these equations to predict TE max as a function of FEV,
in 53 patients with CAL (mean FEVI 1.0 1). Exercise testing
(incremental cycle ergometry) revealed a peak 1.7E of
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37.7(13.6) 1.min4 and a 17021,a, of 1.05 1.min4. The fE
exceeded the mean MVV (32.9 1) perhaps indicating dynamic
compression of the airways whist performing this manoeuvre.
The group concluded that the most robust equation used to
predict tE	 was FEV1 x 37.5. This group of patients had a
strong relationship between FEV 1 and fE .
In summary, 7o2 and fE are consistently increased at rest
and limited at maximal exercise in patients when compared
to normal. The degree to which they are limited appears,
very broadly to relate, to the severity of the disease. It
has been suggested that lung function tests explain only
50% of the variance of measured exercise tolerance (Carlson
et al 1991). There appears to be a general trend that the
more able patients (assessed by FENT, values) attain both a
higher VE and a higher i7o2k (Spiro et al 1975). Whilst
the severely affected patient had a reduced ventilatory and
cardio-vascular response to exercise, consistent with a
ventilatory limit to exercise. The documented heart rate
response at a given ilo2 is not unanimous. Matthews et al
(1989), Spiro et al (1975) and Nery et al (1983) quote
higher than normal values at a given rc)2, while Wasserman
and Whipp (1975) did not see this raised heart rate
response. Similarly Jones and co-workers (1971) proposed
that this relationship was normal. Some of the increase in
heart rate may be accounted for by the requirements of the
respiratory muscles, but Matthews et al (1989) indicates
that the low r021„, k may indicate co-existing cardiovascular
pathologies.
The variety of test methods may contribute to the lack of
agreement, added to which a number of test procedures were
adopted with incremental increases varying in both the
timing and intensity of the increase. Where large
resistance is applied maximal data may not have been
measured because of the influence of skeletal muscle
fatigue which may account for the results reported by Mihn
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et al (1979). The results of Jones et al (1971) and Spiro
et al (1975) are attractive when examining the patients'
response to exercise as they allow the examination of the
response to exercise at different stages of the disease as
defined by spirometry.
2.7 THE MEASUREMENT OF BLOOD LACTATE CONCENTRATIONS AND
METABOLIC ACIDOSIS IN PATIENTS WITH CAL
The frequency and degree of metabolic acidosis and the
identification of an anaerobic threshold during exercise in
patients with CAL is unclear. The confusion is compounded
by the choice of measurement of the anaerobic threshold.
Shah (1992) examined five methods of assessing this
threshold that are commonly applied to normal subjects. He
found little agreement between them with the results
varying from 43% to 84% /o 2 , these values also had a
random relationship with the ventilatory threshold. This
doesn't give any confidence in the validity of this
approach.
Spiro et al (1975) investigated the effect of exercise on
a group of normal subjects and a group of patients divided
into two groups according to their FEV / . All the subjects
performed an incremental cycle exercise test. The peak rise
in blood lactate (measured from ear lobe sampling) was
smaller for the patient groups than the normals but there
was a difference between the two patient groups. The
patients with the greater FENT / (mean 1.45 1) had a peak
blood lactate concentration of 3.6 mmo1.14 compared to 2.5
mmo1.14 in the more severely affected group (mean FEV 1 0.62
1). Neither of the patient groups exhibited a
disproportionate rise in /E at maximum exercise intensity
associated with a rise in blood lactate concentration. The
mean maximum heart rate attained by the 2 groups
represented 82% (less affected group) and 71% of predicted
maximum.
66
Jones et al (1971) studied the exercise response of 50
patients divided into 2 clinical groups, emphysematous and
chronic bronchitic. The blood lactate concentrations were
calculated using a CO2 balance technique at 60% of maximal
work rate. The change in levels was greatest in the least
affected group (FEV 1 > 1.6 1), 2.4 mmo1.14 in comparison to
a mean change of 1.36 mmol 14 in the most affected group
(FEN11
 < 0.8 1). The total patient group, unlike the study
above (Spiro et al 1975) demonstrated a relationship
between /02 and HR that did not differ significantly from
normal. However the exercise protocol varied the study from
the Spiro et al (1975) who employed a maximal test. However
the trend in both studies is similar, ie the patients with
the more severe disease process (assessed upon FEVO are
less likely to develop a pronounced metabolic acidosis.
Jakobsson et al (1990) studied 18 patients divided into
2 groups (8 with chronic respiratory failure (CRF), 10
without (NCRF)]. Both groups had severe CAL (mean FENT, 0.69
and 0.99 1). Blood lactate concentrations was measured at
30 W (the mean maximal work rate for the CRF group which
was sub-maximal for the NCRF group). Blood lactate
concentration was significantly higher at a standard 30w
work rate in the CRF group (3.3 vs 1.9 mmo1.14), although
the maximal blood lactate concentrations were not
significantly different. The mean maximal HR was almost the
same for both groups (131 vs 129 beat.min4).
Sauntier et al (1979) studied glycolysis in a group of 11
patients with CAL and hypoxaemia (the mean maximal I.TE was
37.27 1.min4 and the N/o2pca was 1.19 1.min4). The blood
lactate concentration rose to 4.6 mmo1.1 4 after a maximal
cycle test. The authors recognised that the lactate levels
are considerably higher than those measured in young
sportsmen during similar exercise but the $02 vs blood
lactate relationship paralleled the values obtained from
normal subjects between 50 - 60 years.
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The studies described above do not attempt to identify an
anaerobic threshold in patients with CAL. However this is
becoming increasingly important as a physiological
indicator of the potential efficacy of a rehabilitation
programme. The achievement of an anaerobic threshold is
considered by some to be of primary importance when
selecting patients for exercise training. Casaburi et al
(1991) proposes that a reduction in blood lactate is a
primary physiological effect of a training programme.
Sue et al (1988) studied the usefulness of the V-slope
method proposed by Beaver et al (1986) to identify an
anaerobic threshold in patients with CAL (briefly, this
involves identifying the point at which the 7co 2 vs O2 plot
deviates from its linear relationship due to the increased
CO2 production, indicating the buffering of lactic acid).
Comparing those results with the change in blood
bicarbonate. The study identified 14 patients who developed
a metabolic acidosis and 8 patients who had no significant
metabolic acidosis. The metabolic acidosis appeared to be
greater in patients who have the least restriction upon
their functional capacity indicated by their FEV//FEV ratio
and VC. They could not be separated by their FEV 1 (1.16 1
for the group that did not and 1.23 1 for the group that
did develop a metabolic acidosis) or FVC alone. The maximal
heart rate for the 2 groups was slightly but not
significantly different, but when the values were expressed
as a percentage of predicted maximum it became apparent
that those patients able to exercise nearer to their
maximum heart rate were more likely to develop a metabolic
acidosis. Furthermore the patients who were able to attain
a NIE	 near to their MVV, (83% and 96%) were also more
likely to reach an anaerobic threshold. The of the two
groups was 1.01 1.min4 (n=8) and 1.28 1.min4 (n=14). An
anaerobic threshold was identified at 0.97 and 0.89 1.min-I
using the two methods (significantly lower than that
identified in a normal group, 1.5 and 1.4 1.min-I ). Although
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these two methods employed by Sue et al (1988) had a strong
relationship they were significantly different. Despite
this the authors proposed that the V-slope method is a non-
invasive satisfactory method of anaerobic threshold
detection.
Nery et al (1983) in the study described above (n=6 FEV1
1.1 1) identified the AT as the 1102 at which various
alterations in the gas relationships occurred, primarily
the V02 at which the gas exchange ratio increases abruptly
without hyperinflation. Interestingly the CAL patients had
a similar /o2 at their anaerobic threshold compared to the
normals (15.7 and 16.6 m1.min-l .kg-1 respectively), consistent
with the proposals of Wasserman (1984), indicating that CAL
patients exhibit a similar threshold but a decreased Vo2
max. However, the heart rate was significantly higher at
this point (138 vs 107 beat.min 4) and the work rate was
considerably lower. The Vo2 values at the anaerobic
threshold represent 85% and 54% respectively of the
patients and normals Vo2pmdmu.
Kanarek et al (1979) discussed why there seemed to be
some discrepancies regarding the measurement of an
anaerobic threshold in these patients. His trial
retrospectively divided a group of 12 subjects into two
separate groups, that were based upon the detection of an
anaerobic threshold by gas exchange alone, although blood
gas and pH measurements were obtained. The subjects (mean
FEV1 1.03 1 for the group that reached an anaerobic
threshold and 1.04 1 for the group that did not) performed
an incremental cycle test to exhaustion. Despite the two
groups being clinically similar at rest there were
fundamental differences in their response to exercise. The
group that developed an anaerobic threshold had a
significantly higher 7E (37.8 vs 28.7 1.min4) and
consequently attained a higher percentage of their
predicted VE, and also reached a much higher heart rate
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(159 vs 136 beat.min4 ). There was no significant difference
between the .7o2pei,k (1.05 1.min4 for both groups), the 1co2, R
value or the oxygen pulse. The arterial blood gas results
support the ventilatory measurements of the threshold, both
the pH and the bicarbonate dropped significantly in the
anaerobic threshold group.
From the data Kanarek and colleagues (1979) develop a new
perspective when considering the development of an
anaerobic threshold. The patients who demonstrate an
anaerobic threshold utilised 100% of their breathing
capacity, whilst the group that did not utilised just 74%
indicating that it was unlikely to be a ventilatory limit
to reaching an anaerobic threshold. Kanarek and colleagues
(1979) postulated that the group that reached a threshold
level were stimulated to increase ventilation and had a
higher cardiac reserve, but an anaerobic threshold is not
reached within the limits of exercise in many patients. The
authors continued to suggest that the group developing the
anaerobic threshold in fact have cardiac dysfunction. This
assumption is based upon the 7o 2 at the threshold level
(comparable to that detected in heart disease ,ie 02 flow to
the muscles is reduced) and the high heart rate at the end
of exercise. The group that did not reach this threshold
level, despite reaching a similar workload do not appear to
fall into a distinct category of patients limited solely by
their respiratory or cardio-vascular system. It is
suggested that these patients are limited in their response
to exercise by a combination of factors including muscle
fatigue and weakness.
Elliott et al (1987) compared a direct (arterial lactate
sampling) and indirect method (ventilatory response) to the
determination of AT in a group of 6 patients (mean FEV I 1.25
1) performing maximal cycle ergometry tests. The mean 1.7E
and 1 'o2puk and HR were 50.8 1.min4 , 1.31 1.min4 and 143
beat.min4
 respectively. The mean maximal blood lactate was
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6.3 mmo1.14 . In line with the study of Sue et al (1988) the
patients that developed the greatest increase in blood
lactate also developed the greater 11E , maximal HR (and %
predicted), and 11o2puk . These values did not appear to relate
to the patients' spirometry. Elliott et al (1978)
identified a strong relationship between the two methods,
the most resilient ventilatory measurement that identified
an AT in all six patients was the R value and the end tidal
CO2 (FETCO2). A mean anaerobic threshold was identified in
these patients at a 1102 of 10.3 ml.min4 .ke at a low work
rate exercise.
In conclusion it appears that a rise in blood lactate
concentrations can be detected with an incremental exercise
test in some patients with CAL. However the degree of this
lactic acidosis appears to depend upon how severely the
patient is affected, reflected in his resting spirometry
and how well the patient is able to utilise his exercise
capacity. This is commonly assessed by measuring the heart
rate and max 11E. There appears to be a diversity of opinion
on the measurement of an anaerobic threshold relating to
both the heart rate and work rate at which it occurs, if
indeed it does. The apparently logical conclusions drawn
from the work of Spiro et al (1975) and Jones et al (1971)
relating to the severity of the lung disease are questioned
by the work of Kanarek et al (1979), who identified an
anaerobic threshold in a group of severely affected
patients and proposed cardiac abnormalities in the group of
severely affected patients that attained an anaerobic
threshold.
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3• GENERAL METHODS
3.1 EQUIPMENT
3.1.1 Lung function testing
The lung volumes, FEVI and the FVC were measured on a
vitalograph wedge bellows spirometer. The same type of
instrument was used at both Loughborough and Glenfield
Hospital. The tests were performed at all times in
standing. The correct procedure was explained to the
patients. Expectoration of sputum was encouraged prior to
testing. Subjects were required to perform three acceptable
manoeuvres, that were at least 60 seconds apart.
Acceptability was defined as a forced expiration time of at
least 6 seconds, no detectable volume changes over the last
2 seconds, no coughing and no obvious leak. The best two
results were required to fulfil the reproducibility
criteria; the two FEV1 and FVC values were recorded as being
less than 5% different. The spirometry was recorded for
every patient on each visit as for the study employing
'normal' volunteers. Predicted values of the FVC and FEV,
were taken from those recommended by the European Community
for Coal and Steel (Quanjer 1983) and are specific to an
individuals age, height and sex. All values are expressed
at B.T.P.S. (body temperature, ambient pressure and
saturated with water vapour) FEV, and FVC measurements are
taken to the nearest 0.05 1.
3.1.2 Height
Subjects' height was recorded for all of the trials. At
Loughborough this was assessed using a Holtain Stadiometer,
whilst at Glenfield a stadiometer attached to the balance
scales was used. All subjects were bare footed and the
measurement was taken to the nearest 1.0 cm.
3.1.3 Weight
Subjects were weighed at both Loughborough and Glenfield
with a beam balance (Loughborough - Avery Ltd., Model 3306
ABV. Glenfield - Marsden Ltd., Model 150). All subjects
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were weighed in bare feet wearing the items of clothing
that they would exercise in and any extra items/articles
were discarded. Measurements were made to the nearest 0.05
kg.
3.1.4 Blood pressure
The patients and healthy volunteers had their blood
pressure measured for each visit as a safety precaution.
The measurements were made with a sphygmomanometer. The
cuff was wound closely around the upper arm and the site of
the brachial artery was identified by palpation. The cuff
was inflated to approximately 180 mmHg and slowly deflated
and the systolic and diastolic points were detected by
auscultation.
3.1.5 Heart rate
Heart rate was monitored using two different methods.
For the shuttle walking test and the six minute test the
Sports Tester PE3000 (Cranlea & Co) was used. This is a
short range telemetry device that can monitor and record
ambulatory heart rate. The patient was required to wear a
transmitter that was fastened to an elasticated strap
around the chest. The transmitter was positioned on the
left hand side of the thorax approximately over the heart.
To aid transmission it was necessary to dampen the two
electrodes before positioning the strap. A 'watch like'
receiver was worn on the patient's wrist. It was possible
to define the upper and lower limits of a patients heart
rate and programme the Sports Tester to alarm if either of
these limits were violated. The upper limit used was 85% of
the predicted maximal heart rate using the formula 210 -
(0.65 x age). In addition, the Sports tester had a memory
that when activated stores a particular set of values until
the device is used again. The monitor also had a stopwatch
facility that allowed the synchronisation of the heart rate
response with the start of the exercise test. Reading were
taken every 15 seconds.
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Alternatively, for the trials employing the treadmill,
the heart rate was monitored during each test using a Rigel
oscilloscope (model 302) from three chest electrodes at
Loughborough and a Graseby Medical heart rate monitor at
Glenfield General Hospital. Two electrodes were placed on
either side of the chest, the third was placed proximal to
the right shoulder. Before the electrodes were applied the
skin was cleaned with a Steret and abraded slightly to
ensure a satisfactory contact was made. In addition some
contact jelly was applied to improve the contact further.
During the incremental treadmill test the heart rate was
recorded every 15 seconds.
3.1.6 Borg breathlessness score
Patients were requested to report their perceived
breathlessness at rest and post exercise for all the
shuttle walks and the six minute walking test. Patients
were advised to indicate the severity of their
breathlessness on the scale ranging from 0 to 10, where 0
represents nothing at all or no discomfort with your
breathing and 10 indicates that the intensity of the
breathlessness is maximal. During the treadmill exercise
tests patients were asked to indicate their breathlessness
in the final minute of each stage of walking (Appendix B).
3.1.7 Borg exertion score
Normal subjects were required to report their perceived
exertion on a Borg exertion scale with values ranging from
6 - 20. This was performed at the same times as described
above during treadmill tests (Appendix B).
3.1.8 The Chronic Respiratory Disease Questionnaire (CRDQ)
The CRDQ (appendix C) requires an operator to administer
the questionnaire to the guidelines provided (Guyatt et al
1987) and takes about 20 minutes for the first
administration and 10-15 minutes for subsequent visits. The
initial test requires the patient to identify 5 activities
74
that make him feel short of breath. These can be from the
provided list or patients can volunteer activities specific
to them. The activities that the patient selected form the
dyspnoea component of the questionnaire and are the
activities repeated in follow-ups use for the dyspnoea
component. The questionnaire has a total of 19 questions
that when analysed are divided into four component parts,
dyspnoea as described above, fatigue, mastery, ie does the
patient feel in control of their chest disease and
emotional function. After each question the patient is
presented with a colour coded card upon which are seven
numbered responses and the patient selects the number that
best corresponds with their perceived breathlessness/
fatigue etc. For follow-up questionnaires the patient is
informed of the answer he gave last time. The 19 questions
have a potential total score of 140, although the four
components do not have an equivalent potential score.
Significant change is documented if the score for each
block has increased on average of 0.5 per question
(dyspnoea 2.5, fatigue 2.0, emotion 3.5 and mastery 2.0).
3.2 EXPIRED AIR COLLECTION (Douglas bag collections)
Expired air was collected via a rubber mouthpiece
(Harvard Equipment). A nose clip was worn (Harvard
Equipment) during collection of expired gases. The
mouthpiece was connected to a light weight two-way valve.
Wide bore (30 mm) tubing (Falconia) connected the valve to
a two way tap which was opened and closed manually at the
appropriate time to allow the collection of the expired air
in the 150 litre Douglas Bags (Harvard equipment).
3.3 EXPIRED GAS ANALYSIS
i. Oxygen analyser The oxygen content of the expired air
was measured using a paramagnetic oxygen analyser (Sybron;
Taylor Servomex, model 570A), with a digital display
accurate to 0.1%. The calibration and gas analysis
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procedure are described more fully in Appendices D and E.
ii. Carbon dioxide analyser An infrared carbon dioxide
analyser (Mines Safety Appliances Ltd.; Lira Model 303) was
used to measure the carbon dioxide content of the expired
air. The percentage of carbon dioxide was expressed on a
meter in an analogue form that was converted to a
percentage of carbon dioxide with a dedicated calibration
curve. The calibration and analysing procedures can be
found in Appendices D and E.
iii. Gas meter The expired air was evacuated from the
Douglas bags using a Moulinex vacuum pump. The volume of
expired air was determined using a dry gas meter (Harvard
Instruments). A thermistor linked to a thermometer (Edale
type 2948, Model C), was sited inside the air inlet pipe
allowing measurement of the temperature of the expired air.
3.4 SUBJECT RECRUITMENT AND CONSENT
Patients were contacted either by letter or informally at
the medical out-patients clinics. Regardless of the method
of contact the patients received a document outlining the
aims of the study and their involvement if they consented
to participate. This initial communication briefly outlined
both the potential risk and the benefits from taking part
in the study. At this stage patients were requested to
complete a form indicating interest in taking part in the
study. Further contact (telephone) confirmed the patients
interest, resolved any queries and arranged the first
appointment. At this first appointment written consent was
sought and patients were informed that they could drop out
from the study at any stage without having to give a
reason.
3.6 STATISTICAL METHODS
Standard parametric statistical techniques were used
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throughout (Cohen and Holliday 1979, Hicks 1988) for the
data that was interval and/or ratio. Relationships between
two or more variables was examined using the Pearson
Product Moment correlation coefficient. To examine the test
retest reliability of the shuttle walking test and the six
minute walking test an intraclass correlation coefficient
(R) was employed as recommended by Baumgartner and Jackson
(1987). Students t-test was used for testing the
significance between two correlated means. Differences and
relationships were considered significant at the 0.05
level. According to the recommendations of Bland and Altman
(1986) the level of agreement was analysed and expressed as
the mean difference between two variables and their 95%
confidence interval.
Non-parametric statistical analysis was employed for
sample sizes of n<10, according to the recommendations of
Siegel (1956). Spearman Rank order correlations are used to
compare two sets of results and the Wilcoxon matched pairs
signed ranks test is used to examine the difference between
two related samples. In addition the results of the CRDQ
and reported Borg scale data (both ordinal scales) for the
study were analysed using non-parametric tests (Friedman
two-way analysis of variance by ranks for repeat visits and
the Wilcoxon matched pair signed ranks test for the
comparison of two visits). However it is not uncommon in
medical and related journals to analyse this data using
parametric statistical analysis. For this reason the
results relating to these two areas do express both the
Pearson Product and the Spearman rank order correlation
coefficients enabling a comparison to be made from data
relating to similar patient groups.
Unless otherwise stated the values expressed in the text
and the tables refers to the group means (x) and the
standard deviation (S.D).
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4. DEVELOPMENT OF A 10 METRE SHUTTLE WALKING TEST OF
FUNCTIONAL CAPACITY IN PATIENTS WITH CHRONIC AIRWAYS
LIMITATION.
4.1 INTRODUCTION
It is well documented that a patient's responses to
static lung function tests are poorly related to their
ability to perform exercise and cope with the activities of
daily living (Swinburn et al 1985). Exercise testing is
therefore employed to provide objective measures of
functional capacity and quantify disability. Laboratory
assessment, using a treadmill or cycle ergometer test is
both expensive and time consuming. Consequently, attention
has focused upon the development of reliable field exercise
tests. These are predominately walking tests, although step
tests which have their origins in the assessment of cardiac
patients are also employed (Johnson et al 1977).
The most commonly used field tests are the 6 and 12
minute walking test (6 and 12 MWT). These tests are self
paced and rely upon the individual to gauge an appropriate
walking speed aiming to cover as much ground as is possible
in the time allowed. It is assumed that the distance
completed allows the operator to estimate an individual's
functional capacity. Many authors have questioned the
validity of these self paced walking tests as a means of
assessing patients effectively and monitoring change in the
patient's condition (Morgan 1989).
The purpose of this study was to develop and examine the
reproducibility of an incremental, externally paced field
exercise test that stresses patients with CAL to a symptom
limited maximum performance. The principle was that
employed in the 20 metre shuttle running test proposed by
Ldger and Lambert (1982) and is now widely used to assess
functional capacity in sports men and women. Performance on
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the 20m shuttle running test has a strong relationship
(r=0.92) with directly measured /o2mk (Ramsbottom et al
1988). A modification of this shuttle running test was
first employed for patients with CAL by Scott (1989). The
speeds of walking were directly proportional to the speeds
of the running test. A 10m course was used and Scott
(1989) reported adequate test/retest reproducibility.
Problems were identified with the range of walking speeds
selected and with the timing of the increments. The present
study develops a more appropriate protocol with differing
walking speeds and increments.
4.2 METHOD
In developing the new protocol some problems identified
by Scott (1989) had to be addressed. A slower start was
required that would allow the assessment of the more
severely affected patient. For the less disabled patients
an increased number of increments was needed (10 walking
speeds were originally employed) and a faster final speed
than the initial 10-level shuttle walk protocol. These
modifications were based upon two observations; firstly in
the group studied by Scott (1989) one patient completed the
10-level course, and secondly, as the mean FEV i was just 0.5
1, it was proposed to develop a more demanding test for the
less disabled patients. The final proposal was to
standardise the length of each increments to one minute,
comparable to many incremental laboratory based tests.
4.2.1. TEST PROCEDURE
The test required the patients to walk up and down a 10
metre course (Fig 4.1). The course was identified by two
cones inset 0.5m from either end to avoid the need for
abrupt changes in direction. The speed at which the patient
walked was dictated by audio-signals played from a tape
recorder, originally generated from a BBC micro-computer.
The accuracy of the timed signal was ensured by the
inclusion on the tape of a calibration period of one minute
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FIGURE 4.1
	 The shuttle walking test.
10 metres
1 shuttle = 10 m
1 level = n shuttles
where n depends on walking speed
which could be checked against a stopwatch.
The explanation to the patient was standardised and
recorded on the tape before the start of the test (Appendix
A), advising the patient to "walk at a steady pace, aiming
to turn around when you hear the signal. You should
continue to walk until you feel that you are unable to
maintain the required speed without becoming unduly
breathless."
The start of the test was indicated by a triple bleep.
Thereafter the tape emitted a single bleep at regular
intervals at which points the subject attempted to be at
the opposite end of the course, ie by the time the patient
heard the signal he should be turning around the cone and
proceeding back down the course. Each minute the speed of
walking was increased by a small increment (0.17 m. s'), so
the patient was required to walk progressively faster. A
change of speed to a higher level was indicated by a triple
bleep.
The first speed of walking was referred to as level 1,
the second as level 2 and so on. Each level lasted for one
minute and the tape continued for twelve minutes. The
number of shuttles (10m lengths) in each level depended on
the walking speed at that level (Table 4.1). For example,
the patient is required to complete three shuttles in the
first level. The number of shuttles the patient completes
within consecutive levels increases by one, ie, for level
2, three shuttles, for level 3, four shuttles and so on.
Figure 4.2 shows the total number of shuttles completed at
the end of each level. To help the patient establish the
routine of the test and the first, very slow speed of
walking the operator walked alongside for the first minute.
The patient has 20 seconds to complete each of the 3
shuttles in the first minute.
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TABLE 4.1 The shuttle walking test protocol.
SPEED
Level m.s4 km.h4 mile.
h4
shuttle
time
(s)
No. of
shuttles
in level
1 0.50 1.80 1.12 20.00 3
_
2 0.67 2.41 1.50 15.00 4
3 0.84 3.03 1.88 12.00 5
4 1.01 3.36 2.26 10.00 6
5 1.18 4.25 2.64 8.57 7
6 1.35 4.86 3.02 7.50 8
7 1.52 5.47 3.40 6.67 9
8 1.69 6.08 3.78 6.00 10
9 1.86 6.69 4.16 5.46 11
10 2.03 7.31 4.54 5.00 12
11 2.20 7.92 4.92 4.62 13
12 2.37 8.53 5.30 4.29 14
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FIGURE 4.2	 The cumulative number of shuttles completed
at the end of each level.
2	 4	 6	 8	 10	 12
Completed levels
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After this first minute the patients paced themselves to
co-ordinate their walking speed with the timed signals. If
the patient reached the cone before the signal they were
instructed to remain at the end of the course until the
signal indicated they could proceed with the test.
The operator sat along the 10m course and no
encouragement was given. The only verbal contact was the
advice given each minute to increase the walking speed
slightly. In practice, all patients found it easy to pace
themselves using the cues from the tape recorder.
The end of the test was determined by either (a) The
patient; when he was too breathless to maintain the
required speed or, (b) The operator; if the patient failed
to complete the a shuttle in the time allowed, ie if the
patient being more than 0.5m away from the cone when the
bleep sounded or (c) Attainment of 85% of the predicted
maximal heart rate. Maximal heart rate (beat.min 4) was
predicted by the formula [210 - (0.65 x age)].
The number of completed levels and shuttles was recorded
and was converted from a total number of shuttles to a
distance in metres.
4.2.2 PATIENT GROUP
The entire study was approved by the Leicestershire
Health Authority ethical committee. Ten patients were
recruited from medical clinics at Glenfield General
Hospital and given a full explanation before informed,
written consent was obtained. All patients were clinically
stable throughout the trial, requiring no hospital
admissions or alteration to their drug therapy.
Patients were excluded from the trial if they had
documented:
(i)	 A diagnosis of hypoxia (arterial blood P02 less
than 8 kPa).
84
(ii) Cor pulmonale or ischaemic heart disease.
(iii)Neurological or locomotor disorders.
The exclusion criteria represent an attempt to identify all
patients whose limitation to exercise might not be due
exclusively to the failure of the respiratory system to
meet the demands of the test.
The patients made three visits to the hospital at intervals
of one week, at the same time of day to preclude any
diurnal variation in the disease. They administered no
bronchodilator therapy for three hours prior to testing but
continued to take all other medication as normal. The
baseline measurements for each visit were:
(i) Spirometry (FENT/ and FVC) (3.1.1)
(ii) Borg Breathlessness scale (Borg 1982) at rest
(Appendix B).
(iii)Resting heart rate [measured with short range
telemetry device(3.1.5)].
(iv) The Chronic Respiratory Disease Questionnaire
(Appendix C)
The patient was always asked to report on their perceived
breathlessness prior to the spirometry. The resting heart
rate value was taken after 2-3 minutes of sitting after the
telemetry device had been positioned.
Throughout the test heart rate was monitored and at the
end of the test the patients rated their perception of
breathlessness.
4.3 RESULTS
No patient was excluded or withdrew from the study (Table
4.2 shows the physical characteristics of the group) and no
problems were experienced with patients finding it
difficult to pace themselves. No patient was 'disqualified'
because the speed of walking was misjudged.
The distances walked ranged from 90 m to 520 m ie, from
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TABLE 4.2 Some physical characteristics [mean (SD)] of
the patients, n=10.
(6 male, 4 female)
Trial 1 Trial 2 Trial 3
Age	 X 63.0 - -
(yr)	 SD 6.3 - -
Height	 X 1.65 - -
(m)	 SD 0.07 - -
FEV,	 (1)	 X 1.05 1.10 1.18
SD 0.42 0.43 0.41
FEV1 	 X 41.4 44.1 47.6
%predicted SD 16.9 19.4 18.4
FVC	 X 2.22 2.40 2.52
SD 0.63 0.53 0.59
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level 2 plus 2 shuttles of level three to the end of level
8. No patient completed the 12-stage protocol. The mean
distances walked for trials 1, 2 and 3 were 345, 376 and
378 m respectively (Table 4.3 and Fig.4.3). The agreement
between the trials was examined in two different ways. The
starting point was to examine the relationship between the
distances walked on each trial (Table 4.4). Secondly the
mean difference and 95% confidence interval of this
difference were used to examine agreement.
The mean resting heart rate was 87, 84 and 85 beat.min4
respectively. The results of the heart rate measurements
are presented in Table 4.5 and Table 4.6 and Figure 4.4.
This represented a mean increase from the resting level of
38, 44 and 42 beat.min4 . The increase in the heart rate and
the mean maximal heart rate values were not significantly
different for the three trials. The horizontal line on
Figure 4.4 represents the anticipated maximum heart rate
for a 63 year old, the mean age of the group. The
relationship between the distance walked and the percentage
of maximal heart rate attained is shown in Table 4.7.
Figure 4.5 represents the relationship from these values
for trial 3. Figure 4.6 shows the heart rate values taken
at the end of each minute for two representative patients.
There was a poor correlation between walking performance
and patients' lung function values for all three trials
(Table 4.8).
The Borg breathlessness ratings post-exercise are shown
in Table 4.9 and 4.10. The mean increase from the resting
values were 2.7, 2.5 and 2.6 for the 3 trials. There were
no significant differences between trials for the reported
ratings post- exercise test. There was no relationship
between the Borg breathlessness rating and the spirometry
results (FEVI and FVC).
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TABLE 4.3 Mean, standard deviation and range of distances
(m) completed on the 10m shuttle walking tests.
Trial X SD Range
1 345 121 90 - 470
2 376 125 150 - 520
3 378 117 140 - 510
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FIGURE 4.3	 Mean (SEM) maximal distance (m) walked on
trials 1, 2 and 3.
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TABLE 4.4 Mean and standard deviation of between trial
differences (m) together with 95%
confidence	 intervals
	 (in )	 and	 Intraclass
Correlation coefficients (R) describing the
relationship between distance walked on the 3
trials.
comparison X SD 95% CI R
1 vs 2 -31.0* 25.1 -49.0 to 13.0 0.97
1 vs 3 -33.0* 21.1 -48.1 to 17.9 0.74
2 vs 3 -2.0 27.8 -21.9 to 17.9 0.87
* significantly different p<0.05
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TABLE 4.5 Mean and standard deviation maximal heart rate
(beat.min4 ) during the 10m shuttle walking
test.
Trial X SD range
1 125 17 97 - 145
2 128 17 97 - 151
3 127 17 95 - 150
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TABLE 4.6 Mean and standard deviation for maximal heart
rate (beat.min4 ) expressed as a
percentage of predicted maximal heart rate
[210 - (0.65 x age)].
Trial X SD range
1 74 10 57 - 87
2 76 10 57 - 86
3 75 10 55 - 86
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FIGURE 4.4	 Mean (SEM) maximal heart rate (beat.min4)
recorded for trials 1, 2 and 3.
1
	
2
	
3
Trial
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TABLE 4.7 Pearson Product Moment correlation evaluating
the relationship between the distance walked
and percentage of predicted maximal heart rate
attained.
Trial r
1 -0.11
2 0.08
3 0.13
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FIGURE 4.5	 Mean maximal heart rate expressed as a
percentage of predicted maximum plotted
against the distance walked (m), trial 3.
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FIGURE 4.6 The heart rate response (beat.min4) to the
shuttle walking test for two representative
patients.
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TABLE 4.8 The relationship between three lung function
variables and patients' performance (Pearson
Product Moment correlation) for three trials.
Trial FEV1 FVC % FEV1
1 0.58 0.28 0.25
2 0.53 0.37 0.46
3 0.24 - 0.04 - 0.09)
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TABLE 4.9 Post exercise Borg breathlessness scale scores
for the three trials.
Trial mean SD range
1 3.7 3.6 1 - 7
2 4.1 4.1 2 - 6
3
_
3.8 3.6 2 - 7
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TABLE 4.10	 Mean (SD) difference and the 95% confidence
interval between the Borg rating for trials
1, 2 and 3 and the Spearman Rank Order
Correlation coefficients, evaluating between
trial relationships of these ratings.
Trial d SD 95% CI rho
1 vs 2 -0.4 1.3 -1.3 to 0.5 0.49
1 vs 3 -0.1 1.6 -1.3 to 1.1 10.58
0.12, 2 vs 3 0.3 1.9 -1.1 to 1.7
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The results of the CRDQ, analysed according to the
recommendations of Guyatt and colleagues (1987), identified
a haphazard pattern of significant difference between
visits for the four components of the questionnaire for the
individual patients, the majority of the differences
occurring between trials one and two. However using the
Friedman two-way analysis of variance by ranks test there
were no differences between the four components over the
three trials. The patients were therefore assumed to be
psychologically stable over the study period.
The relationship between the CRDQ response and the
patients' spirometry measures for the 3 occasions is shown
in Table 4.11. There was a moderate relationship between
the dyspnoea and fatigue scores and the patients' FEV1 and
FVC, in particular the FEV/ value for all three trials. The
correlations between each individual component of the CRDQ
and the distance walked are shown in Table 4.12. (r-values
to allow comparison with other similar trials where this
was the chosen test).
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TABLE 4.11 Relationship between the CRDQ responses and
the patients' spirometry results shown by
the Spearman Rank Order Correlation
coefficient	 (Pearson	 Product	 Moment
Correlation).
Trial Spiro- Dysp- Fatigue Emotion Mastery
metry noea
FEV1 0.44 0.42 0.17 0.52
1 (0.75) (0.27) (0.24) (0.60)
FVC 0.31 0.45 0.13 0.34
(0.48) (0.49) (0.06) (0.36)
FEVI 0.55 0.41 0.62 0.20
2 (0.83) (0.48) (0.63) (0.37)
FVC 0.47 0.77 0.42 0.23
(0.48) (0.68) (0.40) (0.19)
FEV1 0.42 0.56 0.46 0.45
3 (0.75) (0.57) (0.61) (0.52)
FVC -0.27 0.57 0.29 0.23
(0.11) (0.59) (0.32) (0.27)
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TABLE 4.12	 Spearman Rank order Correlation coefficients
(Pearson Product Moment) between the four
components of the chronic respiratory
disease questionnaire and the distance
walked on the three trials.
Trial Dyspnoea Fatigue Emotion Mastery
1 - 0.20 0.36 0.33 0.30
(0.33) (0.42) (0.18) (0.39)
2 0.30 0.70 0.36 0.70
(0.36) (0.61) (0.24) (0.64)
,
3 -0.39 0.30 0.17 0.51
(-0.02) (0.38) (0.18) (0.43)
,
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4.4 DISCUSSION
The performance of patients with CAL is limited by
breathlessness due to a mixture of abnormalities of gas
exchange, chest wall and pulmonary mechanics. However the
limitation to individual performances cannot be predicted
by the measurement of these factors alone (Lancet editorial
1987). It has been proposed that day to day activities are
mostly of an irregular nature with a steady state rarely
being achieved (Spiro 1977). Consequently, it is likely
that the patients' symptoms are revealed or identified most
clearly during an incremental exercise test.
The shuttle walking test fulfils the basic criteria for
an exercise test in patients with CAL. It is based upon a
familiar activity and, unlike cycle ergometry or treadmill
walking, is simple for both the patient and operator and
requires minimal equipment. The test is standardised,
incremental and externally paced, diminishing the effect of
the operator's influence. Although the operator walks
alongside for the first minute this cannot constitute a
positive effect on the speed of walking as this is
externally paced and the operator invariably for the first
minute is required to slow patients down. The operator then
sat alongside the course and issued no encouragement.
Obviously the presence of an operator can influence the
patient's performance as is true for any other exercise
test this influence is minimised because the external
pacing does not allow the patient to walk faster. External
pacing allows inter and intra-subject comparison. Patients
who complete 500 m of an incremental exercise test have
experienced a similar cardio-respiratory stress and
therefore a comparison of individual performance is valid.
There was a significant difference between the distances
walked in trial 1 and 2 but the difference between trials
2 and 3 was not significant, suggesting a small learning
effect before the test is a reproducible measure of
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disability (Fig.4.4 and Table 4.4). Therefore the shuttle
walking test is a reproducible exercise test of disability
after just one practice walk. The shuttle walking test
appears to be an attractive alternative to existing field
exercise tests on the strength of the test/retest results
alone, because existing field tests require more than two
practice walks before these test are considered
reproducible. A training effect is an unlikely explanation
for the increase in the distance walked between trials 1
and 2 as the trials were conducted at intervals of just one
week, during which time the patients continued with their
daily routine, participating in no extra strenuous
activity. The possibility of a type II error (not rejecting
the null hypothesis when it should be rejected) is possible
because of the small group of patients. However the mean
difference of -2m is equal to a difference of approximately
0.5% decreasing the possibility. Employing the nomogram
proposed by Altman (1980) a vast number of subjects would
need to perform the shuttle tests to be confident that
there would be an 80% chance of detecting a significant
difference at the 5% level if the mean difference was 2m.
The heart rate data (Fig.4.4, Table 4.5) supports this
proposal of a learning effect; there is a strong
correlation of the mean maximal heart rate between the
three trials. There was a slightly greater difference
between the maximal and resting heart rate values for trial
1 vs trial 2, but this was not a significant difference
(Table 4.5). These data suggest that the difference in
distance achieved between trials 1 and 2 was not due to
patients utilising a higher percentage of their cardio-
respiratory reserve during later trials. In fact the
patients exercised to an equivalent level of cardio-
respiratory stress in all three trials. The difference in
distance between the two tests can therefore probably be
assigned to patient familiarisation with the routine of the
test. This study is consistent with the study of Brown et
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al (1985) who confirmed the reproducibility of heart rate
response during maximal exercise in patients with CAL.
No patient was stopped by the operator whilst performing
the shuttle test because 85% of the mean maximal heart rate
was attained. The mean maximal heart rate attained by these
patients was well below 85% of the predicted maximal heart
rate threshold, suggesting that the capacity of the cardio-
vascular system was not the limiting factor in the
termination of an incremental exercise test in this patient
group. This assumption is supported by the data of Figure
4.4. The horizontal line drawn represents the mean maximal
heart rate anticipated for a 63 year old, the mean age of
the group. A ventilatory limit to functional capacity,
although an attractive assumption in this group of
respiratory patients, cannot be concluded from this data.
This issue is addressed in Chapters 5 and 7 where the
ventilatory response to exercise is measured directly.
There appears to be no relationship between the distance
walked and the mean maximal heart rate expressed as an as
a percentage of that predicted (Table 4.7). Therefore we
are unable to suggest that a patient's performance and
their ability to utilise their cardiac reserve is related.
Figure 4.6 demonstrates that the test provokes a
significant increases in heart rate and a graded cardio-
vascular response. The incremental stress presented by the
shuttle walking test shown is confirmed by the graded
cardio-vascular response but could be examined more
rigorously by measuring the ih% requirements to the exercise
test. Furthermore the heart rate date highlights the safety
and the low risk of the shuttle walking test, the patient
gradually responds to the controlled increase of walking
speed to a point equivalent to a symptom limited maximum
performance. The increase in the heart rate to this point
indicates that the test presents a physiological challenge
to the patients and stresses their cardio-vascular system
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to a definite maximal end point unlike a sub-maximal
unpaced test where the end point is not defined
physiologically but usually by duration.
The lung function values, in agreement with other
exercise studies (Knox at al 1988, Swinburn et al 1985),
bore a poor relationship with the patients' performance
(Table 4.7) and confirm the need to perform objective
exercise tests to assess the true extent of a patient's
disability. The ability to exercise is multi-factorial and
is not reflected solely in an individual's ability to
expire air forcefully. This finding is in agreement with of
Dillard et al (1985 & 1989) who suggested that PIFR and
peak inspiratory pressure measurements may aid the
prediction and relationship between lung function values
and exercise tolerance.
There was a small but significant difference between the
resting Borg scale between trials one and two (p<0.05),
otherwise the scores were not significantly different. This
initial difference in the resting values could not be
explained by the patients and no alteration in
breathlessness (dyspnoea) was reported in the CRDQ for the
week prior to the second trial. The initial higher score in
the mean Borg rating may be related to an underlying
anxiety during the first trial. The Borg data is in
agreement with the work of Silverman et al (1988) and
opposes the finding of the study of Belman et al (1991).
That is, the Borg scale appears to be a reproducible
measure of breathlessness in the present study group. The
similarity between this study and that of Silverman and
colleagues (1988) is that both employed maximal exercise
tests. From these results it was concluded that the Borg
scale, although a subjective measure, provided an easily
applied, reproducible scoring of breathlessness that could
be used in conjunction with the shuttle walking test on a
day-to-day basis to assess patients' response to the
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physiological stress of exercise.
No difficulties were experienced in administering the
CRDQ except in one patient who failed to identify the
required five activities that cause breathlessness. The
CRDQ scores were highly reproducible. From the data
obtained it was concluded that our patient group was
psychologically/ emotionally stable throughout the period
of observation and it was therefore unlikely that the
distances walked on the three occasions were influenced by
pronounced mood changes.
Like the report of Weir et al (1991), examining the
relationship between the CRDQ response in patients with CAL
and cystic fibrosis, our patients did not demonstrate a
strong correlation between the CRDQ scores and their FEV/
and %FEV/ values (Table 4.10). However the relationship that
was identified was considerably stronger than that of Weir
et al (1991). For example the correlation coefficient
reported by Weir between FEV 1 and dyspnoea was 0.068,
whereas the strongest relationship that was identified in
the present study for the same variables was evaluated as
0.55 (rho). It should be noted that Weir and Colleagues
(1991) do not describe their method of statistical
analysis. In the development of the CRDQ Guyatt et al
(1978) analysed the data using parametric tests to examine
between test differences (t-test) and the relationship
between exercise test performance and the results of the
CRDQ (Pearson Product Moment Correlations). Although not
strictly correct, using a Pearson Product Moment
Correlation to examine the relationship between the CRDQ
scores and patients lung function values a strong
relationship was identified for this patient group.
The distance walked also had an inconsistent and
generally poor relationship with the CRDQ scores (Table
4.11). These findings are consistent with the study of
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Guyatt and colleagues (1987) validating the CRDQ. Using
parametric analysis Guyatt et al (1987) identified a
moderate correlation between the CRDQ scores and patients'
performance on a six minute walking test (r=0.46, 0.35 and
0.19 for dyspnoea, fatigue and emotion respectively). This
moderate link between performance on the shuttle walking
test and the CRDQ scores indicates that exercise tolerance
and the individual's subjective assessment of their quality
of life may be linked. However a patient's perception of
feelings such as breathlessness or fatigue does not
quantify functional disability. Despite the continuing
number of quality of life measures being published, they do
not offer a replacement for exercise testing but are rather
a useful adjunct in the overall assessment of the patient.
In conclusion, the results of this reproducibility study
suggest that the modified 12-stage protocol is, after just
one practice walk, a reliable indicator of exercise
tolerance in patients with CAL. Moreover, the protocol is
easy for both the operator and the patient to perform. The
results confirm that this modified protocol suits a wider
range of patients having a more appropriate range of
walking speeds and increments than the original protocol
employed by Scott (1989). The 12-stage protocol had a
slower start and more increments than the 10-stage protocol
and could therefore accommodate the assessment of the more
severely affected patient and stress the more able patients
to a symptom limited maximum performance. However,
reproducible results are obtained regardless of whether the
patient completes 1 or all 12 levels of the shuttle test,
lending itself to the assessment of both in- and out-
patients. An objective measure of change in a patient's
functional capacity is allowed with greater objectivity
with the shuttle walking test than with the currently
available alternative field walking tests.
From the work presented so far it is possible to state
108
that the shuttle walking test is both standardised and
incremental, facilitating a valid intra- and inter-subject
comparison of exercise tolerance. A measure of functional
capacity can therefore be obtained from those patients with
severe CAL through to those with minimal restriction of
their exercise capacity.
The shuttle walking test has the potential to be used as
a cheap and effective research tool to monitor patients
response to various therapeutic interventions. For the
shuttle walking test to become a widely accepted method of
assessment it is necessary to validate the test against a
traditional measurement of functional capacity. In addition
it would be prudent to compare a patients response to the
shuttle walking test and the traditional field walking
test, the six minute walking test. These issues are
examined in the following chapters.
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5. EXAMINATION OF THE VALIDITY OF THE SHUTTLE WALKING
TEST AS A MEASURE OF FUNCTIONAL CAPACITY BY
COMPARISON WITH SYMPTOM LIMITED OXYGEN UPTAKE
5.1 INTRODUCTION
The results reported in Chapter 4 indicate the
reproducibility of the shuttle walking test as a method of
measuring exercise tolerance in patients with CAL. However
to become an accepted method of assessment the shuttle
walking test has to be valid as well as reproducible.
The traditional indicator of cardio-vascular fitness is
considered to be the N.702 (Astrand & Rodahl 1986).
Unfortunately there is a paucity of data validating field
exercise tests against /o2 . The original paper proposing
the 12 minute walking test (McGavin et al 1976) revealed a
poor relationship with directly measured N.7o2puk (r=0.52).
Despite this, the test is commonly used as an indicator of
exercise tolerance. Comparison of the 12 minute walking
test against a treadmill test was performed in patients
with pulmonary vascular disease (Cremona et al 1991). A
moderate relationship was identified between 17o 2pad, and
distance walked (r=0.60).
The aim of this study therefore was to examine the
relationship between the shuttle walking test performance
and the 1O measuredured directly during a comparable
activity, ie during a treadmill walking test.
5.2 METHOD
5.2.1 Patient group
Twenty-two patients were recruited for this study from
medical out-patients	 clinics.	 Informed	 consent was
obtained. The	 selection	 of	 patients	 conformed to the
criteria described	 in	 Chapter	 4	 (4.2.2).	 None of the
patients had performed a treadmill test prior to this study
although a few of the volunteers had taken part in the
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previous study. No allowances were made for this and all 22
patients followed the prescribed protocol. The patients
were required to make three visits, two to Glenfield
General and one to Loughborough University. These visits as
far as possible were made at intervals of one week. The
patients were instructed to withhold relevant medication
(4.2.2) and the baseline measurements including the CRDQ
were as described for the reproducibility study (4.2.2) for
all three visits. All patients were clinically stable.
5.2.2 Familiarisation visit
This first visit was conducted at Glenfield General
Hospital. Patients were required to perform one practice
shuttle walk and a submaximal treadmill test. The shuttle
walking test was conducted according to the protocol
established in Chapter 4 (4.2.1). The initial treadmill
test (Cambridge Medical Instruments 3060) was conducted in
the Cardio-respiratory Department.
The treadmill protocol chosen was modified Balke
protocol (Nagle et al 1965). This test requires the
individual assessment of speed appropriate to each patient
aiming to reach a maximal performance in 6 - 10 minutes.
All the patients then follow the same protocol, the
inclination of the treadmill was increased from 0% by 2.5%
every 2 minutes to a symptom limited maximal performance.
The aim of this first visit was to familiarise the
patient with treadmill walking and to establish an
appropriate speed for that individual to evoke a symptom
limited maximal performance either 1 or 2 weeks later at
Loughborough University. The treadmill test at this stage
was sub-maximal and a suitable speed to evoke a maximal
performance was gauged by a patients' heart rate response
(Sports Tester PE3000 3.1.5.) and their perceived rate of
breathlessness (3.1.6). During the treadmill walk the
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patients had the opportunity to breathe through a mouth-
piece with nose-clips in place, in preparation for the
expired air collection at Loughborough University. (The
test was sub-maximal primarily because there was no medical
cover). The patients were also requested not to hold on to
the hand rail as far as was possible.
The second and third visit were a balanced design of a
visit to Loughborough and a shuttle walk test at Glenfield
Hospital or vice versa.
5.2.3 The shuttle walking test
The second shuttle walking test was conducted according
to the protocol described in Chapter 4 (4.2.1). Heart rate
was monitored using the Sports Tester PE3000 (3.1.5) during
the walk and the Borg breathlessness scale (3.1.6) was
recorded at the end of the exercise test.
5.2.4 The treadmill test
The visit to Loughborough required the patients to
perform a symptom limited maximum treadmill walking test.
The patient's height and weight was recorded (3.1.2) and
three electrodes were attached to the chest to monitor
heart rate (3.1.5). The patients performed the treadmill
test at the predetermined speed. Expired air was collected
into Douglas bags (3.2) for the second of each two minute
increment. During this second minute patient's heart rate
and the Borg breathlessness scale response was recorded.
When the patient felt that he could continue for only one
more minute he indicated this with a previously agreed
signal. During this final minute of the test expired air
was collected and recordings made as above. The visits to
Loughborough had full medical cover.
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5.3 RESULTS
Twenty-two patients completed the study, but three were
excluded from the final analysis. The reasons for exclusion
were, invalid Douglas bag measurement, patient discomfort
during the shuttle walking test (foot soreness) and thirdly
one patient developed a 'cold' affecting his shuttle
performance. This patient made a repeat visit for the
shuttle test but had not recovered and felt in view of the
seasons changing he was unlikely to be completely well
until the spring (in 6 months time). The results of the 22
patients will be reported initially with a subsequent
report on the 19 patients for whom complete data sets are
available.
The physical characteristics of the group are shown in
Table 5.1. There was no significant difference in the
spirometry values recorded for the patients between the
three trials. The mean FEV I /FVC ratio for the three trials
was 52%, 52% and 54%, consistently demonstrating moderate
impairment. The range of this value fell to below 30%,
indicative of severe impairment, and in one individual rose
to 78% indicating mild impairment. The group of patients
therefore represented a wide range of disability.
As anticipated there was no strong relationship between
the FElli values and the shuttle performance (shuttle 2 vs
FENT, r=0.36).
Throughout the trial period the patients were assessed by
the CRDQ to be both psychologically and emotionally stable.
Examination of the results for the four components of the
questionnaire revealed an occasionally irregular
distributed difference between trials for five of the
patients. This difference proved not to be significantly
different with test/retest.
No patient was excluded from the study because of non
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TABLE 5.1 Some physical characteristics of the patients,
Mean (SD). n=22 ( 17 male, 5 female)
1 Shuttle Treadmill
Age 61.5 - -
(yr) (7.2) - -
Weight 72.49 - -
(kg) (14.58) - -
Height 1.70 - -
(m) (0.06) - -
FEV/	(1) 1.39 1.38 1.45
(0.52) (0.55) (0.57)
FEV1 47.4 46.9 49.9
% predicted (16.8) (17.6) (18.7)
FVC (1) 2.69 2.63 2.67
(0.75) (0.79) (0.73)
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compliance to the protocol of the shuttle walking test and
all patients tolerated the treadmill test and mouthpieces
well.
The distance the patients walked on the two shuttle
walking tests is summarised in Table 5.2. There was a
significant difference between the two shuttle test
distances. The mean maximal heart rate attained at the end
of each shuttle was not significantly different (mean
difference -2.2 beat.min4). The mean maximal heart rate
represents 67% and 68% of the predicted maximal heart rate
for this group. The distance completed on the second
shuttle walking test had a moderate relationship with the
mean maximal heart rate (r=0.65).
The mean maximal Borg score reported post exercise was
not significantly different for the two shuttle tests, ie
4.3 post shuttle 1 and 4.3 after the second shuttle walk
(p>0.05). Both exhibited a very weak relationship with the
distance walked (r=0.18, shuttle 2).
The result of the treadmill test are shown in Table 5.3.
The mean speed the patients walked was 2.52 mph. The mean
duration of the treadmill test was 7.1 (1.7) minutes (range
4-10). The ventilatory measurements for the 22 patients are
also expressed in Table 5.3. The mean to2peak was measured to
be 14.72 ml.min4 .kg4 . The individual percentage of predicted
maximal to2 is shown in Figure 5.1. The mean percentage of
predicted t02 attained was 48.9% employing the
calculations proposed by Bruce et al (1973). This method
uses the patient's age, sex, weight and level of physical
activity to estimate a to 2 . These values were based upon
treadmill exercise testing of 295 healthy individuals, 170
of which were 45 years or over (100 males & 70 females).
The measurements of maximum IE were calculated initially
to STPD (mean 37.44 1.min4 ), however the majority of
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TABLE 5.2 Mean and standard deviation, distance (m)
walked on the two shuttle walking tests and the
mean difference (m) and 95% confidence
interval.
Mean SD
1 379.5 137.3
2 412.7 142.3
Mean 95% confidence
interval
1 vs 2 -33.2* -52.4 to -14.0
. p<0.05
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TABLE 5.3 Mean (SD) treadmill performance and
ventilatory results from the treadmill test,
n=22.
Measurement Mean (SD)
FEV,	 (1) 1.45	 (0.57)
FEVI /FVC 53.9	 (11.5)
iro2pea (ml.min4 .kg4 ) 14.7	 (4.8)
% predicted t:)2 48.9	 (16.1)
NIE	 (1.min4) 45.3	 (15.1)
% predicted ilE 96.3	 (25.8)
Heart rate max (beat.min4 ) 136	 (21)
% predicted max HR 80	 (13)
Oxygen pulse (ml.beat4 ) 7.8	 (2.6)
NB.
"(702 expressed at STPD, Standard temperature (0°C) and
pressure (760mmHg), dry.
N/E expressed at BTPS, Body temperature (37°C) and ambient
pressure saturated with water vapour.
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respiratory physicians present these values at BTPS. It was
therefore necessary to apply a conversion factor (Cotes
1979) to express these values at BTPS (Throughout this
chapter /E from this point is expressed as BTPS).
Consequently the mean maximal ventilation increased to 45.3
1.min4 . Using the equation proposed by Spiro et al (1975)
to predict maximal ventilation, 1:7E = (FEV1 x 18.9) + 19.7,
the mean value for the group reached 96.3% of predicted.
The individual values of maximum /E(BTPS) plotted against
predicted 1.7E are shown in Figure 5.2 [(FEV 1 x 18.9) +
19.7]. Eleven patients exceeded their predicted values
indicating the difficulty in estimating patients exercise
performance from resting spirometric measurements. The mean
maximal R value was 1.06(0.12), indicating that these
patients achieved level of exercise equivalent to their
maximum aerobic capacity.
The heart rate data relating to the treadmill test (Table
5.3) revealed a mean maximal heart rate of 136 beat.min4,
representing a mean value attained of 80% of patients'
predicted maximal heart rate. This value is elevated in
particular by four patients who exceeded 85% of their
predicted maximal heart rate on the occasion of the
treadmill test. The correlation coefficient for the
treadmill performance and the maximal 1o 2 and the maximal
heart rate was r=0.74, comparable to the values obtained
from performance and heart rate response in the shuttle
walking test. However the mean maximal heart rate for the
treadmill test was significantly higher than at the end of
the shuttle walking test. The elevated heart rate response
demonstrated in the majority of patients can be observed in
a comparison of equivalent work rates during the shuttle
and treadmill test. Taking the speed of the treadmill and
the heart rate at 0% inclination a comparable speed from
the shuttle walking test was taken as a reference point to
compare the heart rate, these results are expressed in
Table 5.4. It can be seen that for the majority of
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against the measured 1.7E during the treadmill
test (n=22).
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TABLE 5.4 Patients heart rate (beat.min 4) at comparable
speeds on the treadmill (0%) and on the shuttle
walking test.
Treadmill shuttle test
Pt Speed
mile .h'
HR Level HR A
treadmill-
shuttle
1 1.5 106 2 98 8
2 1.5 92 2 77 15
3 3.0 115 6
-
106 9
4 1.8 113 3 111 2
5 2.0 106 3/4 89 17
6 3.5 116 7/8 106 10
7 3.0 107 6 100 7
8
_
2.5 107 4/5 89 18
9 2.8 93 5/6 92 -1
10 2.8 133 5/6 113 30
11 2.5 109 5/6 112 -3
12 2.5 94 5/6 99 -5
13 2.5 100 5/6 111 -1
14 1.75 138 2/3 120 18
15 2.0 107 3/4 91 16
16 1.5 120 2 99 21
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TABLE 5.4 Cont'd
Treadmill 	 shuttle test
Pt Speed
mile.h4
HR Level HR A
treadmill-
shuttle
17 3.25 122 6/7 111 11
18 3.5 137 7/8 122 15
19 3.5 117 7/8 122 -5
20 2.0 120 3/4 96 24
21 3.25 129 6/7 135 -6
22 2.8 118 5/6 105 13
N.B The speed of the treadmill is matched as far as
possible to the speed of a level of the shuttle walking
test. The values are taken at the end of the minute. The
intermediate speeds that do not correspond directly to a
shuttle speed an intermediate heart rate is taken.
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patients there is a considerably elevated response to the
treadmill test for an equivalent speed and grade.
The mean oxygen pulse at the final stage of exercise was
measured to be 7.8(2.6) ml.beat4.
The heart rate data (Fig. 5.3) and ventilatory
measurements (Fig. 5.4 & 5.5) demonstrate the anticipated
increase in these measurements with an increasing workload
for these three patients, a trend which was evident in all
of the patients. This heart rate response has previously
been demonstrated to occur in the shuttle walking test and
was also apparent in the treadmill test.
The Borg breathlessness scale was found not to be
significantly different at the end of the shuttle and
treadmill test. Mean score post shuttle was 4.2 and post
treadmill test was 5.0. Neither values had a strong
relationship with performance indicators; distance on the
shuttle test vs Borg was just rho=0.18 and the relationship
between the Borg score and the 17o2pcw, was even weaker (r=-
0.02).
In the comparison between the distance walked in the
shuttle walking test and the directly measured 1.7o2pw,
revealed a correlation of 0.72.
Excluding the three patients who failed to complete the
study protocol satisfactorily, the relationship between the
distance walked on the shuttle walking test and the
measured 'Cro2puk increased to r=0.88, Figure 5.6. The
regression equation and 95% confidence interval for this
relationship was Vo2peak = 4.19(1.12 to 7.17) + 0.025(0.018 to
0.031) distance (Fig.5.7). The FEV I values for the three
excluded patients (No. 11, 14 & 18) were 2.55, 1.00 and
1.15 1 altering the mean FEV 1 of the group (n=19) to
1.5(0.55)1. The mean values of Vo2pak drops slightly to
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FIGURE 5.5 Oxygen uptake (ml.min4.kg4) response
measured during the treadmill test of three
representative patients.
30-'
0	 I	 .	 I	 I 1•	 I 
0	 2	 4	 6	 8	 10	 12
Time (min)
126
30 —
0
•	 o
O00o	 o
o o oo 
o
0
r=0.88
FIGURE 5.6	 1102 puk (1111 . miril .kg-1 ) measured on the
treadmill test against performance [distance
walked, Cm)] on the shuttle walking
test. (n=19)
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FIGURE 5.7	 t02pcsk (ml.min-l .kg-1 ) measured on the
treadmill test against performance [distance
walked, (in)] on the shuttle walking
test. (n=19) With the 95% confidence
intervals for the relationship.
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TABLE 5.5 Some physiological variables [mean (SD)] of the
two sub-groups divided by their FEV I values.
Characteristic FEV1 < 1.4 1
n=9
FEV1 > 1.4 1
n=10
FEV1	(1) * 1.03(0.23) 1.80(0.48)
weight (kg) 69.2(16.2) 76.3(14.5)
maximum HR
(beat.min4 ) 129(16) 133(18)
102
 peak
(ml.min4 .kg4 ) 13.2(3.2) 15.0(4.7)
% predicted V02
MAX 46.0(13.7) 48.4(13.3)
IIE
(L.min4 ) 40.3(11.3) 47.7(16.0)
% predicted 147E
MAX 101.6(23.5) 88.7(24.4)
oxygen pulse
(ml.beat4 ) 7.0(2.8) 8.5(2.4)
Significant difference between the two groups p<0.05
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the two groups was 133(18.6) and 129(16.3) beat.min4
representing 76.6% and 76.4% of predicted for the less and
more severely affected patient groups. The oxygen pulse for
the two groups at the final stage of the treadmill exercise
test was 7.3 ml.beat4 and 8.5 ml.beat4 for the groups with
the lower and higher FENT' values. None of these
physiological parameters represent a significant difference
between the two groups.
5.4 DISCUSSION
The measurement of 1.1o2puk is considered to be the
traditional measure of functional capacity. In order to
ensure that the shuttle walking test accurately reflects a
patients functional capacity it was necessary to examine
the strength of the relationship between these two
variables.
The group of patients that volunteered to participate in
the study presented with a diverse spread of lung function
values. This was important for this stage of the study to
recruit a wide range of patients with CAL and not confine
the study to a group falling predominately into the mild,
moderate or severe category.
There appears to be no consensus of opinion regarding a
universal treadmill test for patients with respiratory
disease, unlike the assessment of cardiac patients were
there is some measure of agreement. By adopting an
individualised constant speed the protocol employed was
therefore identical for each patient. This appeared to have
several advantages for this patient group:-
- Each patient's exercise test could be individually
tailored to his/her capacity, although patients would
adhere to the same protocol.
- A fixed speed protocol would not have evoked a
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symptom limited performance in all of the patients in 6 -10
minutes. In addition to this a universal speed would
require some patients to walk at a steep incline where the
limitation to exercise may in fact be peripheral. The
treadmill protocol selected is in line with the views of
Myers et al (1992) advocating the use of an individualised
protocol to ascertain the 1.1o2peak.
The primary aim of this study was to validate the shuttle
walking test in this cohort of patients. In the group of
patients who completed the study successfully (n=19) there
was a strong relationship between the distance walked on
the shuttle test and the to2p„k measured with Douglas bag
techniques whilst performing a treadmill exercise test
(r=0.88). The strong relationship between the Iro 2pm, and the
patients' shuttle performance allows the prediction with
some accuracy of the patients' N:7402A. The coefficient of
determination is 77.4%, indicating that 77.4% of the
variance is common to both measures.
Although it is acknowledged that the accurate measurement
of a 'true' symptom limited iro2p„,k is multi-factorial a large
majority of patients (35 of the 38 exercise tests) stopped
exercising due to the limits reportedly imposed upon their
exercise tolerance by their respiratory system. None of
the present study group reported leg pain but a small
section reported fatigue the following day which they
attributed to the exercise although this tiredness did not
appear relate to their spirometry and degree of respiratory
impairment. Patients did not report their perceived level
of exertion because it was felt that it would confuse some
patients to report on exertion and breathlessness as
separate entities. However this may have identified
alternative reasons for the termination of exercise.
All of the patients reported breathlessness to be the
limiting factor on the treadmill test and all but three
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reported it as their reason for withdrawal from the shuttle
walking test. The remaining three patients were withdrawn
by the operator due to their inability to maintain the
required speed, however two of the three patients reported
moderate or severe breathlessness post-exercise. It was
felt that with the third patients there was a considerable
lack of effort during both the shuttle walking test and the
treadmill test despite reporting a level of 1 8" on the Borg
breathlessness scale at the end point of the treadmill
test.
Overall, the patients' subjective opinion of the two
exercise protocols was not significantly different judged
by the Borg breathlessness scale. This study did not aim to
make a comparison of the relative merits of the treadmill
and shuttle test. The treadmill is a more comprehensive
exercise test that allows detailed and sophisticated
measurements to be made. However, one theoretical
/practical advantage of the treadmill test over the shuttle
test is the facility to increase inclination to further
increase the intensity of the exercise. A point may be
reached in the very minimally affected patient were they
find it impossible to walk faster due to the biomechanical
constraints of their limbs during the shuttle test. However
this did not occur in the present study which consistently
provoked a symptom limited maximal performance.
These results are consistent with the conclusion drawn
from the reproducibility study (4.3); one practice walk is
required to counteract any learning effect and the heart
rate data indicates that it is unlikely to be the cardio-
vascular system limiting exercise performance.
The heart rate responses for both exercise tests produced
the same pattern of an incremental increase in rate with
the increase in exercise intensity. There was some
disparity in the heart rate recordings for the two tests.
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The treadmill test evoked a significantly greater heart
rate than the shuttle test (mean 18 beat.min4 higher). This
may have been due to one or a combination of four factors.
Firstly the patients may have had a higher cardio-vascular
response to exercise due to the anxiety associated with the
unfamiliarity of the laboratory at Loughborough. This
suggestion is supported by the data presented in Table 5.4
where it is apparent that at broadly comparable work levels
the patients exhibit a higher heart rate on the treadmill.
Nevertheless it is difficult to make any valid statistical
comparison at comparable speeds. This effect may have been
compounded by the breathing apparatus that the patient was
required to wear. Secondly, the patients may have had an
elevated resting heart rate. This was not measured but
would consistent with the reasoning above, or it may be
that the heart rate increased disproportionately at the
start of exercise with the mouthpiece positioned and
supported. Thirdly the patients were offered some verbal
support to reach their 1)%12pea, unlike during the shuttle
walking test.
It is generally accepted that a 1.7o21,,,„k in normal healthy
subjects cannot be increased with encouragement although
performance can be ie, the individual would begin to rely
increasingly on anaerobic glycolysis and the distance
completed may increase although the So2pcar is a definite
point that cannot be influenced by encouragement. The level
of encouragement offered to patients during a laboratory
exercise test is not commonly documented and it is worth
considering the potential effects of encouragement on a
patient's performance. Unlike healthy individuals, patients
with moderate/severe CAL do not consistently reach an
anaerobic threshold and therefore often exercise within the
limits of their aerobic capacity. The question that needs
considering is whether patients tolerate the same degree of
symptoms to produce a reproducible symptom limited maximum
performance regardless of encouragement. Finally the
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treadmill test may genuinely have been a more stressful
exercise test, although this is not supported by the
patients' subjective ratings of the two tests. Without the
knowledge of the to2puk during the shuttle walking test this
cannot be resolved. This issue is addressed in Chapter 7.
The strong relationship between the patients' performance
on the shuttle walking test and 1o2pmk allows the prediction
of a patient's functional capacity, unlike self paced field
exercise tests (McGavin et al 1976). In addition it
potentially enables an objective training stimulus to be
chosen for any individual patient based upon their
performance on the shuttle walking test and matching this
to the to2 measurements. From this value a walking speed
(that relates to the speed of any particular level in the
shuttle test protocol) could be selected that relates to
the prescribed percentage of the attained 12A. This level
of training can be secured further by matching it to a
perceived level of breathlessness or heart rate.
The use of a variety of testing methodologies may
contribute towards the disparity of measurements within
clinical exercise testing. Allowing for these differences,
comparison of the ventilatory measurements from this study
appear to be consistent with those previously reviewed
(Belman et al 1991, Kirsch et al 1989, Mihn et al 1979). To
make valid comparisons is further compounded by other
between patient differences that may influence results
including the patients nutritional status (Donahoe et al
1989) and drugs used. All the studies reported above seem
to document a proportion of the physiological parameters
that make only a partial comparison possible. It should be
noted that, for many patients with CAL psycho-social
characteristics may interact with physiological
abnormalities to work limitation (Carlson et al 1991).
The group of patients in this present study revealed a
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wide range of FEV 1 values (0.55 - 3.10 1), constituting a
heterogenous cohort, with a mean 7ro2pc,d, of 14.2(range 7.9 to
22.7) ml.min4 .kg4 (n=19). Kirsch et al (1989) reported in
his small group a mean Vok wa of 1.04 1.min4 . This latter
group, despite its relatively young age reached a mean
maximal heart rate of just 101 beat.min4 , considerably lower
than the heart rate of the present study results. In a
slightly larger group of patients with comparable airways
disease to the present study Brown et al (1991) reported a
to2 of 1.3 1.min4 and a tE of 52 1.min4 . These values appear
to be slightly high compared to the present study and other
reports (ZuWallack et al 1991, Mihn et al 1979).
By creating the two separate patient groups (judged by
spirometry,ie FEV1 above or below 1.4 1) the present results
are in even closer agreement with previously documented
studies that have recruited small patient groups. The
present results parallel the trend documented by Spiro and
colleagues (1975) and Jones et al (1971). Both of these
studies divided the initially large study group into
smaller groups based on the FEV 1
 and reported higher tE and
To
	 the less severely affected patients.
However unlike the study of Spiro et al (1975) the
present study demonstrated that the mean maximal heart rate
was similar in both groups. Alternatively, Kanarek et al
(1979) retrospectively identified a significantly different
cardio-vascular response in a group of patients with a mean
MI of just 1.04 1. This single group manifest two distinct
responses.
The discrepancy between ventilatory values is similarly
less pronounced in the present study than in the study of
Spiro et al (1975). The more severely affected group in the
present study reached a 11o2limic 46% of their predicted,
corresponding to 13.2 ml.min4 .kg4 whilst the less severely
affected group attained a to2k
 48% of their predicted,
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corresponding to 15.0 ml.min4 .kg-1 . The values are not
expressed as a percentage of predicted by Spiro et al
(1975). Jones et al (1971) do not present data on 110 2peak . The
magnitude of tE values for the two separate groups in the
present study and that of Spiro et al (1975) are more
closely related, with the less severely affected group able
to consume a relatively larger volume than the more
severely affected group. These values, again in agreement
with Spiro et al (1975) (not expressed by Jones 1971)
translate into a greater percentage of predicted maximal
ventilation being achieved by the more severely affected
group. Lockhard (1979) suggested that the limitation to
ventilation is accompanied by an almost proportional
reduction in Io2p„k . The present data would go some way to
supporting this proposal.
The prediction of maximum tz is difficult especially in
patients with a severe restriction. Belman (1986) comments
that 'although the use of these equations has been
suggested to be valuable it is difficult to see how they
can be useful when the range of predicted values is so
wide'. This comment is supported by the work of Spiro et al
(1975). Formulae employing the FEV1 alone have poor
precision (Dillard et al 1985), although this can be
reduced by incorporating more sophisticated measurements of
peak inspiratory and expiratory pressures. The simple
commonly employed equation, ie FEV I x 35 considerably
underestimates 'O'E	 in patients with an FEV 1 less than 1.0
1 (Spiro et al 1975). However of the patients presenting
for this study only two had an FENT, of less than 1.0 1.
Spiro et al (1975) proposed the formula (FEV i x 18.9) + 19.7
to predict tE in a wide range of patients with CAL, which
was the formula adopted for this particular study,
unfortunately no 95% confidence interval is quoted for this
equation.
Cotes et al (1982) suggests that if a patient with CAL
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discontinues exercise at a maximal 1.7E below the lower limit
of the 95% confidence interval then an alternative reason
to breathlessness must be sought.
In the present study, nine (of the 19) individuals
reached 100% or more of their predicted tm, consistent with
the findings of Spiro et al (1975). Analysis revealed that
the FEVI values of these patients were at the lower end of
the range. Contrary to this one of the female patients
(No.15) with FEV1 greater than 1.4 I reached less than 60%
of predicted tE. Despite the results portrayed in Figure 5.2
all of the patients reported breathlessness post-exercise
and that this was the limiting factor to the continuation
of the exercise test. Viewing Figure 5.2 it can be seen
that 18/22 and 16/19 (excluding No. 11, 14 & 18) patients
exceeded 75% of their predicted maximum tE. On the other
hand it is reported that in healthy individuals
approximately 60% of their ventilatory capacity is reached
at the point of their 1.102p„k (McArdle et al 1991, Beck et al
1991).
Maximal ventilatory values from this present study are in
excess of these values and would support an overall trend
towards a ventilatory limit to exercise. Perhaps the most
curious result is that of the disparity between the
percentage of predicted NYE the two patient sub-groups are
able to utilise. It is probable that the more severely
affected patients were inhibited by a ventilatory limit to
exercise, utilising 100% of their ventilatory capacity.
Cardio-vascular factors appear to be relatively
insignificant in limiting the exercise tolerance in this
patient group, the maximal heart rate values falling well
short of the predicted values anticipated for the patient's
age. An alternative cause of limitation, ie peripheral
muscle limitation was not monitored (blood lactate
concentration) at this stage.
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The sub-group with the greater FEV i values contained three
patients exceeding their predicted E ma and all but two
patients exceeded 75% of predicted 1TE . These female
patients reached 42% (No. 15) and 69% (No.5) of predicted
lh,m ; post exercise they both appeared moderately stressed
and reported that dyspnoea was the limiting factor. As
Belman (1986) hypothesised, these subjects may manifest a
heightened perception of breathlessness limiting exercise
tolerance rather than a true ventilatory limit.
By forming these two sub-groups there was no disparity in
the level of breathlessness reported post exercise or the
mean maximal heart rate. It should be noted, however, that
two patients (FEV, >1.4 1) did exceed 85% of their predicted
heart rate. One of these two patients also exceeded their
prescribed ventilatory limit. The remaining five patients
did not reach either a ventilatory or cardio-vascular limit
and although these patients reported severe breathlessness
the results of their tests do not allow us to draw any firm
conclusions as to the limiting factors of exercise. Besides
lack of motivation and probable deconditioning in this
group, Matthews et al (1989) proposes three alternative
mechanisms for the lack of definitive results. Firstly, the
patient's lung function may be at a transient stage where
it is becoming the limiting factor to exercise over and
above the normal cardiac limit. Secondly, he suggests that
the increased heart rate is a compensatory mechanism for
the pulmonary dysfunction and finally he acknowledges that
it is more likely to be a combination of factors including
a mechanical limit to ventilatory capabilities, eg occult
left ventricular failure, developing respiratory muscle
weakness or deconditioning. A lack of effort was apparent
in at least one of this group. It seems apparent that the
cycle of dyspnoea, reduced activity, more dyspnoea and so
on may in fact begin at the moderate stages of the disease
as shown in this group of patients. Several recent reports
have suggested that the strength of the respiratory muscles
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and, consequently, the inability of the lungs to support
the increased ventilatory ,demand may be an important
determinant of exercise tolerance (Grassino 1979, Bye et al
1985).
In a recent publication, Rampulla et al (1992) identified
that the most frequently reported factor limiting exercise
(on the treadmill) was in fact fatigue and not dyspnoea in
patients with CAL. Surprisingly, of those patients who were
identified as stopping due to breathlessness only 10/28
rated the sensation near to maximal.
The sub group with the FEV I less than 1.4 1 included just
one patient who exercised within the theoretical
constraints of his respiratory system. Surprisingly this
patient with severe airways disease (No.1) exercised to
only 62% of his predicted 17E. Clinically this patient was
exhibiting respiratory embarrassment post exercise and
undoubtedly reached a symptom limited maximum performance.
This patient was extrdmely thin and the calculations of his
VE m, may have over estimated his capacity. One patient
exercised to 144% of her predicted CTE demonstrating the
unreliability of predictive resting measurements.
The oxygen pulse at maximal exercise was consistent with
the measurements of Nery et al (1983). These authors
suggest that the low value is not indicative of compromised
02 transportas suggested by Mihn et al (1979) but is simply
the result of the patient terminating exercise due to a
ventilatory limit before the cardio-vascular system was
maximally stressed.
The average speed of walking on the treadmill was 2.5
mph. This was a speed (with an increased gradient) at which
a maximal performance would be provoked for this present
group. Examining the data comparing the Vo2pe.„k and the
shuttle tests results a mean N.7o2p„k of 14.2 ml.min4 .kg4 is in
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indicative of a maximal walking speed of between 3.3 and
3.7 mph. From this value a speed relating to 60 -70% of the
t2o2 peak would equal approximately 2.2 to 2.6 mph corresponding
to 8 - 10 ml.min4 .kg4 (see Figure 5.7). Alternatively, for
healthy middle aged adults, a comfortable walking speed (3
mph) would demand oxygen at a approximately similar rate
(11 ml.min4 .kg4 ). For patients with CAL the increased cost
of breathing both at rest and with the increasing intensity
of exercise diverts a significant fraction of the overall
Vo2 away from the peripheral muscles. For this reason it is
difficult to apply 'healthy adult values' of to 2 to the
patient population and draw comparisons between
physiological responses at definite speeds in the patient
group and normal healthy adults. The data presented in this
study supports this point. The predictive values used are
from a population performing a treadmill walking test. The
treadmill protocol was not the same as that employed for
this study which may in itself be unrepresentative of the
values obtained from a modified Balke protocol used.
To summarise, the results from the treadmill test
indicate that the patients had a compromised ventilatory
response to exercise, exhibiting a maximal ventilatory
response well in excess of predicted values for 'normal'
exercise responses. As a consequence of this premature
cessation of exercise there was a concomitant reduction in
the maximal 11(32 values compared to those predicted.
Overall the study substantiated the proposal that the
shuttle walking test is a maximal field exercise test of
disability in patients with CAL that would give an
objective measure of a patient's cardio-respiratory status.
The validation of the shuttle walking test provides the
evidence that this exercise test provides a superior
measure of functional capacity to the existing field tests
in patients with CAL. Furthermore it allows the prediction
with some confidence of a patients to2 p„k estimated from
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his/her performance on the shuttle balking test alone.
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6. EXAMMATION OF THE PORTABLE OXYGEN CONSUMPTION NETER
6.1 INTRODUCTION
This chapter addresses the validity of using a portable
device for the measurement of oxygen uptake ('Oxylog o , PR
Morgan). The analysis of this piece of equipment is vital
to the experimental procedures adopted in Chapter 7,
examining the ventilatory and metabolic response to the
shuttle walking test. However, more importantly there seems
to be very little substantial data on the validity of
employing this piece of equipment for patients presenting
with CAL. There are some validation studies (Harrison et al
1982, McNeill et al 1985) examining the performance of the
Oxylog in normal individuals. The levels of ventilation
recorded in these individuals is considerably higher that
those anticipate in a group of patients with CAL. Therefore
it was considered necessary to examine performance at lower
levels of ventilation.
This section will be divided into three main parts.
Firstly a brief description of the Oxylog. The second
section will describe four experimental studies examining
the validity of measurements of the Oxylog: This was done
by comparison with measurements made using traditional
Douglas bag techniques in healthy volunteers, and secondly,
two separate groups of patients performing both sub-maxim'al
and maximal tests. The final section investigates some of
the properties of the Oxylog that may have contributed to
the discrepancy of measurements identified in the previous
sections.
6.2 DESCRIPTION
The Oxylog (PR Morgan) is a portable device to measure
oxygen consumption and ventilation Inman (Humphrey &Wolff
1977). The equipment weighs 2070 g without the leather
casing and strap and 2610 g with the casing. The dimensions
including the casing are 18.5 x 8.2 x 21.5 cm. The
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manufacturers suggest that the Oxylog should be worn with
the shoulder strap passing diagonally across the chest and
over the shoulder with the Oxylog sited in close proximity
to the opposing hip. The subject wears a face mask
incorporating both inspiratory and expiratory valves. The
subject breathes in atmospheric air through a small turbine
flowmeter which also contains a thermistor. Inspiratory
volume is measured in the range 6 - 80 1.min4 ventilation
and displayed as either total ventilation (maximum reading
99999 litres) or as minute ventilation, (of the proceeding
minute) with resolution to 1 1.min4 . These values are
expressed digitally. The expression of ventilation is not
corrected to S.T.P.D but corrected to 0°C dry at the
pressure of the experiment. This is achieved by measuring
the atmospheric temperature at the inspiratory flowhead and
correcting the volume of air, assuming 50% relative
humidity. Deviations in relative humidity from 50% produce
less than a 1.5% error in estimation of gas volumes (PK
Morgan) except in extreme humidity or dryness at
temperatures above 26°C (McNeill et al 1987).
Expired air passes through a flexible wide bore tube to
the body of the oxylog where 1.5 cm 3
 /breath is pumped into
a mixing chamber by an integral pump triggered by a
decrease in the inspiratory flow rate at the end of each
inspiration. Simultaneously a similar size sample of
atmospheric air is drawn into a second mixing chamber. Both
samples of air are dried by passing the samples prior to
analysis through drying tubes containing 'Drierite' (CaSO4)
before analysis. Small samples of the contents of these
mixing chambers are analysed with two compact polargraphic
oxygen sensors (Beckman, USA) and the p0 2 difference between
the two samples is used, in conjunction with the
inspiratory flow rate to calculate the oxygen consumption.
The analyser derives a total oxygen consumption up to
9999.9 litre (resolution 0.1 1) or the minute oxygen
consumption (range 0.25 - 3.00 1.min4 , resolution 0.1 1).
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The 102 is expressed as S.T.P.D. The calculation of the
volume of oxygen consumed is based upon the formula,
=
()02
 inspired air -p02 expired air) x volume inspired air
760
This formula is only correct if the R value is equal to
unity. In situations were the R value is less than 1 the
use of the inspired volume to calculate Vo2 will be
incorrect. The manufacturers suggest error in calculations
ranging from -5.3% if the R value was equal to 0.7 to +1.8%
if the R value was equal to 1.1. Volume is expressed at
A.T.P.S (ambient temperature & pressure, saturated with
water vapour).
The Oxylog is powered by internal rechargeable batteries
with an endurance of up to 24 hours. A recorder output is
available with a 3V positive pulse 30 msec long for every
0.1 1 of 02 consumed and minute 0 2 output was recorded as 1
volt. 14 .min4 . Ventilation was recorded as 3 v positive pulse
30 msec wide for every 1 1 of tE and as 0.1 v for every 10
1.min4 . This recorded output was utilised to transfer and
recorded data in a solid state data logger, the Squirrel
(see below), which was preferable to manual collection of
values in the laboratory and essential when the Oxylog was
used in the field.
6.3 THE SQUIRREL
The Squirrel 1200 (Grant Instruments) is a solid state
data logger used to interface with the Oxylog. It weighs
500 g and measures 18 x 12.5 x 6 cm. The display and
logging functions are controlled by three push-buttons. The
squirrel requires 6 AA manganese-alkaline batteries and has
19 channels available for monitoring a variety of physical
parameters. However for this study 5 channels were employed
to recorded an output of minute oxygen voltage and pulse
output for each 0.1 litre of total oxygen and each 1 litre
of ventilation. The Oxylog and Squirrel were connected with
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a dedicated plug from the Oxylog (Lemo PE 0304 NY U). The
corresponding connections to the Squirrel (15 way D-socket)
were delicate and required stabilising with external
fixation which demanded repeated checking. To receive the
signals from the Oxylog the channels of the Squirrel had to
be adjusted to accept the appropriate voltage. The internal
clock was also calibrated before each trial with an
external stop watch. Signals were recorded once logging was
initiated and a visual display was monitored for each
channel for continuity of logging. This was however only
practical during the laboratory evaluation of the Oxylog.
The recorded data could then be transferred and stored to
disc using an IBM computer and a dedicated Squirrel
program.
6.4 ROUTINE USE OF THE OXYLOG
Prior to using the Oxylog for each separate study the
equipment (oxygen sensors) was calibrated according to the
manufacturers instructions to zero p0 2 (see appendix D).
Prior to each individual subject use of the Oxylog the
oxygen sensors were calibrated against atmospheric p0 2 . The
controls were set to record minute /1 and tro2 . The connector
was then secured in the Oxylog recorder socket and placed
into the receiving socket of the Squirrel.
The subject was then fitted with a face mask supplied by
P K Morgan and requested to breathe normally. The face mask
was secured by two straps, one placed horizontally around
the back of the head and the other placed at 45 0 to the
first rising to just below the crown. The straps are
tightened to ensure minimal movement of the mask and
therefore minimal leakage of air. A digital reading of tE
and /o2 would usually appear after 2-3 minutes. It was
essential to ensure that the minute signals of tE and /o2
synchronised exactly with the internal clock of the
Squirrel and in turn that both of these measurements
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synchronised with the timing of the incremental increases
treadmill test. The internal clock of the Squirrel was set
exactly against a stopwatch which was used to time the
treadmill tests and the increments thereof. It therefore
remained for the reading of the Oxylog to be transmitted at
exact times. This was ensured by pressing the reset button
of the Oxylog (at XX.00 secs on the stopwatch and Squirrel)
which effectively 'zeroed' the timing of the signals from
the equipment.
6.5 EXAMINATION OF THE VALIDITY OF THE OXYLOG (HEALTHY
SUBJECTS
6.5.1 INTRODUCTION
Initially the Oxylog was examined in a group of healthy
volunteers to identify and rectify any problems prior to
patient involvement. Instead of employing a simultaneous
measurement technique we explored the validity of the
Oxylog for measuring i7o2 against the conventional Douglas
bag technique, on two separate occasions.
6.5.2 METHOD
Ten students from the department of Physical Education
and Sports Science were recruited. The protocol required
them to perform two identical treadmill tests. On one
occasion measurements were taken with the Oxylog using the
face mask supplied by the manufacturers and on the other
visit ventilatory measurements were made using Douglas bag
techniques (see Chapter 3). The two visits were presented
in a randomised balanced design.
On the first visit the subjects height, age and
spirometry was recorded (3.1.1 & 3.1.2). For both visits
weight was recorded (3.1.3).
For the visit employing the Oxylog the heart rate
electrodes were attached and the face mask of the Oxylog
placed in the most suitable position. Every attempt was
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made to correct any identified leaks of the face mask. The
body of the Oxylog and the attached Squirrel were placed on
the bench alongside the treadmill. The subject was
instructed to breathe normally and the readings of the
equipment were co-ordinated.
The subjects performed an incremental treadmill walking
test at a constant speed of 3 mph with increases of the
incline from 3% by 3% every 4 minutes for a total of twelve
minutes. The test was sub-maximal in an attempt to review
the Oxylog in a range of measurements appropriate to
patients with CAL. Subjects were asked to report their
perceived rate of exertion (Appendix B) during the final
minute of each incline.
The Douglas bag test employed the same protocol except
that expired air was collected in Douglas bags during the
final minute precisely, of each stage.
6.5.3 RESULTS
All the healthy subjects completed both the exercise test
with relative ease. The physical characteristics of the
group are shown in Table 6.1.
After preliminary testing a discrepancy was identified in
the values of ventilatory measurements of the Oxylog
compared to the Douglas bag in three of the subjects. It
was thought that a problem existed with the face masks and
their fitting. The facial features of one of the three was
small and eventually a small mask was obtained from the
manufacturer. The small mask did not appear to solve the
problem of leakage in the other two subjects and as an
alternative chiropody felt was applied around the bridge of
the nose to block any potential leaks. The ventilatory
Values improved considerably with these modifications and
these are the results presented.
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TABLE 6.1 Some physical characteristics of the group
(mean and SD). N=10.
4 males, 6 females
mean SD
Age (yr) 31.1 8.1
Height(m) 1.70 0.08
Weight(kg) 63.00 6.66
FENT/	(1) 3.83 0.36
PVC (1) 4.80 0.74
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The expressed volume (1.min4) of air measured with the
Oxylog is the inspired air at ambient pressure, temperature
and 50% relative humidity is assumed. The volume of air
measured using the Douglas bags is expired air and is
expressed as S.T.P.D. It was therefore necessary to convert
the Oxylog measurements to S.T.P.D using the formula
VI sTpD = VI x 	 273 	 x _1PB - WVP,1_
273+t	 760
t = temperature (°t)
PB = barometric pressure (mmHg)
SWVP = saturated water vapour pressure (mmHg)
A subsequent calculation was necessary to convert the
expired air volume of the Douglas bag to an inspired volume
,ie equivalent volume to the Oxylog. in can be determined
from 1,7E using the relative change in nitrogen via the
'Haldane transformation'.
sTpD X tk12E
%Nn
The values at each of the four stages of the exercise test
are shown in Table 6.2 for 1102 and in Table 6.3 for in
using both the Oxylog and Douglas bag techniques. The
values are plotted in Figure 6.1. and 6.2. The level of
agreement and the Pearson Product moment correlation of the
iIO2
 measurements are detailed in Table 6.4 . There was no
significant difference in the 17°2 values at the third stage
of the exercise test. There was however a significant
difference at the first, second and forth stages. The mean
difference in /o2 values recorded were -2.3, -1.8 and 1.3
ml.min4 .kg4 greater with the Oxylog than the Douglas bag
for stages one, two and four respectively.
The ventilatory measurements, however, present a
different scenario from that described above (Table 6.5).
The corrected values of in reveal a significantly lower
measurement with the Oxylog at the end of stages two, three
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TABLE 6.3	 Mean (SD) values measured in normals for #1
(STPD) 1.min4 . n =10.
Stage Oxylog Douglas bag
1 19.7 (2.7) 21.5 (3.85)
2 25.0 (3.2)
_
28.3 (3.6)
3 30.7 (4.0) 34.5 (4.3)
4 38.1 (5.9) 40.9 (4.6)
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FIGURE 6.1
	 The relationship between the mean (SEM) 1102
(ml.min- 1 .kg-1 ) measurements with the Oxylog
and Douglas bag at each stage of the
exercise test.
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MIME 6.4 The mean differences and the 95% confidence
intervals of the Douglas bag and Oxylog
measurements at each stage for 170 2 (ml.min4.kg
) and the Pearson Product Moment correlation.
Stage X
differ
-ence
SD 95%
confidence
interval
r
1 -2.3 1.9 -3.7 to -0.9 -0.15
2 -1.8 1.0 -2.5 to -1.0 0.22
3 -1.1 2.1 -2.6 to 0.4 -0.43
4 -1.3 1.6 -2.5 to -0.24
- 0.2
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TABLE 6.5 The mean (SD) differences and the 95%
confidence intervals of the Douglas bag and
Oxylog measurements at each stage for #1 (1.min
4 ) and the Pearson Product Moment correlation.
Stage X SD 95%
confidence
interval
r
1 1.8 3.0 -0.3 to 4.0 0.27
2 3.3 2.1 1.8 to 4.8 0.71
3 3.8 3.2 1.5 to 6.1 0.50
4 2.9 2.9 0.8 to 5.0 0.78
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and four. A significant difference was not found between
stage one (p>0.05). The percentage differences in the
measurements of 7C)2 exhibit a systematic decrease in the
magnitude with an increase in the intensity of exercise. At
stage one the difference is 14.5%, this value decreases
(9.6% level 2, 5.0% level 3) to 3.8% at level 4. The
corresponding values of in do not demonstrate the same
pattern. The largest difference is at stages 2 and 3 (11.7
and 11.0% respectively) whilst levels 1 and 4 reveal a
slightly lower difference of 8.4% and 6.8% respectively.
The mean R values obtained from the Douglas bag
measurements for each stage of the protocol are shown in
Table 6.6. (NB the Oxylog assumes an R value of 1). These
values represent a significant difference from 1 for all
Four stages. The greatest difference is observed at stages
one and two where the mean R value was measured to be 0.89
(range 0.83 to 0.96) and 0.93 (0.85 to 0.98) respectively.
If it is assumed that with repeat testing an individuals
ventilatory response produces the identical R values then
this deviation from an R value of 1 during the Douglas bag
test would lead to a underestimation of the inspired
volumes by approximately 1.8% with the Oxylog.
The mean maximal heart rate at each level for both the
Oxylog and Douglas bag are shown in Table 6.7. Each
individual responded with an incremental increase in the
heart rate. There was no significant difference between the
two different methods of testing, see Figure 6.3.
The mean Borg exertion score for each increment is
represented in Table 6.8 and plotted in Figure 6.4. These
values increased with the increased intensity of the
exercise test but represent no significant difference
between measurement techniques.
The individuals who participated in the trial are
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MIME 6.6 Mean and standard deviation of R values measured
at each stage during the Douglas bag
measurements.
Stage mean SD
1 0.89 0.04
2 0.93 0.04
3 0.95 0.03
4 0.97 0.02
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MESE 6.7 Mean (SD) heart rate (beat.min4 ) recorded at
each stage of exercise with the Oxylog and
Douglas bag.
Stage Oxylog Douglas bag
1 94 (11) 94 (9)
2 107 (12) 106 (11)
3 118 (14) 120 (14)
4 133 (16) 134 (17)
No significant difference at any stage.
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TABLE 6.8 Mean (SD) Borg exertion scale recorded at each
stage of the exercise test with the Oxylog and
Douglas bag.
Stage Oxylog Douglas bags
1 7.3 (1.2) 7.1 (0.9)
2 8.6 (1.6) 8.2 (1.1)
3 9.8 (1.7) 10.0 (1.6)
4 11.6 (1.7) 11.4 (1.6)
No significant difference at any stage.
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FIGURE 6.4 Mean (SEM) Borg exertion score reported at
each stage of exercise with the Oxylog and
Douglas bag
familiar with physiological measurements but reported
that the face mask was uncomfortable because it had to be
a tight fit and some reported that they felt
claustrophobic. Another important point raised was the
inability to communicate effectively and consequently
subjects felt slightly wary that if a problem arose they
could not convey this to the operator and the mask was
difficult to remove. A handful of subjects felt that it may
have altered their breathing pattern during exercise,
particularly as Douglas bag measurements demand mouth
breathing and these subjects felt the Oxylog for some
unexplained reason compelled them to breathe through their
nose.
6.5.4 DISCUSSION
The results of this initial study using the Oxylog reveal
that the equipment provides a method for ventilatory
measurement that corresponds moderately well to the
measurements of the Douglas bag. This result is in
agreement with the work of both Ballal & McDonald (1982)
and Jones et al (1987) but conflicts with that of Harrison
and colleagues (1982). The former two studies on healthy
subjects identified a significant underestimation of
ventilation by the Oxylog compared to their usual gas
analysis equipment (Douglas bag and computerised equipment
respectively). Ballal and McDonald (1982) incorporated an
RAF face mask in their Oxylog system to decrease the
possibility of leaks although the underestimation of
ventilation by the Oxylog persisted. Harrison et al (1982)
incorporated a mouthpiece in to the Oxylog system found no
significant differences in the measurements of either Vo2 or
Ms except at the highest work rates. At stages prior to this
the authors had identified no significant differences in
the measurements of the Oxylog with an RAF face mask
=pared to their gas analysis equipment (mass
spectrometer) at all but the lowest work rates.
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Examining the individual results there were three
subjects who recorded higher levels of VI at stage 1, none
at stage two, one at stage three and two at stage four.
Correcting the volumes by approximately 1.8% at levels two,
three and four would decreased the difference but it would
be unlikely to account for all of the difference. The
discrepancies in the tx measurement are believed to be in
part due to undetected leaks in the system occurring
seemingly in the majority of subjects. Every effort was
made to correct leaks but this was obviously inadequate. It
is possible that the negative pressure generated during
inspiration would in fact enhance the leaks by dislodging
the face mask slightly as it was not adequately secured. On
expiration the magnitude of the leaks may have decreased
with the expired air forcing the mask against face.
difficulties were encountered with the variety of facial
anatomy presented. The weight of the hosing was also
thought to lift the mask away from the face and the head
straps did not provide adequate support.
The measurements of V% by the Oxylog revealed a different
pattern of results being consistently higher at each stage
of exercise compared with Douglas bags. The oxygen
consumption results are in partial agreement with the work
of McNeill et al (1987) who identified overestimation by
the Oxylog of both 1)1 and and that of Harrison and
colleagues (1982) (using the mouthpiece) who demonstrated
that the Oxylog consistently overestimated 'o significantly
so until the final stages of the exercise. The consistently
higher .1(32 of the Oxylog may be erroneously elevated due to
the additional work created by breathing through a meter or
may in part be due caused by the differing patterns of
breathing required by the mouthpiece and mask.
It should be noted that a fundamental difference in this
study design compared to those documented above is the use
of consecutive measurements as opposed to simultaneous
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which therefore overcomes day to day variation. The natural
physiological variation that occurred with repeat testing
on 1E and 1702 employing Douglas bag techniques was studied
by Hardman (1982, unpublished). The results revealed a
coefficient of variation of 1.5 - 4.6% for measurements of
(702 and 2.7 - 7.4% for the corresponding 7E values on an
incremental cycle test, performed on successive days (n=
10). The magnitude of the difference between the Oxylog and
Douglas on the whole exceed these values. The natural
physiological variation may in part account for the
measurement differences. Nonetheless it would be unwise to
hypothesise that the measurement errors were due to a
biological factor rather than to a systematic difference
associated with the equipment.
Perhaps the most important difference to consider when
comparing other studies is that all except the present
relied on simultaneous measurements of the Oxylog and gas
analysis equipment connected in series to the patient with
the Oxylog communicating directly with the patient. This
should however (excluding natural physiological variation)
make very little difference to the overall results unless
the two pieces of equipment employed for the present study
provoked different patterns of breathing. The Douglas bag
was connected to the expiratory port of the Oxylog and
unless there were expiratory leaks as well, then the volume
passing to the Douglas bag would include that volume of air
by-passing the Oxylog flow meter and be comparable to the
volume expired into the Douglas bag in present study.
The underestimation of has not translated into an
underestimation of i7o2 (the reader is referred back to
equation in section 6.2). This could possibly be explained
by the increased work (and cost) of breathing associated
with the Oxylog. This is secondary to the greater
resistance of the equipment compared to the Salford valve
employed with the Douglas bag. Alternatively, but unlikely,
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an error may have occurred at the site of the oxygen
sensors despite careful calibration of the equipment. The
reader is again referred back to the equation documented in
section 6.2. If the oxygen sensors were not correctly
calibrated or were unstable over even a short time period
the under estimation of the inspired volume may,
theoretically be adjusted for in the equation by erroneous
measurements of the partial pressures of inspired and
expired oxygen concentrations. Alternatively an error in
calculations may arise because of the assumption that the
response of the oxygen sensors is linear to the actual
oxygen consumption.
Both the heart rate data and the Borg ratings reveal no
significant difference at any stage of the exercise test
between the two methods of analysis, suggesting that the
two methods presented a comparable physiological strain
both subjectively as well as objectively.
Overall, the Oxylog appeared to provide a reasonable
estimation of individual's 'Ti and i7o2 and was worthy of
examination in a patient group. The option of the Oxylog
was pursued especially in view of difficulties with
alternative methods of gas analysis.
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6.6 EXAMINATION OF THE VALIDITY OF THE OXYLOG IN
PATIENTS WITH CAL (SUB-MAXIMAL)
6.6.1 INTRODUCTION
Having concluded that the Oxylog provides a relatively
valid method of assessing ventilatory parameters in normal
subjects it was necessary to repeat the validation
procedure in a patient group. In the previous study (6.5)
a possible cause of error in the Oxylog and face mask
system was identified. It was important to be confident
that the equipment would perform well in a group of patient
with altered respiratory mechanics before applying it to
the field environment. A 2-stage sub-maximal exercise test
was adopted, at a speed that all the patients in this study
group would be able to perform.
The aim of this study was to assess the validity of the
Oxylog in a group of patients. The test was sub-maximal to
ensure that an adequate number of equivalent data point
were generated.
6.6.2 METHOD
Five patients were recruited for this stage of the trial
and were required to make an initial visit to the hospital
for baseline measurements as detailed in 2.2.2. During the
same visit patients equipped with the Sports Tester
performed a sub-maximal test on the treadmill. It was
necessary to gauge a speed appropriate for all five
patients that would allow them to complete the test at two
separate increments, 0 and 3%. The speed selected was 2
mph. Each increment lasted for 4 minutes, allowing the
patient: to reach 'steady state'. At this stage the patients
also experienced the two forms of gas analysis equipment.
The Oxylog with the face mask and the standard Douglas bag
measurements.
The two subsequent visits to Loughborough were presented
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ina randomised balance design and were performed with full
medical cover at intervals of one week. The Oxylog was set
up as described above 6.4 and all measurements were taken
as described above. The heart rate and Borg breathlessness
rating was recorded in the final minute.
6.6.3 RESULTS
The physical characteristics of the patients are shown in
table 6.9. There was no significant difference in their
lung function values for the three visits (p>0.05).
Employing the analysis proposed by Guyatt et al (1987)
there was a marked change in one patient's response to the
CRDQ in the dyspnoea, emotion and fatigue component. The
patient however assigned this to the menopause. Overall
there was no significant statistical difference in the
results of the CRDQ for the three visits (p>0.05).
Tables 6.10 and 6.11 shows the mean t02 and recorded at
the two levels represented in Figures 6.5 and 6.6. The mean
difference and 95% confidence interval at the 0% gradient
was 1.90 ml.min4 .kg$ (0.1 to 3.7) greater using the Oxylog
for the t02 . The mean TE was 2.84 1.min4 (5.49 to 0.19)
higher with the Douglas bag. Comparable differences were
also recorded at 3%, the '°2 was 2.1 ml.min4 .kg4 higher with
the Oxylog whilst the mean 1/1 was higher with the Douglas
bag, 2.62 1.min4
 (5.95 to -0.71). Applying the Wilcoxon test
for matched pairs no significant difference was identified
in the measurements of the i102 or NIE at either level of
exercise.
The mean R values of the Douglas bag tests were 0.87 and
0.88 for stages one and two respectively. These values
would translate to an underestimation of in with the Oxylog
of approximately 1.8% below that of the Douglas bag.
The mean heart rate at each stage is shown in Table 6.12.
The values represent no significant difference between the
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TABLE 6.9 Some physical characteristics of the patient
group, n=5, [mean (range)].
4 males, 1 females.
1 Oxylog Douglas bag
Age (yr) 64.4 - -
(52-79)
Height(m) 1.69 - -
(1.59-1.70)
Weight(kg) - 65.33 65.41
(49.55-67.8) (49.20-67.60)
MI (1) 1.31 1.23 1.23
(0.78-2.25) (0.75-2.35) (0.8- 2.15)
FEV, % 47.6 45.3 45.0
predicted (25.3-93.0) (24.4-97.1) (24.8-86.8)
FVC (1) 2.82 2.75 2.63
(2.16-3.03) (1.92-3.05) (2.10-2.97)
169
TABLE 6.10 Mean (range) 1702 (ml.min-1 .kg-1) measurements
at the two stages of exercise with the
Oxylog and Douglas bag.
1
Stage	 Oxylog	 Douglas bag
1 10.6 (7.9-12.9)
-.0.-
8.7 (5.9-10.4)
2 12.1 (9.8-13.7) 10.0 (8.0-11.1)
t
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TABLE 6.11 Mean (range) 71 (1.min4 ) measurements at the
two stages of exercise with the Oxylog and
Douglas bag.
Stage Oxylog Douglas bag
1 17.4 (11.7-22.4) 20.3 (14.4-22.5)
2 21.0 (15.3-26.0) 23.6 (15.7-26.8)
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FIGURE 6.5 Mean (SEX) to 2 (ml.min4 .kg4) measurements at
the two stages of exercise with the Oxylog
and Douglas bag.
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FIGURE 6.6 Mean (SEM) .7I (1.min4 ) measurements at the
two stages of exercise with the Oxylog and
Douglas bag.
' 0 Douglas bag
Oxylog
0%
	
2%
/ .
Incline
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TABLE 6.12 Mean (range) heart rate (beat.min4)
measurements at the two stages of exercise
with the Oxylog and Douglas bag.
Stage Oxylog
_
Douglas bag
1 107 (91-123) 104 (84-127)
2* 115 (96-130) 110 (88-126)
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two stages with a mean difference of 3 and 5 beat.min4
higher using the Oxylog. These differences were
not significantly different.
Examination of the relationships between the two
ventilatory measurements at the two stages revealed a
Spearman rho of 0.30 and 0.70 for the two measurements of
Vo2 and rho = 0.70 and 0.97 for the VI measurements.
The mean Borg scores (Table 6.13) at the end of each
stage were 1.9 and 2.3 for the Oxylog and 1.1 and 2.0 for
the Douglas bag. This represents a mean difference of 0.8
and 0.3 for stages one and two respectively, these values
do not constitute a significant difference at either level.
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TABLE 6.13 Mean (range) Borg breathlessness scores recorded
at the two stages of exercise with the Oxylog
and Douglas bag.
Stage Oxylog Douglas bag
1 1.9 (0.5-3) 1.1 (0.5-2)
2 2.3 (0.5-4) 2.0 (0.5-3)
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6.6.4 DISCUSSION
Initially six patients were recruited but one of the
subject withdrew unable to tolerate the face mask. The
other five patients were tolerant of the face mask and we
endeavoured to obtain an adequate fit using either a small
or medium face mask (P.K.Morgan).
The spirometry and CRDQ indicate the patients were
clinically stable for the duration of the study. The heart
rate data and the Borg scores indicate that the patients
worked to the same level for both modes of testing
Patients consistently reported a preference for the
Douglas bag system, not least because they were required to
endure the mouthpiece for just the final minute of each
stage of exercise whilst the face mask worn throughout the
exercise test was intimidating and claustrophobic. Patients
also found it difficult to identify possible causes of air
leaks. The ventilatory measurements indicate a satisfactory
level of agreement between the two methods of measurement.
The results present a similar trend to that identified in
the normal group, an overestimation of il02 despite an
underestimation of 17i. The magnitude of the difference in
the patient group is comparable to the difference
documented in the healthy volunteers. As the values
recorded for the patients are lower this translates into a
greater percentage error, although this did not correspond
to a significant difference. The possible reasons for this
are as described for normal subjects (6.5.4). There is a
natural biological variation in oxygen requirements and the
efficiency of oxygen utilisation during a repeated exercise
test, however these results deviate in a common direction
indicating a real difference in the two measurement
techniques. Swinburn and colleagues (1985) documented no
significant difference in the measurement of VE or Nk12 over
the range of work rates patients could achieve compared to
mnputerised equipment.
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Because patients found the face mask unacceptable and the
inherent difficulties encountered with providing an
adequate sealing a viable alternative was sought that could
be incorporated into the Oxylog system.
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6.7 EXAMINATION OF THE USEFULNESS OF THE OXYLOG
INCORPORATING A MOUTHPIECE (HEALTHY SUBJECTS)
6.7.1 INTRODUCTION
As a consequence of the problems identified with the
fitting of the mask and possible leaks (also considering
the results described in the patient group) it was proposed
to assess the usefulness of a mouthpiece and nose-clips. It
was thought that a mouthpiece would ultimately be more
acceptable to the patients; the group of students use to
exercise testing were very co-operative regarding the
identification of leaks and it was felt that unless the
leak was large patients would not be able to do so.
Although RAF face masks appeared to provide an adequate
seal they were reported to be cumbersome (Harrison et al
1982). Secondly, being compared with the Douglas bag
technique (employing a mouthpiece) it was felt more
appropriate to assess comparable equipment as far as
possible. A mouthpiece was therefore incorporated into a
modified Oxylog system and its reliability examined in the
original group of healthy subjects.
6.7.2 METHOD
For this stage the treadmill protocol was as described
above 6.5.2. However it was possible to recruit only eight
of the original ten subjects for the exercise test. The
mouthpiece was constructed in the Cardio-respiratory
department at Glenfield General Hospital. It contained the
components of a nebulising chamber and two one way valves
connected in series. It allowed a mouthpiece to be fitted,
the flow meter to be attached with a connector [sealed with
adhesive tape (sleek)] and the tubing to pass from the
mouthpiece to the body of the Oxylog. For the treadmill
exercise test the mouthpiece, which protruded laterally
approximately 10-12 cm, was supported by the operator as
there was a tendency for the mouthpiece to be dislodged
with the weight of the flow meter.
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6.7.2 RESULTS
The physical characteristics of the eight subjects is
shown in Table 6.14.
The inspired gas volumes were subject to the same
conversions applied above (6.5.3). The mean values obtained
for the ventilation and "/c12 at the end of each level are
shown in Tables 6.15 and 6.16. The measurements for the /o2
are again consistently higher for the Oxylog with the
mouthpiece than the Douglas bag, the values are
significantly higher, except for the first stage of
exercise (p>0.05), the mean difference values range from
2.6 to 3.5 ml.min4 .ke . The values for the mouthpiece were
slightly higher for than the face mask although these
differences were not statistically significant (p>0.05).
The mean differences between the Oxylog (mouthpiece) and
the Douglas bag and the 95% confidence intervals are
expressed in Table 6.17. The values for the two techniques
are plotted in Figure 6.7. The relationship was
considerably stronger between the Douglas bag measurements
using the Oxylog and mouthpiece than the face mask.
The values of using the mouthpiece underestimated the
volume of air inspired (Table 6.18). The values for the two
techniques are plotted in Figure 6.8. The difference
between the mouthpiece and the Douglas bag is significant
at all levels, including level one where the mean
difference was just 1.7 1.min 4 . This difference rose to a
mean value of 5.6 1.min4 at stage four. The values of '(Ti
using the mouthpiece and face mask were not significantly
different, except at level 2. The mean differences and 95%
confidence intervals between lro2 values measured using the
Oxylog with the mouthpiece compared with the Douglas bag
are presented in Table 6.18.
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TABLE 6.14	 Some physical characteristics of the group
(mean and standard deviation). n=8.
3 males, 5 females
mean SD
Age (yr) 31.2 7.9
Height(m) 1.67 0.07
Weight(kg) 61.80 6.95
FEVI	(1) 3.77 0.36
FVC	 (1) 4.63 0.70
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TABLE 6.15	 Mean (SD) values measured in normals for 1702
(STPD) ml.min4 .kg-1 . n=8.
Stage Oxylog Douglas bag
1 15.6 (1.3) 12.1 (0.7)
2 19.7 (0.7) 16.5 (0.5)
3 23.8 (1.0) 21.1 (1.1)
4 29.1 (2.1) 26.3 (0.8)
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TABLE 6.16
	
Mean (SD) values measured in normals for
(STPD) 1.min4 . n=8.
Stage Oxylog Douglas bag
1 19.1 (1.5) 20.7 (2.7)
_
2 23.8 (2.0) 27.7 (3.3)
3 28.6 (2.9) 33.9 (3.7)
4
r
34.6 (3.9) 40.3 (5.1)
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MIX 6.17
	 Mean (SD) differences and the 95%
confidence intervals of the Douglas bag and
Oxylog measurements at each stage for /702
(ml.min4 .kg4) and the Spearman rank order
correlation.
Stage X SD 95%
confidence
interval
rho
1 -3.5 1.8 -5.0 to -1.9 0.88
2 -3.2 1.1 -4.1 to -2.3 0.79
3 -2.6 1.7 -4.1 to -1.2 0.69
4 -1.3 2.3 -3.3 to	 0.6 0.43
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FIGURE 6.7 Mean (SEM) values of 1702 (ml.min-'.kg-1)
at each stage for the oxylog and Douglas
bag.
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TABLE 6.18	 The mean (SD) differences and the 95%
confidence intervals of the Douglas bag and
Oxylog measurements at each stage for 1.1r
(1.min4) and the Spearman Rank Order
correlation.
Stage X SD 95t
confidence
interval
rho
1 1.7 2.3 -0.3 to 3.6 0.48
2 3.9 1.8 2.3 to 5.5 0.69
3 5.4 2.0 3.7 to 7.1 0.78
4 5.6 4.1 2.1 to 9.1 0.72
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The mean R values, 0.88, 0.92, 0.94 and 0.96 for levels
1,2 3 and 4 respectively represent a significant difference
from 1.0 at each stage (p<0.05). Although this difference
translates into the Oxylog underestimating the volume of
inspired air by a mean value of less than 1.8%.
The heart rate data and the Borg scoring were again not
significantly different.
Finally the subjects reported less discomfort with the
mouthpiece of the Douglas bag which was more compact and
lighter than the mouthpiece of the Oxylog.
6.7.3 DISCUSSION
The measurements generated are in agreement with Ballal
& McDonald (1982) producing lower values for in and greater
values of to2 for the Oxylog compared to the Douglas bags.
Harrison et al (1982), using a mouthpiece, identified no
significant difference between the two methods except at
the highest work rate where the 
'°2 was significantly lower.
Overall the use of the mouthpiece does not correct the
discrepancy in the values for in or iTo2 of the face mask
compared to the Douglas bag, in fact the difference between
the two measurement techniques increased slightly. The
oxygen cost of the exercise with the modified (mouthpiece)
equipment was even higher than with the original face mask.
This was a genuine increase in the 'cost' of exercise
/breathing and not as a result of the increased ventilation
being recorded (see equation, section 6.2). The increased
cost of breathing was thought in part to be due to the
modification of the equipment increasing the external
resistance to breathing.
For half of the subjects the mouthpiece appeared to
approximate Oxylog measurements to the Douglas bag
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measurements, whilst the other half did not. This second
group of subjects can be further divided into those
subjects who had a consistently lower reading at all stages
of exercise with the mouthpiece compared to the Oxylog with
the face mask and those who just had a lower reading at the
fourth stage of exercise. The reading for this second group
at this fourth stage were lower than the Oxylog and mask
readings (mean 4.1 1.min4
 n=2). As the first three stage
measurements of these individuals matched it can be assumed
that there was some movement around the mouthpiece to
facilitate the passage of air around the mouthpiece and by-
pass the flow meter. For the other half of this group the
measurement error using the mouthpiece appeared to be
systematic, increasing with the intensity of exercise. This
could be accounted for (as the subjects described) by the
unsatisfactory mouthpiece and its inherent instability that
appears to increase with the intensity of exercise. The
technique required to secure the plastic mouthpiece was
reported to be quite demanding in comparison with that of
the Douglas bag and may in part account for the increased
Vo2. Added to which the jaw was not relaxed and may have
provoked an unfamiliar ventilatory pattern.
Despite the overall acceptability of the mouthpiece
certain problems presented during the course of the study.
Due to the weight of the flow meter (despite attempts to
support it) the subjects felt awkward. A further criticism
was of the actual mouthpiece, due to the aperture of the
inspiratory limb of the valve a plastic mouthpiece was
attached. This mouthpiece was not only difficult to secure
safely by the patient because of the short flanges but the
plastic moulding made it difficult to retain in one
position successfully. In addition the subjects were
required to bite the mouthpiece to maintain its position,
quite a different technique to the mouthpiece of the
Douglas bag.
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Despite these difficulties it was decided to pursue the
option of a commercially available mouthpiece. This
decision was based upon a number of points -
- the initial problems sealing the face mask and
identifying leaks (equal to 25-30% in initial study results
not reported 6.6)], despite co-operative subjects.
- communication difficulties for the patient.
- patient discomfort.
- comparable technique to Douglas bag measurements.
- more acceptable to the patient.
Finally it was proposed that the resistance of the modified
mouthpiece developed may have had a greater resistance to
breathing than a commercially available mouthpiece.
190
6.8 EXAMINATION OF THE VALIDITY OF THE OXYLOG (fi
MOUTHPIECE) DURING MAXIMAL EXERCISE TESTING IN
PATIENTS WITH CAL
6.8.1 INTRODUCTION
The final stage of this investigative procedure was to
address the validity of the Oxylog during maximal testing
in patients with CAL incorporating the commercial
mouthpiece. The ultimate aim being to examine precisely and
confidently the physiological response to the shuttle
walking test (sub-maximal measurements), culminating in a
symptom limited maximum measurement.
6.8.2 METHOD
Six patients with stable CAL volunteered to participate.
Again three visits were required, a practice visit to
Glenfield and the following two 'test' visits to
Loughborough University. At Glenfield [after consent had
been obtained and baseline measurements recorded (4.2.2)]
an appropriate treadmill walking speed was gauged to evoke
a symptom limited maximum performance at Loughborough. The
speed was assessed individually for each patient and based
upon heart rate and the Borg breathlessness response. The
test at Loughborough was at a constant speed with increases
from the flat, of 2.5% in inclination every two minutes.
The Oxylog and Douglas bag measurements were made as
previously described. The mouthpiece employed with the
Oxylog was a Hans Rudolph 27 -1400 light weight (272 g),
law resistance valve. The mouthpiece had two, one way
valves and incorporated a saliva trap. The flow meter of
the Oxylog was attached to the inspiratory side of the
valve with a connector and the expiratory port was attached
to the tubing to the Oxylog. The tubing was slightly
narrower than had been previously used allowing an adequate
seal around the valve. The valve was supported with a head
harness (Hans Rudolph). The actual mouthpiece was of rubber
(P.K.Morgan) with slightly enlarged flanges to help secure
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it in the patients mouth.
6.9.3 RESULTS
The physical characteristics of the six patients are
MWAM in Table 6.19.
The mean FEV 1
 values represent 44%, 47% and 48% of
predicted for the practice, Oxylog and Douglas bag trials
respectively, indicating a moderate impairment to
respiratory function.
The mean speed the patients walked was just 2.6 mph. The
mean time for each treadmill test was 7.7 minutes for the
Oxylog and 7.3 minutes for the Douglas bag. The mean
difference in time was 0.4 minutes, (p>0.05).
The mean maximal heart rate attained during the two
exercise tests was 131 beat.min4 and 130 beat.min4 for the
Oxylog and Douglas bag respectively. This represents
approximately 76% of predicted maximal heart rate. The mean
difference and 95% confidence interval was 1.2 beat.min4 (-
8.0 to 10.2) higher in the Oxylog trial than the Douglas
bag.
The Borg ratings were not significantly different for
either test, the two mean maximal values were 5.5 for the
Oxylog and 5.6 for the Douglas bag test, the mean
difference and 95% confidence intervals was -0.17 (-0.96 to
0.62).
The mean 1702 and mean 171 are expressed in Table 6.20.
The mean differences and the 95% confidence intervals are
shown in Table 6.21. The values for the 1,702 are not
significantly different (p>0.05), unlike the values for the
i. The relationship between the two values for the
measurement of III and Io2 are relatively strong having a
Spearman Rank order correlation of 0.83 and 0.59
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TABLE 6.19	 Some physical characteristics of the patient
group, mean (range).
N=6, 3 males, 3 females.
Trial 1 Oxylog Douglas bag
Age (yr) 58.0 - -
(50.3-68.6)
Height(m) 1.72 - -
(1.63-180.0)
,
Weight(kg) - 73.78 73.35
(56.50-98.80) (56.00-97.90)
FEVI	(1) 1.42 1.55 1.47
(0.90-2.80) (1.0- 3.1) (1.0-2.8)
MI % 43.8 47.3 47.9
predicted (31.4-74.3) (34.8-88.2) (34.8-71.6)
FVC (1) 2.72 2.73 2.66
(2.20-4.00) (2.10-4.15) (2.10-3.7)
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Douglas BagOxylog
12.6 (7.9-16.6) 14.0 (8.5-18.8)V02
28.3 (15.5-51.3) 39.6 (26.5-65.3) 1
TABLE 6.20	 Mean (range) maximal measurements of to2
(ml.min-1 .kg-1 ) and Vi(1.min4 ) for the Oxylog
and Douglas bag at the patient's maximum.
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TABLE 6.21 Mean differences, standard deviation and the
95% confidence intervals of the maximum
Douglas bag and Oxylog measurements values
for i7o2 (ml.min-l .kg-1 ) and 1)1 (1.min4 ) and the
Spearman Rank Order correlation.
Mean SD 95% confidence
interval
rho
'(702 1.7 3.0 -1.4 to 4.9 0.59
1)I 11.3 4.6 6.4 to 16.1 0.83
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respectively. The R values of the Douglas bag measurements
have a mean value during the final minute of the exercise
test of 0.96(0.10) which if similar in the Oxylog trial
would lead to no error measurement of VI.
6.8.4 DISCUSSION
The patients for this stage of the trial were both
physiologically and psychologically stable and the two
tests appear to have presented a comparable physiological
strain assessed both objectively and subjectively.
Overall the mouthpiece and the head harness was more
acceptable to the patient than the face mask.
There was only moderate agreement between the
measurements of ,T02p„k using the Oxylog and Douglas bags in
these patients. The values obtained for ventilation were
more closely related, although there was a systematic
difference. The values for both Vo2 and VI that were
obtained in the present study are of a similar magnitude to
those reported by Swinburn et al (1985) who also employed
the Oxylog for a clinical trial. Swinburn et al (1985)
reported a mean maximal Vo2 and 1:// during three exercise
tests ranged from 0.8 - 1.0 1.min4 and 26 -31 1.min4 , his
group had severe airways limitation with a mean FEV 1 of 0.8
1. Both Belman et al (1991) and Zuwallack et al (1991)
employed treadmill testing and quote similar levels for Nb2
(further discussion on this topic regarding relative and
comparative measurements is located in chapter 5.4) As with
this present study and other reported trials, the number of
subjects is small and it is therefore inappropriate to draw
any conclusions regarding the population as a whole.
As the measurements of the 'gold standard' l/o2 are
=parable for the two techniques it is proposed that the
196
subjects may in fact adopt an alternative breathing
strategy for the Oxylog, which may account for the
differences observed in the VI. This does not, however,
exclude the possibility of leaks (not exclusive to the
Oxylog system) or the possibility that the Oxylog system
may inhibit maximal ventilation by increasing resistance to
breathing. To confirm this suggestion further
investigations into the properties of the Oxylog and
associated mouthpiece would be required.
At any given work rate prescribed for an individual
patient the energy requirements will be comparable
(providing the 02 cost of breathing is the same), this is
confirmed by the tO2 measurements (regardless of the 1.7E
response). Patients will adopt a breathing strategy to
ensure an adequate extraction of oxygen and as a
consequence, ventilatory volumes may alter slightly. This
however is unlikely to account for all the difference in IT'
which is observed, as is natural physiological variation.
It appears that the system leaks and although it was
assumed that the source of the leak was around the mouth
this was not confirmed. In addition, as described above,
the ventilatory response of the patients may have been
constrained by the system, increasing the work of breathing
to prevent maximal ventilation. Examining the individual
data, there appears to be a systematic increase in the
magnitude of the error with the increasing intensity of
exercise for 4/6 patients. For the remaining two the error
remained stable. The resistance to breathing caused by the
system is likely to increase with increasing flow and would
account for the observed variation in 4 of the 6
individuals tested.
The calculation of 7(:)2 by the Oxylog derives a total 1
from the flow rate and the partial pressure of 02 from a
small sample of each breath. It appears that despite the
underestimation of ".TI the value of ,702 is not distorted.
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Despite the difference in (Ti measurements it was proposed
primarily on the basis of the (102 measurements
(demonstrating a strong agreement between the maximal
measurements of the Douglas bag measurements and the
Oxylog) that the Oxylog was worthy of use in a field study
examining the response to the shuttle walking test. This
decision was reinforced by the fact that Douglas bags were
impractical and that the limitations of the Oxylog by this
stage were already documented and, at least in part
understood.
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6.9 INVESTIGATION OF THE RESISTANCE TO INSPIRATION OF
THE OXYLOG AND DOUGLAS BAG
6.9.1 INTRODUCTION
Examining the results presented in the proceeding
sections it appeared that the Oxylog equipment (with the
original mask and the two subsequent adapted mouthpieces)
presented measurement difficulties compared to the Douglas
bag system. On initial testing (unreported data) it
appeared that a loss of measurable ventilation was
occurring around the face mask and this was overcome to
some extent by correcting the leaks (6.5). It was obviously
unreasonable to expect patients to identify leaks and the
option of a mouthpiece was pursued. This appeared to be
satisfactory, although ventilation continued to be
underestimated and to2 overestimated (6.7). The use of the
Hans Rudolph valve (in series with the Oxylog) in the
patients (6.8) resulted in the underestimation of both the
ventilation and the
This section of the thesis therefore reports studies
undertaken to examine the resistance to inspiration of the
Douglas bag valve and the individual Oxylog systems. An
alteration in the measured resistance to breathing with
each modification of the Oxylog compared to the Douglas bag
(incorporating the Salford valve) may explain some of the
differences observed in the results.
The resistance of breathing apparatus comprises laminar
and turbulent components. When the flow is laminar, the
resistance is mainly dependent upon the diameter of the
tubing, rising sharply as the diameter decreases. The
resistance due to local turbulence arises in the region of
constrictions and sharp bends (Mushin & Jones 1987).
Resistance is measured in units of pressure drop (cm1120) per
unit flow (1.min-I).
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6.9.2 METHOD
Resistance to airflow was measured using a water
manometer connected across the inspiratory port and
breathing port of each valve. Resistance to flow was
defined as the pressure drop across the two ports and
expressed in cm of H20 in a range of 10-100 1.min4 (at 10
1.min4 increments), ie cmH20 per 1.min4 , (cmH2O.1 1 .min). The
air flow was generated by a flow calibration set (Model
19116, Gould Inc). A continuous flow rate was used in the
place of the intermittent breathing of patients. A series
of adaptors were made to allow fixation of the valves to
the flow generator. The measurements were taken in
duplicate and the mean values presented below. The internal
diameter of the valves was also taken using a pair of
Philips callipers.
6.9.3 RESULTS
The measurements of the internal diameter of the
respective inspiratory valves were
1.Salford valve	 2.8 cm
2.Oxylog valve	 2.5 cm
3.Hans Rudolph	 1.5 cm
The resistance to flow is summarised in table 6.22. There
was a strong relationship between the resistance of the
Oxylog and the Salford valve and an equally strong
relationship between the resistance to inspiration of the
Salford valve and the Oxylog valve with the addition of the
Hans Rudolph. However, there was a significant difference
(p0.001) between the resistance to breathing of the
Salford valve compared to both the Oxylog alone and its
subsequent modification. The mean (SD) difference between
the Salford valve and the Oxylog alone was 0.72 (0.42)
cmH20.14 .min. over the range 10-100 1.min4. The
corresponding mean difference between the Salford valve and
the Oxylog with the Hans Rudolph was 2.4 (1.37) cmH20.1.4.
min.
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TABLE 6.22 Resistance (cmH20) of the inspiratory ports
of the Salford, Oxylog and Hans Rudolph
valves.
Flow
(1.min4 )
Salford
valve
,
Oxylog
valve
Hans
Rudolph
valve (HR)
HR +
Oxylog
valve
10 0.20 0.40 0.40 0.90
20 0.30 0.55 0.50 1.20
30 0.45 0.80 0.78 1.70
40 0.55 1.00 0.98 2.10
50
,
0.65 1.25 1.10 2.55
60
.
0.68 1.45 1.25
_
3.10
70 0.73 1.65 1.55 3.70
80 0.80 1.85 1.80 4.45
90 0.87 1.05 2.10 4.95
100 0.93 2.35 2.40 5.50
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Figures 6.9 and 6.10 plot the resistance of the valves
employed for the studies described in Chapter 6. Analysis
of the slopes reveals that the flow versus resistance slope
for the Salford valve and Oxylog valve were similar. The
mean difference and 95% confidence interval for the
differences between the slopes was -0.01 (-0.02 to 0.01) cm
1120.1. 4min. This was calculated using a pooled standard
deviation from the deviations about the individual fitted
regression lines. This pooled standard deviation was used
to calculate the standard error of the differences and then
the 95% confidence interval. Since zero difference between
slopes is near the middle of the confidence interval there
is no evidence that the two population regression lines
have different slopes (Gardner and Altman 1989). However,
it is more useful to examine the vertical distance between
the intercepts ie, the vertical distance between the
parallel lines. The mean difference between the fitted y
values was calculated using an equation incorporating the
original mean x and y values of the two slopes and the
gradient of the common slope. The resulting mean (and 95%
CI) estimated vertical distance between the slopes is -0.67
(-0.92 to -0.43) cm H 20. It is apparent from Figure 6.9 that
the Oxylog consistently results in a higher resistance to
breathing than the Salford valve.
The comparison of the slopes of the regression lines
• between the Oxylog incorporating the Hans Rudolph valve and
the Salford valve produced a mean difference and 95%
confidence interval of -0.45 (-0.05 to -0.04)cm H20.1-1.min.
Since zero did not pass through the confidence interval, it
can be concluded that the regression lines have different
slopes. Any further comparison of the regression lines
would be invalid as the slopes are not similar (Altman
1991).
The dead space of the three systems was measured as
accurately as possible. The dead space of the Salford valve.
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FIGURE 6.9
	
The resistance (cmH20) to inspiration
(range 10 - 100 1.min4) of the Salford
valve and the Oxylog inspiratory valve.
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FIGURE 6.10	 The resistance (cmH20) to inspiration (range
10 - 100 1.min4 ) of the Salford valve
and the Oxylog connected with the
Hans Rudolph valve.
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is documented to be 80 ml (Jakeman 1979). An approximation
(measured in mls of H20) of the dead space of the Oxylog
face mask employed is 150 ml, whilst that of the Oxylog and
Hans Rudolph combination was approximately 280 ml.
6.9.4 DISCUSSION
It has been demonstrated that a reduction of to 2 peak may
occur if ventilation is impeded by high resistance
introduced into the breathing circuit (Ceretelli et al
1969). The World Health Organisation (Anderson et al 1971)
recommend that for the purpose of collecting respiratory
gases a low resistance breathing valve (less than 5 cmHpat
300 1.min4 ventilation) should be employed into a circuit.
Furthermore it is suggested that all biological systems
change or adjust their response to external loading and
such changes may be undesirable (Butler et al 1986).
It is apparent that the Salford valve offers considerably
less resistance to breathing that the other two systems
employed in the studies described in Chapter 6. At a rate
of 30 1.min4 , the mean value for the patients performing a
maximal test with the Oxylog and Hans Rudolph equipment
(6.8), the resistance increases from just 0.55 cmH2() to 1.00
craH20 to 2.10 cmH20 using the Salford valve, the Oxylog and
the Oxylog with the Hans Rudolph respectively. It can
therefore be concluded that for both the final study
reported in Chapter 6 (validation of the Oxylog, 6.8) the
Oxylog and the Hans Rudolph valves have increased
resistance to breathing for the patients. This increase is
in the order of 300% compared to the Salford valve.
The initial group of healthy volunteers (6.5) and
patients (6.6) employing the mask experienced a small but
consistently increased resistance to breathing with the
Oxylog as compared to the Salford valve. A zero difference
falls outside the 95% confidence interval for the vertical
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distance between the two slopes. This indicates that the
vertical distance between the slopes is statistically
significant at the 5% level (Gardner & Altman 1989).
However it remains to be judged whether or not this
difference is clinically significant. McGregor & Becklake
(1961) demonstrated that resistance breathing
(incorporating lengths of 5 mm tubing into the breathing
circuit) ,
 in normal subjects (n=5) consistently increased
the /o2 and decreased 1TE in 4 out of 5 subjects. The
resistance to breathing is likely to be lower for this
present study but the principle remains, increasing the
resistance to breathing increases the demand for oxygen but
depresses ventilation. A theoretical model proposed by
Macintyre and Leatherman (1989) suggest that impedance
changes (resistive breathing or disease state) result in a
rise in total energy demand, since an increase in muscle
stimulation is required to maintain a level of ventilation.
The second comparison of this present study revealed that
the Oxylog (with Hans Rudolph valve) had a markedly higher
resistance to flow than the Salford valve. This discrepancy
increases with increasing levels of ventilation. It is
apparent that there is considerable resistance to
inspiration in the Oxylog system. At 100 1.min4 the
resistance of the Oxylog with Hans Rudolph valve was 5.5
araH20 exceeding the WHO recommendations (5 cmH 20 at 300
1.min4 ). It is therefore reasonable to suggest that the
resistance of the latter is clinically significant. The
value found for the Salford valve in the present study was
similar to that reported by Jakeman and Davies (1979). The
manufacturer's measured resistance of the Hans Rudolph
valve is 4.1 cmH20 at 150 1.min4 , potentially exceeding the
WHO guidelines. Connected in series, the Hans Rudolph and
Oxylog valve presented a series of differing diameters to
the flow of air. The Hans Rudolph valve was considerably
narrower than the Oxylog valve. These variable diameters
mate turbulence which probably accounts for some of the
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resistance. The right-angled bend in the flow of air to the
mouthpiece compounds the problem of resistance in a narrow
bore tube. The clearly reported increased resistance to
breathing measured with the Oxylog valve compared to the
Salford valve would theoretically result in a disparity of
the oxygen consumption with increasing levels of
ventilation. The results documented inf act show the
reverse. Unfortunately the measurements made reveal no
alternative mechanism and there appears to be no ready
explanation for the disparity.
The majority of muscular work required for breathing is
performed during inspiration, even in patients with CAL
(Rochester et al 1979). Therefore the inspiratory muscles
are at risk of developing fatigue. If a load is of
sufficient magnitude it will result in changes in the
muscles' ability to generate force and move the required
minute ventilation (Macintyre & Leatherman 1989). It is
proposed that respiratory muscle fatigue may represent a
21imiting factor in exercise tolerance (Pardy et al 1981,
Fitting 1991) in patients with CAL. Fitting (1991) suggest
two reasons for these observations. Patients with CAL have
two ways of increasing their ventilation during exercise.
Firstly to breathe at higher lung volumes increases the
maximum expiratory flow, however this further mechanically
disadvantages the inspiratory muscles. The alternative is
to prolong expiration to enhance lung emptying. This
results in a shortened time for inspiration requiring the
inspiratory muscles to contract with an increased velocity.
If breathing equipment offers a considerable resistance to
inspiration it is apparent that the inspiratory muscles are
disadvantaged further and are consequently severely limited
in their ventilatory response to exercise. The oxygen cost
per litre of ventilation increases with both increasing
levels of ventilation and external resistance. Consequently
a greater proportion of oxygen is consumed by respiratory
muscles. A point is reached when any increase in oxygen
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uptake is accounted for by the demands of the respiratory
muscles (Collett et al 1985). In patients with CAL the
total resistance to breathing is a combination of the
external resistance of the equipment employed and the
intrinsic resistance of the airways. The added external
resistance may be just enough to jeopardise a patient's
ability to maintain adequate ventilation, effectively
disrupting the already compromised flow volume
relationship.
The results of the study of maximal performance in
patients with CAL (6.9) are surprising when taking into
account the added resistance of the Oxylog and Hans Rudolph
system. Overall treadmill exercise performance has not been
impaired; there was no significant difference between the
Oxylog and Douglas bag trial in total time on treadmill,
maximal heat rate or Borg score. However, there was a
significantly lower maximal VE but not /o2 recorded with the
Oxylog. In contrast to the previous studies (6.5 to 6.7),
the final study (6.8) demonstrated an underestimation of 1%
measured using the Oxylog and Hans Rudolph valve compared
to the Salford valve but an underestimation of ventilation
was again recorded (6.8). This may be due to considerable
leaking of the equipment around the mouthpiece causing a
decrease in the calculated 1102 [see equation (6.2)] or
alternatively a genuine decrease in ventilation because the
increased resistance of the equipment inhibits the
performance of the inspiratory muscles. This demand for 02
is met despite the low levels of ventilation.
At a given alveolar ventilation an increase in the
resistance to breathing will reduce the amount of oxygen
available for non-ventilatory work. This is usually
compensated for by an increase in ventilation, but if this
resistance increases (airways obstruction, external
resistance) performance may be impaired (Collett et al
1985). The problems of the increased resistance of the
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equipment described are compounded by the additional dead
space. As dead space increases alveolar ventilation
decreases (for a constant level of ventilation), ie
alveolar hypoventilation. The addition of dead space
increases end tidal CO2 , therefore the normal response is to
increase the levels of ventilation to maintain PaCO 2 . In
patients with CAL dead space is already increased (V/Q
mismatch), however ventilation is increased to maintain or
even increase alveolar ventilation (Cherniak 1977),
although the magnitude of increase of dead space required
to provoke this ventilatory response remains uncertain.
Recently, Sridhar et al (1993) demonstrated that the
addition of a large dead space (500 ml) resulted in a fall
in exercise duration and 1.702p,„k but no significant changes in
1.7E.
In this study the healthy subjects and the patients were
required to increase their level of ventilation to maintain
alveolar ventilation and a stable PaCO2 (blood gas levels
were not measured) with increasing levels of exercise. The
level of ventilation did not appear to even increase with
the system incorporating the largest dead space and is not
therefore a contributory factor to the discrepancies in
ventilatory measurements between the Oxylog and Douglas
bags.
Despite the resistance to breathing encountered with the
Oxylog and Hans Rudolph system, the option was pursued for
use in the field, primarily because of the practical
advantages over the Douglas bags. The mouthpiece was used
in preference to the face mask because of the initial
problems encountered ensuring a seal. An adequate seal
mad not be guaranteed with patients despite a variety of
mask sizes. The measurement of central importance was ir02pal,
and it appeared this measurement by the Oxylog and Hans
Rudolph valve was not significantly different from the
Douglas bag measurement.
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7. THE PHYSIOLOGICAL RESPONSE TO THE SHUTTLE WALKING
TEST
7.1 INTRODUCTION
Having examined both the reproducibility (Chapter 4) and
the validity (Chapter 5) of the shuttle walking test, the
next stage was to examine the physiological responses
during and upon completion of the shuttle walking test. To
measure the ventilatory response we employed the portable
system for measuring 1,7o2 , the Oxylog (the validity of which
had previously been examined Chapter 6).
The aim of this study was firstly to confirm that the
shuttle walking test was an incremental exercise test that
provoked a graded cardio-vascular and respiratory response
to a symptom limited maximum performance. Secondly the data
collected would help in understanding the limitation to
exercise. There is little information available regarding
patients' physiological response to field exercise tests
and this is important when examining the limitations to
exercise. The majority of data relates to maximal values
(McCavin et al 1976, Swinburn et al 1985) and little to the
physiological responses during field exercise testing. The
limitation to this category of information is a practical
one relating to the collection of expired air and heart
rate data whilst the patient is moving. The present study
attempts to overcome these difficulties by using the Oxylog
and the Sports Tester to make ambulatory measurements of
heart rate and ventilatory function.
The hypothesis of this study was that the shuttle walking
test evoked not only a graded heart rate response but also
graded respiratory and metabolic responses.
7.2 METHOD
7.2.1 Patient group
Ten patients were recruited from medical out-patients
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clinics. Informed consent was obtained. The selection of
patients conformed to the criteria described in Chapter 4
(4.2.2). The patients were required to make three visits to
Glenfield Hospital at intervals of one week. The patients,
as previously, were requested to withhold relevant
medication (4.2.2) and the baseline measurements were as
described (4.4.2) for all three visits. Visit one was a
familiarisation visit, whilst visits two and three were
presented in a random balanced design of a shuttle walk
with the Oxylog followed one week later by a shuttle walk
without the Oxylog but with pre- and post-exercise
capillary blood sample collection for blood lactate
concentration analysis. The patients were clinically stable
throughout the study.
7.2.2 Familiarisation visit
This first visit allowed the patients to perform a
practice shuttle walking test conforming to the previously
established protocol (4.2.1.). Heart rate was monitored
using the Sports Tester PE3000 (3.1.5) and the Borg
breathlessness scale (3.1.6) recorded upon the completion
of the shuttle walking test.
7.2.3 The shuttle walking test with the Oxylog
The patients performed a second shuttle walking test
(4.2.1) and measurements were made as above (4.2.2). To
allow ventilatory measurements the patients were required
to carry the Oxylog and the Squirrel data logger (6.2 &
6.4). Unlike the study validating the measurements of the
Oxylog (Chapter 6) the patients were required to carry the
equipment in a backpack. A backpack (Karrimore), was
purchased especially for the study. This was a small
backpack that was rested upon the patients thoracic spine,
which was considered to be the optimal weight bearing
position causing least influence upon the posture of the
subject and minimising the effect upon the patients/
respiratory pattern. The Oxylog rested in the main
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compartment of the backpack while the Squirrel was placed
in the outside zipped pocket to allow ease of access to co-
ordinate the data recordings with the Oxylog. A hole was
cut in the bottom of the backpack to communicate with the
expired air port of the Oxylog. Besides carrying the
backpack the patients wore the head harness and mouthpiece
with tubing connected to the Oxylog and a nose-clip
(Chapter 6).
To take the resting measurements values the patients were
required to rest (seated) for 4 minutes after the initial
values were displayed and the values recorded at the end of
the fourth minute were taken to represent resting steady
state III and /o2 . Heart rate and the Borg scale was also
recorded.
The procedure for the test was as described (4.2.2) but
meticulous timing was required to co-ordinate the timing of
the shuttle walking test with the recording made by the
Oxylog. The instructions to the patient were played while
they were resting. The four second countdown signal
immediately before the triple bleep on the tape was located
and the tape stopped after one of the bleeps ie, leaving
three seconds before the start of the test. After the 4
minute rest period the patient was positioned for the start
of the shuttle test. A stopwatch that had been previously
co-ordinated with the time on the Squirrel was used to
indicate when the shuttle test tape should begin ie, at x
mins and 57 seconds (allowing for the three bleeps
remaining of the 4 second countdown), synchronising the
recordings of the Squirrel and the Oxylog with the shuttle
walking test minute increments.
7.2.3 The shuttle walking test and the collection of
capillary blood samples.
The patients performed a routine shuttle walking test
(4.2.1) independent of any equipment. The only variation
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was the collection of a capillary blood sample pre- and 4
minutes post-exercise.
7.2.4 Capillary blood sampling
Duplicate 20 gl arterialised capillary blood samples were
taken from the thumb or index finger using a sterile blood
lancet (Baxter Scientific Instruments). The collections
were made in 20 ml non-heparinised calibrated micro-
pipettes (Boehringer Mannheim). The samples were
deproteinised in 200 gl of 2.5% perchloric acid. As a
precaution to ensure a free flow of blood and minimise
patient discomfort the hand was soaked in warm water for 2
mins and dried thoroughly prior to sampling. The samples
were stored at -20°C and assays to determine blood lactate
concentration were performed on the supernatant at a later
date. The assay method adopted used the fluorometric
enzymatic micro technique described by Maughan (1982)
(Appendix F).
7.3 RESULTS
The trial taking small blood samples is designated as
the lactate trial and the alternative the Oxylog trial.
The patients coped with the Oxylog and backpack
satisfactorily but consistently reported that it had
inhibited their performance.
The mean FEV1 of the group and their percentage of
predicted values indicate that they were patients severely
affected by their airways disease. Five of the patients had
FEV1 values below 40% predicted falling to as low as 20%.
The patients' spirometry and other physical characteristics
are summarised in Table 7.1. There were no significant
changes in lung function values (FEV i , PVC) throughout the
study. Again only a modest correlation was established
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TABLE 7.1 Some physical characteristics of the patient
group, mean (SD), n = 10.
6 males, 4 females.
lactate
trial
Oxylog
trial
Age (yr) 64.4 -
(7.1)
Height(m) - 1.65
(0.07)
Weight(Kg) - 69.9
(15.3)
MI
 (1) 1.02 1.01
(0.38) (0.37)
FEVI % 40.5 40.1
predicted (15.1) (14.7)
FVC (1) 2.06 2.06
(0.49) (0.55)
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between FE17 1 values and the distance walked (Oxylog trial),
r=0.31.
Examination of the CRDQ revealed that there was no
between trial difference of the scoring using the Guyatt et
al (1987) analysis. Statistical analysis confirmed the
patients emotional/psychological stability.
The mean distances that the patients walked on the Oxylog
and lactate trial was 302 (133)m and 375 (137)m
respectively. The mean difference and 95% confidence
interval and relationship between the Oxylog and lactate
trials was 73(32.2)m 95% CI 49.9m to 96.1m, r=0.97. The
range of distance that the patient walked (60 - 580 m)
represents one level and three shuttles to 8 levels and 8
shuttles. The relationship between the distances walked on
all three trials was strong. Figure 7.1 demonstrates the
relationship between walk two and three. The decrease in
distance walked observed when patients carried the Oxylog
is apparent in all the patients. The mean decrease in
distance in the male subjects was 76.6 m and 67.5 m in the
females.
Analysis revealed no difference in heart rate between the
lactate and Oxylog (mean maximal heart rate lactate trial
120 (11) and Oxylog trial 117 (10) beat.min 4). The maximal
heart rate had a moderate relationship with the distance
walked on the two trials, r=0.56 and r=0.50. As reported in
previous chapters (4 & 5) there was an overall linear
increase in heart rate during the two trials.
The mean resting and post exercise Borg breathlessness
scores are shown in Table 7.2.
The mean resting ' Ti and /o2 are in Table 7.3, and are
expressed at B.T.P.S for the ventilatory measurements and
S.T.P.D for the /o2 recordings. The measurement of /o2
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TABLE 7.2 Mean (SD) Borg breathless score at rest and
post-exercise.
Trial Resting score post exercise
score
lactate 1.7	 (0.3) 5.5	 (0.8)
Oxylog 1.7	 (0.3) 5.1	 (0.6)
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TABLE 7.3 Mean (SD) resting values of ventilation (1.min
4 ) and to2 (ml.min4.kg4).
Measurement Mean (SD)
ti (1.min4 )	 ATP 7.9 (1.9)
BTPS 9.8 (2.6)
1102 (1.min4 ) STPD 0.19 (0.02)
IN (ml.min4 .kg4 ) 2.82 (0.61)
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expressed as ml.min 4 .kg4 do not take into account the weight
of the Oxylog (2070 g). This would however make very little
difference to the overall values of oxygen consumption.
The corresponding mean maximal exercise values are in
Table 7.4. Each patient demonstrated a gradual increase in
VI and 1.1o2 . A linear increase in l702 was demonstrated in
each patient with increasing intensity of exercise with
progressive levels of the shuttle walking test. Figure 7.2
shows the linear increase of /02 in two representative
patients. Patient A demonstrates an increase of 580% from
resting values (0.22 1.min4 ) to a /o2pea of 1.50 1.min4 . The
second patient demonstrates an increase of 273%, (0.17 -
0.65 1.min4 ). The increase in 1102 that patients were able to
achieve their to2 from their resting values ranged from 127%
to 572%. A corresponding linear increase in cu was
demonstrated in consecutive levels of the shuttle walking
test (Fig 7.3). Such pronounced percentage increases were
however not documented, the greatest increase was in
patient 5, rising from a resting /I of 12 1.min4 to peak
exercise of 46 1.min4 (ATP). Two patients 9 and 10 only
increased their by 100%. These individuals did also
record the lowest FEV 1 values. The mean values of /1 and iro2
at each level of the shuttle walking test are shown in
Figure 7.4 and 7.5 (it should be noted that the number of
patients at each level decreases). Figure 7.6 is
constructed from plotting the predicted maximal 1.7E
(employing the formula 37.5 x FEVO against measured The
maximal Si ranging from just 30% to 97% of predicted (mean
69%). This formula utilises volumes at B.T.P.S, therefore
the ventilatory volumes of the Oxylog were manipulated by
a conversion factor (Cotes 1979). This increases the mean
maximal	 to 24.9 1.min4 (it should be noted that a
conversion to /E to allow an entirely legitimate comparison
of predicted versus actual /E is not possible with the
Oxylog system as expired CO2 which would allow the values of
to be subjected to the Haldane transformation is not
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MIX 7.4 Mean (SD) maximal values of ventilation
(1.min4) and 7o2 (ml.min4.kg4).
Measurement Mean (SD)
III	 (1.min4 ) ATP 20.4 (7.9)
BTPS 24.9 (9.5)
N.To2	 (1.min4 ) STPD 0.74 (0.42)
"Go2 (ml.min4 .kg4 ) 10.14 (3.90)
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FIGURE 7.2
	 Oxygen consumption response (ml.min-l .kg-1 ) to
the shuttle walking test in two
representative patients.
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FIGURE 7.3	 Ventilatory response (1.min -1 ) to the shuttle
walking test in two representative patients.
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FIGURE 7.5 Mean (SEM) oxygen requirements (ml.min4.kg4)
to consecutive levels of the shuttle walking
test.
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FIGURE 7.6	 Predicted 1.7E mm (1.min4) plotted against
measured VI	 using the Oxylog for the
individual patients.
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recorded). With this limitation as well as the previously
documented underestimation of the Oxylog system (Chapter 6)
it is possible that the values presented do in fact
underestimate the 'true' maximal ventilation attained
during the shuttle walking test.
There was no strong relationship between the percentage
of iTI attained and the patient's FEV2 (r= 0.44). The mean
resting 11 was 9.85 1.min4 (BTPS); patients increased their
level of ventilation from their resting values by values
ranging from 92% to 208%. The relationship between the
maximal ti and the distance attained on that shuttle walking
test was moderate (r=0.76). There was however a stronger
relationship between the patients' peak 1o2 and the shuttle
distance recorded, r=0.81, Figure 7.7. Employing the
regression equation proposed by Bruce et al (1973) to
predict 1:702 peak Figure 7.8 was constructed to plot the
predicted against the measured 162.
Analysis of the blood lactate concentrations pre (mean
1.38 mmo1.14
 SD 0.24) and post (1.69 mmo1.14 SD 0.19)
shuttle walking test are shown in Figure 7.9. The mean
increase (and 95% confidence interval) was significant, ie
0.31 mmo1.14 (0.06 to 0.56).
Figure 7.10 shows the values of 1o2 measured directly from
the Oxylog during the shuttle walk and those values
assigned to the performance of the shuttle walking test
from the Douglas bag measurements (chapter 5)
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FIGURE 7.7 Maximal tl:02 (1111.Mirri . kg-1) measured with the
Oxylog against performance [distance walked
(m)] on the shuttle walking test. n=10.
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pre-test post-test
FIGURE 7.9	 Mean (SEM) pre and post exercise capillary
blood lactate concentrations (mmo1.14)
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FIGURE 7.10	 Values of peak to2 (ml.min4 .kg4) measured
from the Oxylog during the shuttle walking
test and those from the comparison of
performance and 11o2puk measured with Douglas
bag techniques (Chapter 5).
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7.4 DISCUSSION
The group of patients recruited for this study
demonstrated a mean FEV1 of just 1.0 1. Half of the group
conformed to the 'severe airways disease category' criteria
proposed by the ATS (1986). The patients' clinical and
psychological/emotional stability during the period of
observation was confirmed with the results of' the
spirometry and the CRDQ respectively. All patients
completed the trial satisfactorily but frequently commented
on the weight and general unacceptability of exercising to
maximal levels whilst supporting the Oxylog. The issue of
the suitability of the Oxylog for this stage of the study
was addressed critically. Acknowledging the imprecision of
the Oxylog identified in Chapter 6 (with particular
reference to the measurement of (TE) it was felt that this
system was preferable to a series of smaller Douglas bags
mounted on a back pack. This method would cause
considerable disruption to the patients' rhythm if manual
intervention was regularly required to collect the expired
air and change the bags. The primary physiological marker
adopted was the 7(:)2 , this was shown in Chapter 6 not to be
significantly different to the Douglas bag measurements
(despite the high resistance to breathing of the Oxylog
system incorporating the Hans Rudolph valve (6.9)].
The relationship between the distance walked for the
three shuttle tests remained very strong following the
results documented in Chapter 4 and 5. Patients attained a
similar maximal heart rate on the two trials. The patients
managed to walk to a similar degree of physiological stress
during the shuttle walk with the Oxylog. The added weight
of the Oxylog . manifest its effect in decreasing the
patients' overall performance. Nevertheless this effect
appeared to be systematic and a strong relationship was
maintained with the lactate trial (r=0.97).
The maximal heart rate achieved represented 64 - 84% of
231
predicted. Clearly each of these patients maintained a
cardiac reserve. These findings are consistent with a
ventilatory limit to functional capacity. The absolute
values are consistent with Spiro et al (1975) and Jones et
al (1971) in clinically similar groups.
The difficulties with the Oxylog measurements of /I and
lo2
 were documented in Chapter 6; the measurements of 110 2 do
not differ significantly from the 'gold standard'
measurements (Douglas bag) but the values of /1 reported
must be viewed cautiously as the Oxylog and mouthpiece
system underestimate volume. This loss of volume, although
reducing the overall values for /02 probably does not
distort the value in an important way. The linear increase
of /o2 measured during the shuttle walking test is
consistent with the pattern observed during the treadmill
test in a similar group of patients (Chapter 5).
In this group of patients there was a 29% variation in
the resting /02 and is consistent with the reports of
McNeill et al (1987). This variation increased with the
increasing intensity of the exercise. In 'normal' subjects
the measurement of individual /o2 is highly reproducible
with a variation of some 7% amongst subjects at any
particular walking speed (ACSM 1991, McArdle et al 1991).
Miring the first five levels of the shuttle walking test in
patients this discrepancy rose to 37% (level 5). This
variation shows that the 02 cost of comparable exercise
varies considerably amongst patients, and that this
variation is markedly greater than amongst normal subjects.
The mean /i resting value of 9.85 1.min4 (BTPS) was higher
than normal resting values but was considerably lower than
the values documented by Matthews et al (1989) in a
clinically less severe group and Kirsch and colleagues
(1989) in a clinically similar group. The mean resting i1o2
was again lower than the values cited by the authors above.
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It is feasible that the documented ventilatory measurements
using the Oxylog are lower than the true /I (the reader is
referred to Chapter 6), however the equipment is secure and
the patients pursed their lips around the mouthpiece to
prevent leakage. The mean maximal values of /1 (24.9 1.min4)
represent a mean of 69% predicted. The equation employed
for this stage of the study was that reported by Carter et
al 1987. The present study group closely resembled (FEV/
values) the group Carter et al (1987) recruited to examine
the most useful predictor of tE in patients with CAL. The
absolute values (STPD) are marginally lower than those
quoted by ZuWallack et al (1991), Swinburn et al (1985) and
Cotes (1982) in clinically similar groups (judged on the
M I values) and, although useful, a percentage predicted
value is often not reported to allow comparison. Overall,
the groups cited above appeared to work to similar levels
as judged by heart rate response, but as reported in
chapter 6 no firm conclusions can be drawn as a variety of
test equipment and protocols were employed. .
A broad trend of response to exercise response in
patients with CAL can be nevertheless observed. Compared to
the work of Jones et al (1971) the values reported in the
present study are considerably lower for tE ma . This may be
an artefact of protocol variation or the difference may in
fact be due to the Oxylog failing to detect the patients
total inspired volume misrepresenting measurements of
A small additional increase in /1 may be accounted for by
the variation in the R value at maximal exercise (Oxylog
assumes an R value of 1). Two patients exceeded 90% of
their predicted tE	 , a further two exceeded 80% and
another two exceeded 70%. Three patients failed to reach
50% predicted tE , despite reporting that breathlessness .
was the limiting factor (Borg scores of 7, 4 and 5). These
three patients reached 69, 82 and 63% of predicted maximal
heart rate. This low value of /1 can in part be accounted
for by a lack of motivation in patient 8. Patient 4,
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exercising to a Borg score of 7 possibly, has an increased
awareness to the sensation of dyspnoea limiting his
exercise performance prior to attaining a defined
physiological limit. Six of the remaining seven patients
reached a maximal 171 in excess of 74% predicted. These
patients would be approaching a ventilatory limit to
functional capacity, consistently reporting breathlessness
post-exercise. In view of the results of Chapter 6 it is
probable that the maximal '(Ti is underestimated. It is
therefore likely that these patients reached a higher
maximal 17i than these figures suggest, approximating
predicted 1.7E . These values of maximal in and the
assumption of underestimation together suggest that this
group of patients reached a true ventilatory limit to
exercise. Unfortunately it is not possible to substantiate
this comment although the data in Chapter 6 would go some
way to supporting this.
The mean value of 17o2peg, reported is consistent with that
anticipated for a group of severely affected patients. The
values are slightly lower than other published data but
similar to the values quoted by Swinburn et al (1985) who
coincidentally employed the Oxylog. The strong relationship
between distance walked and the 1io2puk supports the data
reported in Chapter 5. This correlation coefficient is
similar to that documented in Chapter 5.
Seven of the patients who participated in this study also
completed the study reported in Chapter 5. A N/o2pea
measurement was obtained both directly from the shuttle
walking test using the Oxylog and indirectly comparing the
relationship between performance on the shuttle walking
test and the measurement of ilo21=1, from a conventional
treadmill test. The mean Vo2peak measured in this group of
seven patients was 12.9 (3.6) ml.min4 .kg4 during the
treadmill test and 11.1(4.2) ml.min4 .kg4 for the shuttle
walking test. These two values were strongly related
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(rho=0.86) are were not significantly different (mean
difference, 1.8 ml.min4 .kg4 , 95% CI -0.9 to 4.5). The
relationship between the maximal values of ventilation were
less strongly related (rho=0.29) but not significantly
different. These results suggest that the shuttle test does
in fact provoke a symptom limited maximal performance in a
similar manner to the conventional treadmill test. The Borg
score for these patients in the two studies was not
significantly different.
Examining the physiological responses and the Borg scale
it is proposed that the shuttle walking test provides an
incremental exercise test that provoked a symptom limited
maximum performance, and in line with recent work published
it appears that not all patients with CAL terminate
exercise testing due to the limitations imposed by their
respiratory system (Rampulla et al 1992).
The increase in blood lactate concentration was small but
significant (p<0.05). The mean maximal value of 1.69=01.14
is not consistent with the patients reaching an anaerobic
threshold, nor is the accumulation of lactate the likely
explanation for the cessation of exercise. This study
incorporated patients with severe airways disease and it is
well documented that in these patients a lactate
accumulation/anaerobic threshold is not commonly
identified. Spiro et al (1975) documented a mean maximal
lactate concentration of 2.56 mmo1.1 4 in agreement with the
suggestion that these patients do not experience high rates
of anaerobic glycolysis in skeletal muscle during exercise.
Authors who consistently identify an anaerobic threshold in
patients with CAL acknowledge that a group of patients
exists with severe airways disease that do not manifest a
lactate response at maximal exercise (Sue et al 1988).
'Raman (1986) extends this issue further by proposing that
examining the effectiveness of a training programme in
patients with moderate to severe CAL using the conventional
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indicator of the anaerobic threshold and .702peak relationship
is inappropriate because peak levels of exercise in this
group are often below threshold levels. Kanarek et al
(1979) identified a group of patients from gas exchange
ratios who did or did not manifest an anaerobic threshold.
The group that did not reach this threshold level utilised
74% of their predicted . This report is consistent with
this present study group. Overall the results of the
lactate analysis appear to follow the trends previously
observed, that is the more severely affected patients
appear not to produce a significant lactic acidosis upon
maximal exercise, falling well below anticipated levels
observed in a young normal population at 1o2pak (> 8 mmo1.1-
1 ). The blood lactate concentrations measured in this study
are low but this does not mean that the shuttle walking
test does not provoke a symptom limited maximal performance
in this patient group but that exhaustion is not
necessarily associated with high rates of anaerobic
glycolysis in the exercising muscle. The shuttle walking
test does appear to provide a gradual stimulus to maximally
tolerated levels of exercise.
In conclusion it appears that the shuttle walking test
provides an objective measure of disability in this patient
Troup which consistent with the data reported in Chapter 5,
relates well to an individual's to2 . Whilst it appears
that ventilatory limitation contributes directly to the
cessation of exercise the importance of other factors must
not be overlooked. The combined use of the Oxylog and the
Sports tester confirmed that the shuttle walking test
provoked an incremental cardio-vascular and respiratory
response to a symptom limited maximum performance.
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8. EXAMINATION OF CAPILLARY BLOOD LACTATE CONCENTRATION
IN RESPONSE TO THE SHUTTLE WALKING TEST AND A
CONVENTIONAL SYMPTOM LIMITED TREADMILL TEST IN
PATIENTS WITH CAL
8.1 INTRODUCTION
In the previous chapter low blood lactate concentrations
were observed in response to the shuttle walking test. A
considerable rise in the concentration of this metabolite
(> 8 mmo1.14) in young healthy subjects is taken as one
indicator of a maximal performance. However, this magnitude
of response is rarely documented in patients with CAL
although some increase in this metabolite has been
demonstrated (Spiro et al 1975, Elliott et al 1987). In
general it appears that the less severely affected patient
is capable of mounting a 'lactate' response, whereas the
more severely affected exhibit such reduced exercise
capacity that a lactate response may not occur.
The aim of this study was to address more rigorously the
question 'Does the shuttle walking test provokes a symptom
limited maximum performance which is comparable to a
conventional treadmill test?' From the data presented in
the previous chapters (5 and 7) it would appear to provide
a comparable physiological and subjective response. This
study examined the metabolic response to both the treadmill
test and shuttle walking test in a group of patients who
were less severely affected that the group described in
Chapter 7, ie is the low lactate response the test or the
patient group. An apparently healthy control group was
incorporated into the study. They performed an incremental
maximal treadmill test to allow comparison of physiological
and metabolic responses to maximal exercise with those
observed in the patient group.
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8.2 METHOD
8.2.1 Patient Group
Ten patients attending out-patients clinics were
recruited for this stage of the study. Informed consent was
obtained. The selection of patients selected conformed to
the criteria described in Chapter 4 (4.2.2). The patients
were required to attend Glenfield Hospital on three
separate occasions at intervals of one week (to minimise
any training effect), during a period of clinical
stability. The patients were instructed to withhold
relevant medication for three hours prior to testing. The
baseline and exercise test measurements were as described
in Chapter 4 (4.2.1 & 4.2.2).
8.2.2 Familiarisation visit
This initial visit introduced the two exercise tests (and
the associated equipment) to the patient. The patients were
required to perform one practice shuttle walk (4.2.1) and
one practice treadmill walk. Between each exercise test
there was at least a 45 minute rest period to allow
complete recovery.
8.2.3 The treadmill test
The treadmill (Cambridge Medical Instruments 3060) was
as described in Chapter 5. The gas analysis equipment was
anOxyconbeta (Jaegar Ltd). The Oxyconbeta allows breath by
breath measurements incorporating a fast response
differential paramagnetic oxygen analyser and a fast infra
red carbon dioxide analyser. Expired air is passed down a
sample line located in the mouthpiece to the CO2 and 02
analysers. IIo2 and 1.7co2 were expressed in STPD. A bi-
directional digital volume sensor (TripleV volume
transducer) is incorporated into the mouthpiece to measure
ventilatory volume directly (BTPS). This device basically
comprises of a vane suspended inside a tube that rotates
with the airflow, interrupting light beams from two LEDs.
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Two photo-transistors detect these interruptions and
transform the flow into a series of electrical signals. The
volume displaced between two signals is fixed. The time
between the pulses is a measure of flow. Breath by breath
and 8 breath average data was computed and stored on disk.
The speed of the treadmill was calibrated at the
beginning of the study. The Oxyconbeta system self-
calibrates each time the equipment is switched on. Prior to
testing, half way through the study and at the end of the
study period the equipment was calibrated with calibration
gases (of known concentration 5% CO 2 and 95% N2) and a 3
litre syringe pump to calibrate volume measurements. At
each stage the equipment calibrated accurately with no
drift from the standard concentrations or volumes.
The performance of the Oxyconbeta was compared to the
conventional Douglas bag in two subjects. Two healthy
volunteers were recruited to perform identical sub-maximal
incremental exercise tests (3 mph at inclinations of 0%,
2.5%, 5% and 7.5%, 4 minutes stages) on the treadmill at
Loughborough University for Douglas bag collection and at
Glenfield for the Oxyconbeta trial. The results of this
comparison showed little variation in the measurements of
volume or gas concentrations. The mean difference of all 4
stages for /E (converted to STPD) was 1.5 1.min 4 (5.8%)
lower with the Oxyconbeta, and for /o2
 1.5 ml.min4.kg4
(10.5%) higher with the Oxyconbeta.
The symptom limited treadmill test was performed at
Glenfield General Hospital. The speed of walking on the
treadmill was gauged during the first visit from the heart
rate response and the reported Borg breathlessness score.
The protocol employed was the same as documented in Chapter
5, ie an individualised speed with increases in the
gradient from 0% by 2.5% every 2 minutes until the patient
indicated they wished to stop. During the test the
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patient's heart rate was monitored as described (3.1.5). A
pulse oximeter (Ohmeda) with a finger probe was used to
monitor saturation during exercise. Both of these pieces of
equipment linked directly to the Oxyconbeta system and the
results displayed on the computer screen. For the second
treadmill visit resting measurements were made with the
patient sitting adjacent to the treadmill. Resting
measurements were taken for 4 minutes and between minutes
4 and 5 the patient was directed onto the treadmill and the
predetermined walking speed secured before the start of the
test at the start. Whilst resting and for the second minute
of each increment and patients were requested to report on
their perceived level of breathlessness using the Borg
breathlessness scale (Appendix B).
Duplicate 20 pl arterialised capillary blood samples were
taken from the thumb or index finger using a sterile blood
lancet (Baxter Scientific Instruments) as described
previously (7.4.2) after both the shuttle and treadmill
walking test. The samples were stored at -20°C and assays to
determine lactate concentration were performed on the
supernatant at a later date.
8.2.4 The second and third visit
These were presented to the patients in a randomised
balanced design of one shuttle walking test (4.2.1)
(shuttle trial) followed one week later by a symptom
limited maximum treadmill walking test (treadmill trial).
8.2.5 The control group
Ten healthy hospital employees were recruited. As far as
possible these were age and sex matched. These individuals
presented with no significant past medical history and with
an FEV1 greater than 80% of predicted. They performed a
maximal incremental exercise test on the treadmill. An
initial familiarisation visit allowed the operator to gauge
an appropriate speed of walking. An estimated loo,2 	 was
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calculated using the equations of Bruce et al (1973) for
sedentary men and women. From this value an appropriate
walking speed and inclination was determined using the
tables presented in the ACSM handbook (1991). The test on
the initial visit was sub-maximal. The appropriate
intensity of exercise was assessed from the heart rate
response and the reported level of exertion and
breathlessness of the Borg scales (Appendix B). For the
second visit these individuals followed the same protocol
as described above (with the resting measurements),
although some commenced at an inclination of 2.5% to limit
the time of the test. This group of volunteers were also
asked to report on both their perceived level of
breathlessness and overall exertion for the second of each
of the 2 minute increments. Capillary blood samples were
collected as described above.
For each maximal exercise test medical cover was
provided.
8.3 RESULTS
No patient/volunteer was excluded from the study because
of problems with either the protocol or the equipment used.
The results of the CRDQ revealed that the patients were
psychologically and emotionally stable throughout the study
period.
The physical characteristics of the patient group are
summarised in Table 8.1. There were no significant
differences in the spirometry values recorded for the
patients between the three trials. The same variables
recorded in the control group are reported in Table 8.2,
for just the second (maximal treadmill) visit.
The mean FEVi/FVC ratio for the patients for the shuttle
and treadmill visits was 51.4% and 52.0% indicating overall
moderate impairment (range 39.5% to 68.4%).
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TABLE 8.1 Some physical characteristics of the patients,
Mean (SD). n=10 (6 male, 4 female)
Visit 1 Shuttle Treadmill
Age 62.6 - -
(year) (7.6) - -
Weight - - 77.27
(kg) - - (14.31)
Height 1.68 - -
( In ) (0.07) - -
MI 1.25 1.28 1.27
(1) (0.44) (0.45) (0.44)
FEVL 44.9 46.2 45.7
% predicted (13.8) (14.0) (14.2)
FVC (1) 2.46 2.46 2.41
(0.59) (0.59) (0.49)
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TABLE 8.2 Some physical characteristics of the control
group. Mean (SD). n==10 (6 male, 4 female)
,
1
Age
(Yr)
58.1
(2.6)
Weight 72.46
(kg) (14.31)
Height 1.69
(m) (0.09)
FEV1 3.06
(1) (0.77)
_
FEV/ 106.8
%predicted (18.8)
FVC (1) 4.09
(0.94)
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Table 8.3 reports on the mean difference (95% confidence
interval) between these variables for the patients
treadmill test visit compared to the control group and
their statistical significance.
Again there was a poor relationship between FEVI , PVC and
distance completed (r=0.22 and 0.38 respectively) and in
the reported Borg score and distance (rho=0.15). The
relationship between maximal heart rate and distance was
however slightly higher (r=0.45).
The results of the resting measurements taken
immediately prior to the treadmill test are presented in
Table 8.4 with the mean differences and 95% confidence
interval expressed in Table 8.5. The corresponding results
from the maximal treadmill test are summarised in Table 8.6
for both the patients and the control group. The mean
differences, 95% confidence interval and level of
statistical significance is expressed in Table 8.7.
The speed the patients walked at on the treadmill was
2.36(0.65) mph for a duration of 7.6(3.1) minutes. The peak
inclination the patients reached was 10%. The control group
walked for a mean duration of 9.5(1.3) minutes at a mean
speed of 3.89(0.37) mph. The speed the control group walk
was significantly greater than the patient group although
the mean time walked was not.
The maximal levels of 1E were presented as a percentage
of predicted maximal (Spiro et al 1975) for the patients
and represent a range of 62% to 114% of predicted maximum
attained with 4 patients exceeding their predicted values.
These four patients were not the four most severely
disabled patients (judged by spirometry). Two patients had
an FEV1 equal to or greater than 1.3 1. The patient who
attained 114% of predicted /E had an FEVI of 0.75 1. For the
control group, the equation proposed by Jones (1988) was
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TABLE 8.3 Mean difference and 95% confidence interval
between the physical characteristics of the
patient and control groups.
Mean
difference
(C-P)
95% confidence
interval
Age
(yr)
-4.5 -1.1 to 10.12
Weight
(kg)
-4.81 -20.84 to 11.22
Height
(10
-0.05 -0.08 to 0.06
FEV,
(1)
1.79 " 2.39 to 1.19
FEVI
% predicted
61.00 42.9 to 79.1
PVC
(1)
1.68 " 2.41 to 0.96
SD" significant difference between patients and controls
p<0.001
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TABLE 8.4 Mean (SD) resting results prior to the
treadmill test, for both patients and the
control group. (Both n=10).
Measurement Patients
Mean (SD)
Controls
Mean (SD)
1702 (ml.min4 .kg4 ) 2.85(0.70) 3.13(0.84)
/E (1.min4 ) 10.60(2.66) 8.59(1.71)
Heart rate (beat.min4 )
_
79(9) 81(12)
Oxygen pulse (ml.beat4 ) 2.69(0.57) 2.56(0.34)
Oxygen saturation (%) 96.6(2.2) 98.5(1.2)
R 0.83(0.06) 0.90(0.06)
VD/VT 0.45(0.03) 0.41(0.04)
Blood lactate
concentration
(mmo1.14)
0.81(0.49) 0.90(0.48)
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TABLE 8.5 Mean difference and 95% confidence interval
of the resting results prior to the treadmill
test between the patients and control
group. (Both n=10).
Measurement Mean
differ
-ence
95% confidence
interval
lo2 (ml.min4 .kg4 ) 0.25 -0.39 to 0.47
/E (1.min4 ) -2.01 -4.68 to 0.66
Heart rate
(beat.min4 ) 3 -7 to 12
Oxygen pulse
(ml.beat4 ) -0.13 -0.53 to 0.74
Oxygen
saturation (%) 1.9	 • 0.4 to 3.4
R 0.07 ' 0.00 to 0.14
VD/VT -0.04 -0.1 to 0.03
Blood lactate
concentration
(mmo1.14)
,
0.09 -0.34 to 0.53
' Significant difference between controls and patients
p<0.05
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TABLE 8.6 Mean (SD) treadmill performance and
ventilatory results from the treadmill test,
for the patients and control groups. (both
groups n=10).
Measurement Patients
Mean (SD)
Controls
Mean (SD)
/o2p,k (ml.min4 .kg4 ) 17.1(3.4) 26.0(4.7)
% predicted /o2 mn 68.9(15.4) 96.6(20.7)
(1.min4 ) 40.9(9.4) 57.4(15.3)
% predicted i7E 93.9(14.8) 97.1(36.5)
Oxygen saturation 91.7(6.9) 95.7(2.3)
R 0.89(0.09) 1.04(0.06)
Heart rate max
(beat.min4)
127(16) 158(24)
% predicted max HR 75.1(9.3) 91.1(14.4)
Oxygen pulse
(ml.beat4)
10.3(2.8)
,
11.9(3.5)
VD/VT 0.32(0.08) 0.20(0.03)
Blood lactate
concentration
(mmo1.14)
1
1.66(0.95) 4.70(2.39)
4
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TABLE 8.7 Mean difference and 95% confidence interval
of the maximal results of the treadmill test
between the patients and control group. (Both
n=10).
Measurement Mean
differ-
ence
95%
confidence
interval
C-P
N ra (ml.min4 .kg4 ) 8.9	 • 4.5 to -13.4
% predicted /o2 27.7 • 8.0 to 47.4
/E n, ( 1.min4 ) 16.5 • 5.4 to 27.6
% predicted VE 3.1 -25.0 to 31.3
Oxygen saturation (%) 4.00 -1.1 to 9.0
R 0.15 • 0.09 to 0.22
Heart rate max
(beat.min4 ) 30 . 8 to 52
% predicted max HR 16.0 e 3.2 to 28.8
Oxygen pulse
(ml.beat4 ) 1.6 -2.2 to 5.4
•
VD/14 -0.11 . -0.16 to -
0.06
Blood lactate
concentration
(mmo1.14)
3.05 1.28 to 4.8
• Significant difference between controls and patients
p<0.05
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employed [30.6 x (FEV1 -29)]. Five of the control group
exceeded their predicted maximum (range 52 to 155%).
The predicted values for t ro2Fik were calculated from the
equations proposed by Bruce et al (1973), the equation
employed in Chapters 5 and 7. The patients attained a mean
value of 68.9% (range 51.7 to 103.7%) of predicted Vo 2 ,
whilst the control group attained a mean value of 96.6%
(range 66.3 to 127.2%). These two values were significantly
different.
The heart rate data, not significantly different at
rest, indicates that the control group were able to not
only attain a significantly higher mean maximal heart rate
but this also translated into a greater percentage of
predicted maximal heart rate attained.
The measurement of capillary blood lactate concentrations
shows that at rest there was no significant difference
between groups. Post treadmill test, the mean maximal
concentration of lactate were significantly higher for the
controls compared to the patients, Figures 8.1 and 8.2 show
the pre and post treadmill test concentrations of capillary
blood lactate for patients and controls respectively. It
can be seen that of the ten controls 2 individuals exceeded
a post exercise lactate concentration of 8 mmo1.1 4 . A
further 4 individuals exceeded 4 mmo1.14 , and the remaining
4 exceeded 2 mmo1.1 4 . For the patient group no individual
exceeded 4 mmo1.1 4 and just 2 exceeded 2 mmo1.14 . The mean
increase in lactate concentration for the control and
patient group was 3.80 and 0.85 mmo1.14 . This represents a
statistically significant increase for both groups. There
was no relationship between the patients' spirometry and
peak lactate concentration or lactate concentration
increase.
The Oxyconbeta system has the function allowing the
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lactate concentration in the patient group
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FIGURE 8.2 Pre and post treadmill test blood capillary
lactate concentration in the control group
(n=10).
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identification of an anaerobic ventilatory threshold using
the 17co2/Vo2 method described by Sue et al (1988).
For this group of individuals the threshold was reached
in 6 patients and all of the control group, as detected by
the Oxyconbeta system (Fig.8.3 & 8.4). The mean VO2 at which
it occurred in the patient group was 0.70 (0.13) 1.min4
(representing 54.0% (702 mn ) and for the 10 control subjects
the value was 1.01 1.min4 (equivalent to 49.2% of the 1702
max) .
The mean maximal Borg breathlessness and exertion scores
for the healthy volunteer group were 6.4 (2.4) for
breathlessness and 16.8 (1.9) for exertion. The mean
difference between the reported Borg breathlessness score
post exercise between the patients and the healthy subjects
was 1.4 (95% CI -0.45 to 3.25) higher in the control group
although this difference was not significant.
On direct questioning, 8 of the ten patients reported
stopping exercise because of breathing difficulties,
compared to 1 of the control group. Whilst 2 of the
patients and 3 of the control group stopped because of
overall fatigue (combination of legs and dyspnoea). The
remaining 6 of the control group stopped due to leg pain.
Comparing patients' response to both the shuttle walking
test and symptom limited maximal treadmill walking test
(paired t-test) revealed that there was no significant
difference in post exercise capillary lactate
concentrations [(1.23(0.98) mmo1.3:1 post shuttle, 1.66(0.95)
ramo1.14 post treadmill). Neither was there any difference
in the mean maximal heart rate attained (127 beat.min 4 for
both the shuttle and treadmill test). Figure 8.5 shows the
capillary blood lactate concentrations pre and post shuttle
walking test and Figure 8.6 compares the maximum response
in the ten patients in both the shuttle
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walking test and the treadmill test. One patient (patient
10) produced a considerably higher lactate response to the
treadmill than to the shuttle walking test and a greater
response when compared to the remaining nine patients.
Patient three produced a considerable lactate response
after the shuttle walking test and a higher than average
response to the treadmill test. These two patients had an
FEVI
 of 1.05 1 and 1.75 1 and reached 62.2% and 103.7%
respectively of their llo and both reached over 90% of
their predicted maximum IE.
The relationship between symptom limited Io2k and the
distance completed in the shuttle walking test was again
strong, r=0.94 (Figure 8.7).
The subjective ratings for the two test for the patient
group is shown in Table 8.8, with the mean difference, 95%
confidence interval and level of statistical significance
shown in Table 8.9.
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TABLE 8.8 Reported Borg breathlessness score [mean(SD)] at
rest and immediately post exercise for the
shuttle and treadmill test (n=10).
Shuttle test
,
Treadmill test
Resting 1.4 (1.2) 1.2 (1.1)
Post exercise 5.1 (0.8) 5.0 (1.2)
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TABLE 8.9 Mean difference, 95% confidence interval and
Spearman correlation between the reported Borg
breathless score of the shuttle versus the
treadmill exercise test.
Mean
difference
95% confidence
interval rho
Resting 0.25 -0.47 to 0.97 0.59
Post exercise 0.10 -0.82 to 1.02 0.46
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DISCUSSION
The aim of the study reported in this chapter was to
examine the blood lactate response to exercise in patients
with CAL and compare the response between the shuttle
walking test and a conventional treadmill test. The
inclusion of a control group allowed it to be established
that the capillary blood lactate measurements were in fact
disease related rather than a consequence of increasing
age.
The control group did not present with significantly
different physical characteristics except for spirometry
measurements. The resting physiological measurements prior
to the treadmill test for the patient and control group
were again not significantly different except for a
slightly lower oxygen saturation in the patient group and
a slightly increase R value in the control group. This was
raised slightly above the normal resting value of 0.85
(Whipp et al 1984). The latter may be in part due to
unfamiliarity with the equipment and resulting
hyperventilation (Wasserman et al 1987) (the majority of
patients recruited had previously performed laboratory
based exercise tests).
Overall the exercise response of the patients with CAL is
severely impaired in comparison to the age and sex matched
control group. Spiro et al (1975) compared levels of
ventilation at a given level of Io2, ie the ventilatory
equivalent. For this study absolute values were compared as
they were in the studies by Nery et al (1983) and Carter et
al (1987). The increase in the patients level of
ventilation was almost 4 fold while that of the control
group was almost 7 fold. These patients were unable to
increase their level of ventilation to match the increasing
workload primarily due to the abnormal mechanical
characteristics of the respiratory system. In addition, it
has been suggested that patients have an altered
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physiological process; when the set CO 2
 point of ventilatory
control is depressed there is an increase in the
ventilatory requirements of work (Whipp & Wasserman 1988).
This results from hypoxaemia and possibly the effects of
regional distortion of lung tissue on vagal tone, seen in
patients with emphysema. Alternatively, in patients with
chronic bronchitis the tendency is for the patient not to
ventilate adequately in relation to the metabolic demand of
exercise. The CO2 set point is elevated as a consequence of
mechanical limitation to airflow and possibly impaired
chemoreflex function (Whipp & Pardy 1986). The hypoxaemia
is primarily due, during exercise to the V/Q mismatch. The
results of the present study are consistent with the
reports of Spiro et al (1975), Nery et al (1983) and Carter
et al (1987) when comparison of the exercise response of
patients and a control group were examined.
Comparison of performance between the two groups revealed
that the patients walked at a slower speed for a shorter
duration and achieved a lower peak incline. The N.To2puk was
considerably lower in the patient group. A 1102peak is
dependent on a number of factors and a low value in itself
does not indicate a ventilatory limit to functional
capacity. The lack of a relationship between the '7o2
 and
spirometry results are suggestive of a lack of a causal
mechanism between impairment (as judged by spirometry) and
performance.
The equipment employed at this stage also allowed the
examination of the VD/VT ratio and the change with exercise.
At rest there was no significant difference between the two
groups, at peak exercise the ratio was significantly higher
in the patient group. The ratio did fall from the resting
value but remained higher than normal, consistent with the
study by Carlson et al (1991). This is an indication of the
patients' limited capacity to increase the tidal volume and
the poor gas exchange efficiency as a consequence of the
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maldistribution of the V/Q ratios (Jones et al 1985).
The heart rate data shows that the control group were
able to reach a much higher maximal heart rate than the
patient group. The patient group appear to have a normal
incremental heart rate response to the exercise test but at
maximal exercise had a considerable heart rate reserve,
utilising less than 75% of predicted of their predicted
maximum. This would be consistent with a ventilatory limit
to performance. In comparison, it would appear that the
control group were approaching a cardio-vascular limit to
continued performance with little, if any, cardiac reserve.
The lactate response to the treadmill test was
significantly higher in the control group than in the
patient group. Confirming the results documented in Chapter
7, the lactate response of the patients was low. The
results reported are lower than some other published
results (Spiro et al 1975, Elliott et al 1987) but not all.
The data relating to the measurement of a significant
lactate response in this category of patient is both sparse
and conflicting. Some authors appear to overlook a low
response documented in a proportion of their patients. The
patients recruited for the present study were motivated and
subjectively reported that they had performed a symptom
limited maximum test. This would be confirmed by the
minimal ventilatory reserve they were estimated to have
post exercise.
Elliott et al (1987) investigated 6 patients with CAL.
All 6 produced a lactate response during incremental
exercise. The authors suggested that a reliable non-
invasive technique to monitor the AT was the systematic
increase in the R value. Interpretation of the graphs
presented do appear to be somewhat arbitrary. The mean
maximal R value was not reported for this study. Kanarek et
al (1979) recruited 12 patients with CAL and examined the
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incidence of a ventilatory AT. 7/12 patients failed to
demonstrate a ventilatory AT. The 5 patients who reached
this threshold level did not have greater FENT, values
(unlike those of Sue et al 1988) but were able to utilise
a higher percentage of their predicted ventilatory capacity
(FECT 1 x 35). The mean maximal R value was slightly but not
significantly higher for the 5 patients (1.10). The AT
occurred at approximately 55% of the "(7o2 , comparable to
the present study.
Nery et al (1983) identified a ventilatory AT in 5/7
patients with CAL. Analysis of arterial blood gases
revealed a significant drop in pH, a rise in PaCO 2 but no
significant fall in HCO; , suggestive of a lack of
significant rise in blood lactate concentration. Schiffman
(1991) states that the inappropriately low minute
ventilation during exercise that causes this respiratory
acidosis is not due to the decreased respiratory drive but
due to the mechanical derangement limiting ventilation and
an increased VD/VT ratio. Wasserman et al (1987) confirms
this proposing that in these patients the limitation to
exercise is the inability to clear CO 2 effectively rather
than the ability to make 02
 available to the mitochondria.
The patient group in the present study attained a
comparable l7o2puk to the previously cited studies above and
those in Chapters 5 & 7. Sue et al (1988) did not measure
blood lactate concentrations directly (measured a fall in
standard bicarbonate ions, HCO;) but identified an
'anaerobic threshold' (AT) in 15/22 patients with CAL. A
metabolic AT tended to be identified in patients who
utilised a higher percentage of their ventilatory capacity
(over about 95% of MVV). Casaburi et al (1989) selected
patients for rehabilitation, providing a significant
lactate response could be produced. The group selected
(n=7) had slightly higher FEV I and /02 rA values.
Interestingly, the magnitude of the response did not relate
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to their grading of disease severity as has previously been
suggested. This poor relationship was apparent in the
present study.
In the present study the patient with the greatest
lactate response (3.87 mmo1.14 ) had a FEVI of 1.7 1 (the 2nd
highest of the group) and a 11o2puk of 1658 ml.min4 (the
highest female). The mean maximal R value of the patient
group was 0.89, not consistent with reaching a true maximal
oxygen uptake. The lactate concentration at this threshold
value is commonly taken as a value of 4 mmo1.14 , although
values of 2.5 mmo1.14 are sometimes used. The rise in
capillary blood lactate concentration in the control group
is consistent with a metabolic AT being exceeded. The mean
immediately post exercise R value (1.04) suggests that the
control group approached their maximal aerobic capacity.
Computer analysis of the breath by breath relationship
between To2 and Ico2 identified that all the control group
also attained a ventilatory AT, using the technique
reported by Beaver at al (1986).
Breath by breath analysis of the computed data detected
a ventilatory AT in 6/10 patients by the system. It was
proposed in the studies by Sue et al (1988), that despite
not detecting a ventilatory AT in 10/22 patients, (6 of
whom failed to produce a significant HCO3- response) this
method of detecting an AT was "satisfactory in most
individual exercise studies". The identification of the
ventilatory AT in the present study of patients occurred at
a mean i102 of 0.697 1.min4 (below the value predicted by
Wasserman et al 1987), representing a mean value of 54% of
the patients i702pak.
The AT is commonly measured by either blood lactate
concentrations or ventilatory measurements. The proposed
linking mechanism relies upon the non-linear increase in
ventilation being associated with a sharp rise in the
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production of lactic acid (the H+ ions produced by lactate
is principally buffered by HCO3. resulting in an increased
production of CO2 from the dissociation of carbonic acid
(H2CO3). In an attempt to compensate for the high levels of
lactic acid and CO2 production the respiratory centres are
stimulated to increase VE). The ventilatory response is
normally mediated through the carotid bodies.
The detection of a ventilatory threshold in patients with
CAL is documented to be hazardous (Belman et al 1992). One
important reason is suggested to be a large inter- and
intra-observer variability in detecting this point. Other
reasons include the sometimes erratic breathing patterns
that patients adopt during exercise testing, and a short
exercise test generating too few data points to accurately
detect a deflection in the plot (Patessio et al 1993).
It would appear that the relationship between these two
methods of detection is not conclusive (Loat & Rhodes
1993), as demonstrated in this present group of patients.
Patients with McArdles disease (a genetic lack of muscle
phosphorylase) fail to produce lactic acid but do
demonstrate a normal hyperventilatory response during
incremental exercise (Hagberg et al 1982). The most likely
mechanism for this was suggested by the author to be
signals generated from neural centres that communicate with
the respiratory centres of the brain, possibly mediated by
increasing levels of circulating catecholamines. An
alternative theory suggested by the same author was that
working muscles are ideally placed to generate signals via
the peripheral afferents to the respiratory centre. In
response to these suggestions Whipp (1983), who proposes a
causal link between the two methods of detection, replied
that the most likely explanation of the ventilatory changes
in these patients was the associated muscle pain or
anticipation of such pain, a characteristic symptom of
McArdles disease.
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Neary et al (1985), examined lactate and ventilatory
thresholds under normal conditions, under glycogen
depletion and previously exercise states. No significant
changes were found in the ventilatory threshold
measurements demonstrating that lactate accumulation was
not responsible for the ventilatory threshold response.
This supports the theory that the ventilatory and metabolic
AT are coincidentally and not causally linked. Hughes et al
(1982) in another study of healthy volunteers also
demonstrated that the ventilatory and metabolic AT could be
manipulated independently, and therefore uncoupled from the
anticipated relationship.
Other factors can contribute to the non linear increase
in ventilation with increasing oxygen consumption. Local
hypoxia at peripheral chemoreceptors may be more pronounced
during severe exercise causing a rise in ventilation
independent of any rise in lactate concentrations. Astrand
and Rodahl (1986) suggest that impulses from higher brain
centres can also modify ventilation particularly if the
exercise requires 'mental effort'.
One aim of the present study was to confirm the low
lactate response reported in an earlier study (Chapter 7).
The lactate response was again low and comparison with the
control group allows the conclusion that no measurement
error had occurred. This is because the absolute values
obtained from the control group were in a range expected
from this population. Therefore a low blood lactate
concentration after maximum exercise is characteristic of
this patient group.
The subjective response to the treadmill test was not
significantly different between the two groups, although
the control group did report a slightly higher level of
breathlessness. This may indicate a psychological adaption
by the patients to, what for them, is a common feeling. The
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overall level of breathlessness reported by both groups was
slightly lower (5.7) than the value (6) reported by Killian
(1992) in two similar but larger groups. Patients were not
asked to report their perceived levels exertion but 3/10
patients reported overall fatigue as their reason for
withdrawal. The study reported by Killian et al (1992)
documented that 43% of patients stopped exercising because
of leg effort rather than breathlessness. Unlike the
present study a cycle ergometer was employed. In a previous
study by Killian (1985) a diagram demonstrates that the
lower a patients FENT/
 (as a percentage of predicted) the
lower is the percentage of predicted Ijo2p,k attained and the
reported Borg breathlessness score. The mean breathlessness
score reported by patients with a FEVI below 40% predicted
was approximately 5, whilst in the 40-60% range this
increased to 6. These results are consistent with the
present study as they are with the results reported by
Rampulla et al (1992) reported in Chapter 5. Two of the
control group reported 18 or more as their perceived level
of exertion, and another 5 rated it at '17', consistent
with a maximal performance (ACSM 1991).
The comparison of results from the patients performing
the treadmill and second shuttle walking test allows us to
state conclusively that there are no important differences
in the metabolic, physiological or subjective response to
the two exercise tests. Both constitute an incremental
symptom limited maximal exercise test. The strength of the
relationship between the two tests is confirmed by the
strong correlation between distance walked on the shuttle
walking test and the 1:702pmk attained on the treadmill walking
test, confirming the previously reported correlations in
Chapter 5 and Chapter 7. The strength of this relationship
allows the observer to make legitimate estimates of an
patient's pak
 upon completion of the shuttle walking test.
This incremental field test, in the present group of
patients provides a similar metabolic, cardio-respiratory,
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ventilatory and subjective response as the treadmill test.
Therefore performance on the shuttle test would allow valid
conclusions to be drawn about the patients functional
capacity. Obviously the test does not provide all the
information that a conventional treadmill test can provide
(particularly in comparison to the computerised gas
analysis equipment) but it is cheap and simple and provides
a reliable alternative that can yield useful information in
the assessment of disability in patients with CAL.
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9. A COMPARISON OF PATIENTS PERFORMANCE ON THE SHUTTLE
WALKING TEST AND THE SIX MINUTE WALKING TEST.
9.1 INTRODUCTION
Studies reported in previous chapters show that the
shuttle walking test is a reproducible, reliable and valid
field walking test of disability in patients with CAL. The
final stage of this project was to compare patients
performance on the shuttle walking test with their
performance on the well established six minute walking test
(6 MWT). The latter is perhaps the most commonly used field
exercise test to assess exercise tolerance in this patient
group. Although attractive there are several investigators
who have expressed concern about the 6 MWT's
reproducibility and sensitivity (Swinburn et al 1985,
Morgan 1989, see Chapter 3 3.3). The fundamental difference
between it and the shuttle walking test is the incremental
external pacing of the latter and the self pacing of the 6
MWT.
This final study therefore examines patients' performance
and their response to the two exercise tests.
9.2 METHOD
9.2.1 Patient group
Fifteen patients from out-patients clinics were recruited
and informed consent was obtained. The selection of
patients conformed to the criteria described in Chapter 4
(4.2.2). The patients were required to attend Glenfield
Hospital on three separate occasions at intervals of one
week (to minimise any training effect), during a period of
clinical stability. They were instructed to withhold
relevant medication for three hours prior to testing. The
baseline and exercise test measurements were as described
in Chapter 4 (4.2.1 & 4.2.2).
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9.2.2 Familiarisation visit
This visit introduced the two exercise tests to the
patient who were required to perform one practice shuttle
walk (4.2.1) and two practice 6 MWTs (7.2.3) in an attempt
to counteract any learning effect (McGavin et al 1976,
Mungall et al 1979, Knox et al 1988). Between each exercise
test there was at least a 45 minute rest period to allow
complete recovery.
9.2.3 The six minute walking test
The 6 MWT (Butland et al 1982) has no standardised
instructions. For the purpose of this study instructions
for the patient were written down in an attempt to
standardise the procedure. The patient was advised to 'walk
up and down the corridor aiming to cover as much ground as
possible in the time allowed (6 minutes). You should not be
concerned if you have to slow down or stop to rest. The aim
is to feel at the end of the test you could not have
covered any more ground.'
The test was conducted along a 45 m hospital corridor.
The operator sat half way along the corridor in a visible
position to the patient. As the patient passed the operator
standard instructions were issued, either 'you're doing
well' or 'keep up the good work' (Guyatt et al 1984).
913 RESULTS
No patients were excluded from the study because they
failed to judge their performance appropriately on the
shuttle test or the 6 MWT. Likewise no patient was excluded
from the shuttle test because he attained 85% of his/her
predicted maximal heart rate (this criterion is not
commonly employed for the 6 MWT).
The physical characteristics of the group are shown in
Table 9.1. The mean FENT, of approximately 48% indicates a
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TABLE 9.1 Some physical characteristics of the group
(lean, SD), n =15.
10 males, 5 females
1 Shuttle 6 MWT
Age (yr)
,
58.4 - -
(7.5)
Height(m) 1.72 - -
(0.06)
FVC	 (1) 2.81 2.77 2.68
(0.82) (0.82) (0.81)
FEVI	(1) 1.42 1.55 1.47
(0.7) (0.8) (0.5)
FEV1 % 48.3 49.6 45.2
predicted (23.7) (23.5) (25.5)
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moderate degree of airways limitation. There was no
significant difference between the spirometry recorded for
the three visits.
The distances walked on the two shuttle walking tests and
the three 6 MWTs are shown in Figure 9.1. The distances
walked for the shuttle walking test ranged from 230 in to
640 m. No patient completed the end of the 12-stage
protocol. The maximum distance walked on either trial
represented 9 levels and 1 shuttle. The range of distances
walked for the 6 MWT on the three trials was 391 m to 591
m, 418 in to 648 in and 414 in to 651 in for trials one two and
three respectively (Table 9.2). No patient whilst
performing the 6 MWT actually stopped walking although
several appeared to decrease their pace considerably. The
relationship between the trials and the mean between-test
difference is expressed in Table 9.3.
There was no significant difference in the distance
walked between the two shuttle walking tests but there was
a significant difference between the first and second 6
MWT, the patients walked further on the second walk
compared to the first, mean difference -32.1 in (p<0.05).
There was however no significant difference between the
second and third attempt of the 6 MWT. The intraclass
correlations between the three 6 MWTs (trial 1 vs 2 R=0.90,
trial 1 vs 3 R=0.79 and for trial 2 vs 3 R=0.94, Figs 9.2,
9.3 and 9.4) were good. A strong intraclass correlation
between the two shuttle walking tests was identified
(r=0.98, Fig 9.5) indicating that these tests are highly
repeatable. The third 6 MWT and the second shuttle walking
test were used for the comparison between the two exercise
tests. The mean difference between the distance walked on
the two tests was 54 m. The correlation between the two
distances was only moderate (rho=0.68), Figure 9.6. The
identified outlier performed equivalently on the three
occasions of the 6 MWT.
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FIGURE 9.1 Mean(SEM) distances (m) walked on the
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TABLE 9.2 Mean (SD) and range of distances (m) walked on
the shuttle walking test and the six minute
walking test, n=15.
Test Mean (SD) Range
Shuttle walking
test	 1 461.3	 (111.7) 230.0 - 640.0
2 476.7	 (103.8) 330.0 - 640.0
six minute
walking test 1 486.5	 (68.4) 390.9 - 591.3
2 518.6	 (69.8) 418.2 - 648.0
3 530.9	 (73.1) 414.6
_
- 651.3
283.
TABLE 9.3 Mean (SD) differences (m) and 95% confidence
intervals (m) and correlation coefficients in
the distances walked between the two field
exercise test.
Test Mean (SD) 95% confidence
difference R/
interval (m) rho
Shuttle walking
test	 1-2 -15.3	 (29.9) -31.9 to 1.3 0.98
Six minute walk
-ing test
	 1-2 -32.1	 (28.2) -47.8 to -16.5 0.90
1-3 -44.4	 (43.8) -68.8 to 20.2 0.79
2-3 -12.4	 (33.4) -30.9 to 6.2 0.94
Shuttle walk - rho
six minute test -54.3	 (70.4) -93.3 to -15.3 0.68
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FIGURE 9.2 The relationship between the distance (m)
walked on the first and second six minute
walking test.
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FIGURE 9.3 The relationship between the distance (m)
walked on the first and third six minute
walking test.
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FIGURE 9.5	 The relationship between the distances (m)
walked on the two shuttle walking tests.
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The mean maximal heart rate data for the two separate
walking tests is shown in Figure 9.7. There was no
significant between trial difference for either the shuttle
or the 6 MWT but, there was a significantly greater mean
maximal heart rate recorded at the end of the shuttle
walking test than the 6 MWT. There was a moderate
correlation between the heart rate values attained at the
end of the different protocol (r=0.76). The mean maximal
heart rate was 9 beat.min4
 (95% CI 1 to 18 beat.min4) higher
in the shuttle walk than in the 6 MWT. The percentage of
the predicted heart rate attained was also significantly
higher for the shuttle walk compared to the 6 MWT (Table
9.4). The heart rate data confirm that the shuttle test
provokes a slightly greater cardio-vascular response than
the 6 MWT. The rise from resting levels was significantly
smaller for the 6 MWT [ 41 beat.min4 (range 8 - 86 beat.min4
SD 22)] than the shuttle walking test [55 beat.min4 (range
29-91 beat.miril SD 21)]. The relationship between the
percentage of the predicted heart rate attained and the
distance walked is shown in Table 9.5.
The relationship between the distance (m) walked and the
percentage of the predicted maximal heart rate attained was
strong for both of the shuttle walking tests and equally
strong for the third 6 MWT although this relationship was
not consistent for all three 6 MWTs. The heart rate data
obtained whilst performing the shuttle and 6 MWT is shown
in Figure 9.8 and indicates the graded cardio-vascular
response to the shuttle walking test presenting an
incremental rise in exercise intensity, a response not seen
nearly as clearly in the 6 MWT.
The correlation between patients' performance, ie
distance walked, and lung function was moderate for the
first shuttle walking test. For example, the relationship
between FEV1 and FVC and performance for the first shuttle
walk were r=0.57 and r=0.55, respectively. The relationship
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FIGURE 9.7 The mean (SEM) maximal heart rate (beat.min-
1 ) attained on the shuttle walking test and
the six minute walking test.
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TABLE 9.4 The mean (SD) maximal heart rate (beat.min4)
attained and corresponding mean percentage
values on the shuttle walking tests and the six
minute walking tests.
Test heart rate
Shuttle walking test 1 131 (5) 77.5 (12.6)
2 131 (6) 77.7 (14.4)
Six minute walking test 1 114 (5) 67.7 (10.2)
2 119 (5) 70.7 (13.9)
3 121 (5) 72.1 (13.7))
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TABLE 9.5 The relationship between the distance (m)
walked on the shuttle walking test or the six
minute walking test with the percentage of
maximal heart rate attained, [(210-0.65) x
age].
Test r
Shuttle walking test 1 0.71
2 0.74
six minute walking test
1 0.39
2 0.54
3 0.72
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was less strong between the lung function values and
performance on the 6 MWT, eg the same values for the first
6 MWT presented r values of 0.45 (FEVO and 0.40 (FVC). The
correlation coefficients for performance on all the walking
test and lung function values are shown in Table 9.6.
The mean Borg scale reported at the end of each exercise
test is represented in Figure 9.9. The mean maximal Borg
score recorded was not significantly different between the
two shuttle test walks. Friedmans two-way analysis of
variance revealed a significant difference between the
response at the end of the three 6 MWTs. The response rose
from a mean value of 2.9 to 4.2 on trial three. The mean
maximal Borg scale was marginally but not statistically
greater in the final shuttle walk compared to the final 6
MWT. Nine out of the 15 patients reported to be more
breathless upon completion of the shuttle walking test than
the 6 MWT. Two patients reported greater breathlessness
after the 6 MWT, one of these patients did present with an
increased level of breathlessness at rest on the day of the
6 MWT than on the day of the shuttle test. The highest
rating after the shuttle test was 9 (very, very severe
(almost maximal)] and 7 (very severe) for the 6 MWT. The
correlation coefficient for the scoring on these two tests
was moderate (rho=0.60).In addition, the mean base resting
values recorded for the three visits were significantly
different for the first visit compared to the second and
third visits, but the resting value was not different for
the visit of either the shuttle walk or the 6 MWT alone.
The analysis of the CRDQ responses revealed there was a
significant difference between the scores of the mastery
component of the questionnaire between the first visit and
the visit of the 6 MWT. Otherwise, for all other components
on all three visits there was no difference in the scores
that could represent a change in the patients overall
psychological/emotional status. There appeared to be no
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TABLE 9.6 Pearson Product Moment correlations between
the distance (m) walked on the shuttle walking
test or the six minute walking test with the
spirometry results.
I
Test FEV1
1
FVC
_
Shuttle walking test 1 0.57 0.55
_
2 0.52 0.41
—
six minute walking test
1 0.47
_
0.39
2 0.45 0.35
3 0.44 0.38
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relationship between the distance walked and the scoring on
the CRDQ. At best there was a moderate correlation between
the dyspnoea score and the distance walked on the first 6
MWT (rho =-0.61).
9.4 DISCUSSION
The results of the present study suggest that the shuttle
walking test provokes a symptom limited performance in this
group of patients, whilst the 6 MWT although potentially
may stimulate an equivalent performance appears not to do
so.
The fundamental difference between the two walking tests
employed for this study was the element of pacing. The
shuttle walking test is an externally paced and incremental
test whilst the 6 MWT relies on the patients intrinsic
ability to gauge an appropriate speed to provoke a maximal
performance. Furthermore, depending upon the manner in
which the 6 MWT is conducted and the amount of
encouragement offered, the cardio-respiratory system may or
may not have been stressed (Fig.9.8). Inconsistencies of
this nature probably contribute to the considerable
variation in the walking performance reported for
clinically similar patient groups between trials (Beaumont
et al 1985, Swerts et al 1990, McGavin et al 1978). This
makes it difficult to make valid comparisons between
studies. The results (mean distance 530.9 m) of the present
study do not relate well to previously reported distances
in clinically similar groups (Mungall & Hainsworth 1979,
mean FEVi 1.4 1, 12 MWT result 900.6 m, Butland 1982, mean
MI 1.3 1, 6 MWT result 413 m). The results of the present
study allow the direct comparison not only of patients'
response to the shuttle walking test and the 6 MWT but also
the comparison of the ranking of the two tests for the
patients. Removing the outlier increases the correlation to
rho=0.90. Therefore it could be concluded that for most of
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the patients in this study performance on the shuttle
walking test and the 6 MWT were well correlated. The same
two patients performed the longest and shortest distance
for both tests. The ranking for the other positions was
broadly similar +/- 3 positions but there were two patients
for whom the ratings were different. The first patient was
ranked third for the shuttle test but fourteenth in the 6
NWT, suggesting that the patient found it difficult to pace
himself to perform a symptom limited maximum test for the
latter. The second patient was placed second in the 6 MWT
but seventh in the shuttle walking test. This patient may
have performed maximally during the 6 MWT and not during
the shuttle walking test. Alternatively the other patients
may have performed sub-maximally on the 6 MWT and maximally
on the shuttle test to climb the rankings.
As a result of this self pacing the 6 MWT may be either
a sub-maximal or maximal test in any individual at any one
time (for the relative merit of these two forms of testing
see 2.3). Notable authors on clinical exercise testing
(Spiro 1977, Jones 1988) recognise that an incremental
exercise test is more likely to reveal a patient's symptoms
or limitation to exercise than either a self paced or
single rate exercise test. The heart rate data (Fig. 9.7 &
Table 9.4) support the proposal that the shuttle walking
test consistently provokes an apparently symptom limited
maximum performance. For this study there was no
significant difference between the distances walked on
trial 1 and 2 of the shuttle walking test. The patients
stressed their cardio-vascular system equivalently for both
trials. This heart rate response is consistent with the
trials of Spiro et al (1975) and Carter et al (1987)
examining exercise tolerance in patients with CAL and
indicative of a ventilatory limit to functional capacity.
The mean maximal heart rate recorded for the third 6 MWT
was significantly lower that for the second shuttle test as
was the rise in heart rate from the resting values. The
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heart rate for the 6 MWT was significantly different for
trials 1 vs 3 but not for the alternative two comparisons.
These data, combined with the distance walked, tends to
cloud the issue when considering relative reproducibility
and highlights the unpredictability of a self paced test as
patients appear to perform to relatively differing
capacities of their cardiac reserve for each trial.
The shuttle walking test distance, perhaps not
surprisingly, relates more strongly to the percentage of
the maximal heart rate attained than the 6 MWT. The
external pacing again evokes a consistent relationship
whereas the 6 MWT does not appear to do so.
The maximal nature of the shuttle test is further
supported by the Borg breathlessness scale rating and the
results of the present study are consistent with the
previous reports by Silverman et al (1988) and Belman et al
(1991). The shuttle test resulted in a reproducible ratings
which were higher than those following the 6 MWT (Fig.
9.10). On the other hand the 6 MWT resulted in inconsistent
reporting of breathlessness as is often found with a sub-
maximal test. Overall these results suggest that the
shuttle test provokes a consistent maximal performance as
measured both objectively and subjectively and provides a
more reproducible exercise test than the 6 NWT.
External pacing allows valid inter and intra-subject
comparison. Patients who have completed 500 m in an
incremental walking test have experienced a common exercise
challenge. This is not necessarily the case for patients
completing similar distances in self-paced 6 or 12 minute
walking tests so that conclusions regarding their
respective functional capacities may be ill founded. It has
been suggested that the habitual nature of walking may
prevent a self paced test from fully demonstrating the
possible beneficial effects of any treatment (Swinburn et
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al 1985) and treatment effect may be more apparent with an
incremental externally paced exercise test. The shuttle
test may enable more effective comparison of different
approaches to patient management and therapy than has
previously been possible using existing field exercise
tests. It is interesting to note that the one patient who
performed markedly better on the shuttle test than on the
6 MWT (Fig.9.6) found it difficult to pace himself for the
6 MWT on all three occasions. The extent of his disability
was obviously revealed more clearly by the shuttle test
than by the traditional 6 MWT.
The defined speeds of walking in the shuttle test ensure
that the workload increases in a manner which provides an
incremental and qualitatively similar cardio-respiratory
stress for all the patients. The heart rate response
(Fig.9.9) provides evidence of this graded cardio-vascular
response . The shuttle test, unlike the six or twelve
minute tests where effort may be maximal from the start,
stresses the patient progressively to a symptom limited
maximum. This gradual increase in exercise intensity
increases the safety of the test.
It has been reported that an externally paced step test
is a reproducible and standardised method of assessing
functional capacity in normal subjects (Jones et al 1971).
However, the performance of patients with severe CAL on a
paced step test shows a marked learning effect (Swinburn et
al 1985). A 96% improvement in performance over the first
four tests has been reported. Because reproducible results
are obtained regardless of whether the patient completes
just one or all twelve levels the shuttle test is more
appealing for the assessment of patients with severe
airways disease than the 6 NWT. Morrice & Smithies (1984)
reinforced this point in their proposal of the 100 in walk,
suggesting that a 6 MWT was too arduous for the severely
affected patient. The shuttle walking test, by
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incorporating a wide range of walking speeds, allows the
monitoring of the progress of all patients using a single
exercise test.
Taking the results from a previous study (Chapter 5) and
comparing the results with that of McGavin et al (1976) it
is apparent that performance on the shuttle walking test
relates well to the N:lo2p . The original study of the 12 MWT
revealed a correlation coefficient of r=0.52, compared to
the value r=0.88 for the corresponding value in the shuttle
walking test. Swinburn et al (1985) used the fOxylogi
during the 6 MWT but does not quote a correlation
coefficient between the two values. In their study patients
were observed to have a lower ventilatory and ICTo2w. response
than to the self paced walking test than to the paced step
test. This indicates that patients tend to select a speed
that is comfortable rather than stress themselves to a
symptom limited performance. They would consequently fall
short of attaining their 'To
	
a self paced walking test.
In conclusion it appears that the responses to the two
walking tests are quite different. The results suggest that
the shuttle walking test provokes a symptom limited maximum
performance whereas the 6 MWT results in a sub-maximal
performance. The shuttle walking test is as acceptable to
the patients as the traditional 6 MWT, whilst remaining a
simple exercise test for both the patient and operator. It
offers distinct advantages to the operator/investigator
over the 6 NWT, providing a standardised exercise test that
is reproducible and allows valid inter-subject comparison.
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10. GENERAL DISCUSSION
The studies described in this thesis were designed to
develop and validate a performance test which could be used
to assess the functional capacity of patients with CAL.
Patients often present to their doctor with a limitation
in their ability to sustain functional activities such as
walking, dressing and stair climbing. After symptoms are
identified examination is directed towards lung disorders.
Further laboratory based investigations focus on
identifying the disease process. This process relies
heavily on the assumption that the degree of organ
impairment closely relates to the inability to perform
functional activities (disability) and also the severity of
symptoms experienced daily (handicap), ie
Organ impairment -P. Disability -0 Handicap.
It has been repeatedly documented in the literature that
a patient's static lung function neither predicts nor
relates well to his exercise tolerance and consequently his
ability to cope with activities of daily living. Frequently
exercise testing in some form is incorporated into overall
patient assessment. However, to avoid the need for
technically demanding exercise testing some investigators
continue to use lung function measurements (either simple
or complex) to predict a patient's exercise tolerance
rather than measure it directly (Carter et al 1987, Carlson
et al 1991). Such procedures even require the patient to
undergo quite complex respiratory measurements in an
attempt to estimate the patient's
Acknowledgment of the importance of the measurement of
functional capacity in overall patient assessment has
resulted in a wealth of exercise studies proposing a
variety of test procedures in both the laboratory and the
field (Butland et al 1982, Beaumont et al 1985). This has
obviously lead to the measurement of change in exercise
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tolerance as an outcome measure in a variety of therapeutic
interventions. Surprisingly, much of the literature
reporting self paced field exercise test seems to have
overlooked the poor relationship which these tests exhibit
with 1.702peik . Researchers and clinicians continue to use
corridor walking tests, assuming them to be an accurate
indicator of a patient's functional capacity. The self
paced tests are commonly used as a cheap and some would
argue effective exercise test. But, self paced and
conducted over a fixed period of time they cannot guarantee
to provide either a maximal or sub-maximal exercise test.
In practice they be either maximal or sub-maximal,
depending on the patient group being tested and a variety
of psychosocial influences. They cannot claim to provide a
sub-maximal endurance test, often the exercise test of
choice to indicate an improved exercise tolerance after
intervention.
Recognition of the inherent problems associated with the
self paced walking tests led to the development of the
shuttle walking test described in chapter 1. The subsequent
reproducibility studies indicated that the shuttle walking
test was equally as reliable, if not more so than the
corridor self paced tests giving reproducible results after
just one practice walk. In fact, in the study comparing the
shuttle test with the 6 MWT there was no significant
difference between the first and second shuttle walk,
although a small group of patients had performed a shuttle
test previously.
The initial study also indicated that although the
exercise was to a symptom limited maximum there was a
considerable cardiac reserve, suggesting that these
patients' exercise tolerance was not limited by cardio-
vascularsinsufficiency. The lactate data (Chapters 7 & 8)
excludes a local muscle fatigue as the source of limitation
It could of course be argued that maximal testing is very
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unreliable in patients with CAL not least because of the
motivation required and the difficulty individuals
experience judging their individual maximum. In patients
this is compounded by the natural variability of the
condition. Opinions exist suggesting that this is not
necessarily the case and performance on a symptom limited
maximum test in patients with stable CAL is consistent
(Severa et al 1983, Brown et al 1985).
The data presented in this thesis supports this proposal.
The shuttle walking test, a symptom limited maximum
exercise test, produced more reproducible test/retest
results than the 6 MWT. Furthermore the subjective
assessment of breathlessness post shuttle walking test was
more reproducible than that post 6 MWT. This data is
consistent with the results of Silverman et al (1988) and
Belman et al (1991) demonstrating that patients subjective
rating of dyspnoea is more reproducible during/after a
symptom limited exercise test. Reviewing the individual
Borg scores and the maximal heart rate data recorded during
the 6 MWT indicated that the group of patients did not
approach the 6 MWT uniformly, unlike the approach to the
shuttle walking test. As a consequence of this intrinsic
variability of the 6 MWT, misleading conclusions as to the
patients true exercise tolerance could be drawn.
It is widely recognised that the 6 or 12 MWT do not
facilitate comparison of patients' results between centres
because of the lack of standardisation and susceptibility
to variations in the motivation of the patients and
supervisor (Clarke 1991). It is proposed that the shuttle
walking test minimises both of these influences. Firstly,
the external pacing standardises the test and does not
allow the patient to over-ride the signals. Secondly, the
instructions are standardised to limit operator effect and
the only encouragement that was received by the patient was
'good' as a compliment to their pacing, ie if they turned
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around the cone as the bleep sounded. The patient was not
encouraged to walk any faster which, until the final stages
of the exercise would be inappropriate. It would be
interesting to examine the effect of standardised verbal
encouragement on patients' performance. However as the
shuttle test is on the whole a symptom limited maximal test
it is felt that encouragement would be unlikely to alter
the patients' perception of breathlessness, the primary end
point of the test.
The validation of the shuttle walking test provided
strong support for the proposal that this field exercise
test did reflect an individual's cardio-respiratory
capacity, providing a more objective field measure of a
patient's exercise tolerance than has previously available.
Reduced exercise tolerance and a parallel fall in is
well documented in CAL (Patessio et al 1991). It would
therefore seem reasonable to adopt a simple but reliable
exercise test that reflects this physiological parameter to
monitor the course of the disease and the response to drug
therapy etc. This study also allowed the examination of the
limitations to exercise in this patient group. It appeared
that most patients stopped exercising because they were
unable to maintain the level of ventilation demanded for
the task, although a minority appeared to stop before this
point, consistent with the results previously reviewed by
Rampulla et al (1992).
Consideration has been paid to the development of
equations based upon resting spirometric measurements to
define which patients are ventilatory limited. It is
questionable whether any of the resting measures are in
fact of any use in this regard (Patessio et al 1991). This
issue is further complicated by suggestions that exercise
may induce a variable amount of bronchodilation (Sean et al
1989) and a variable increase in the FRC (Dillard et al
1985). The ventilatory requirement for a given level of
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exercise is dictated by the equation-
/E= 	 K X Vco2	
PaCO2 x (1-VD/VT)
(K is a constant)
In CAL patients' ventilation/perfusion mismatching causes
hypoxaemia (lung units with a low V/Q) and a high VD/VT
(reflecting lung units with a high V/Q), the latter a
measure of inefficiency of CO2
 exchange. A second cause of
high ventilatory requirements is an early onset of lactic
acidosis. Employing the Douglas bags techniques reported in
Chapter 5 it was not possible to detect a anaerobic
threshold using the method proposed by Beaver et al (1986),
ie looking for an inflection in the /co2//o2 slope. However
the mean maximal R value for this group exceeded 1.0
consistent with attaining maximal oxygen uptake. It is
widely reported that an anaerobic threshold is measured at
approximately 55-65% of maximal oxygen uptake, therefore it
would be traditionally anticipated that a significant
increase in blood lactate concentration should have been
observed. This traditional view has been challenged by
Brookes (1985) who questioned the notion that the
exercising muscle tissue becomes anoxic and therefore
becomes anaerobic with significant reserves in cardiac
output, muscle blood flow, capillary dilation and arterial-
venous 02 difference. Brookes (1985) then challenges the
fact that no proponents of the anaerobic threshold concept
have in fact attempted to demonstrate muscle anoxia.The
author summarises that It basing the anaerobic threshold on
the presumption of an 02 deficit during sub-maximal exercise
is a serious mistake".
The group included for the validation study included a
wide range of disease severity. Until recently it has been
assumed that the patient most likely to be able to exercise
to a level adequate to produce a lactic acidosis is less
severely impaired. It has now been proposed that the work
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rate at which the anaerobic threshold occurs does not
relate well to resting spirometric measurements (Patessio
et al 1991). The reason for this, it is suggested, is that
the degree of impairment of the pulmonary vasculature does
not necessarily relate to the pathological process
responsible for the airways obstruction. This pathological
mechanism would limit the amount of oxygen supply to
exercising muscles more so that the reduction in lung
volume. This would certainly be true for the two patients
who produced a significant lactate response described in
Chapter 8. These patients did not have the highest lung
function values, in fact one patient was at the bottom of
the range. The development of a significant lactic acidosis
depends upon a number of factors, including muscle bulk,
muscle fibre type and their pattern of recruitment, the
oxidative enzyme capacity of the fibres and the capillary
network serving the exercising muscle. It may be suggested
that the individuals recruited for this present study did
not exercise to a high enough intensity to recruit a high
percentage of type II muscle fibres, known to have a high
concentration of lactate dehydrogenase, facilitating a more
rapid reduction of pyruvate to lactate (Skinner and
McLellan 1980).
Interestingly 6/10 patients were judged to attain a
ventilatory anaerobic threshold during the treadmill test.
The considerable disparity between these two measures
('lactate' anaerobic threshold and 'ventilatory' anaerobic
threshold) is worthy of further investigation in this
patient group. In sports science there is considerable
interest in the coincidental rather than causal
relationship between these two variables (Loat & Rhodes
1993) and with the addition of computerised equipment into
the larger hospitals it is now possible to investigate this
in more depth. It is suggested that the group of patients
who will respond to an exercise training programme are
those who can mount a lactate response [because these
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patients would tend to have more ventilatory drive and
hyperventilation in response.to exercise, accompanied by a
reduced efficiency in gas exchange (Wasserman et al 1989)].
Unfortunately it is likely that this criterion will
automatically exclude a large percentage of the population
with CAL. It should be remembered that the buffering of
lactic acid is not the only cause of increased ventilation
with increasing levels of exercise, but also the increased
aerobic metabolism and possibly hyperventilation with
exercise. The latter may be amenable to modulation.
Interestingly, Wasserman et al (1989) reviewed the work
by Sue et al (1989) and concluded that two thirds of the
patients developed a significant metabolic acidosis
detected either invasively or non invasively and suggested
that exercise training has the potential to improve
exercise tolerance in patients who develop 'metabolic
acidosis' (measured using ventilatory or standard
bicarbonate parameters). Furthermore he proposes that the
V-slope may in fact be preferable to the invasive
monitoring of blood lactate concentrations.
Kumagai et al (1982) examined the usefulness of using the
ventilatory threshold as an assessment tool in performance
evaluation for healthy individuals. Their results
demonstrated that the ventilatory threshold related
strongly to the individual's 1o2 . This principle may also
be valid in the assessment of patients with CAL. Further
evidence supporting the dissociation between the
ventilatory and anaerobic threshold is observed in the
adaption of each threshold to training. Gaesser and Poole
(1986) reported a greater increase in the lactate threshold
that in the ventilatory threshold over a 6 week training
period in normal individuals, suggesting that the
regulatory mechanism between these two thresholds is
different. It is worth considering the implication of these
results for patients with CAL. If we accept the measurement
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of a metabolic acidosis to be valid by either invasive or
non invasive techniques as suggested by Wasserman (1989)
the theoretical acceptance rate to pulmonary rehabilitation
is automatically increased (by virtue of attaining an
anaerobic threshold). It would appear from this results
reported in this thesis and alternative studies (Sue et al
1988, Nery et al 1983) that patients do not necessarily
manifest a threshold value for both variables. Therefore
for the patients who do not produce a significant lactate
response an alternative assessment must be sought. In
conjunction with evidence suggesting that these threshold
values are coincidentally linked it would be worth
incorporating assessment of the ventilatory anaerobic
threshold pre- and post training patients with CAL.
The results of this thesis and the review of other
studies (Sue et al 1988, Hagberg et al 1982, Neary et al
1985, Hughes et al 1982) appear to suggest that the
association between lactate and ventilatory thresholds may
be coincidental in patients with CAL. Although this
relationship has been challenged and investigated in sports
science in respiratory medicine the relationship continues
to be assumed to be causal. During exercise ventilation is
usually driven by a combination of neural and humoral
mechanisms. In the absence of, or modified humoral signals
(McArdles disease and glycogen depletion), or in response
to different input from higher centres or peripheral
receptors (eg speed of movement varies) the respiratory
centre still produces an appropriate ventilatory response.
The shuttle walking test has the potential be used to
estimate an individualised walking speed that would be an
effective training level. By judging a patient's
performance on the shuttle walking test a high or low
intensity training programme can be prescribed. The
possibilities of this potentially simple, accessible and
308
acceptable method of prescribing an appropriate exercise
programme warrants further investigation. The efficacy of
a brisk walking training programme in healthy middle aged
males (Stensel et al 1992) has convincingly been
demonstrated and a study of its application to a patient
population is required. If a low level training programme
proved to be successful in increasing the individual's
functional capacity and/or endurance performance the
implications for decreasing the level of disability of the
patients presenting with CAL would be great. Clinically the
efficacy of low level training has been examined by Freeman
et al (1990) in a group of cystic fibrosis patients with
encouraging results. Unlike the rehabilitation programmes
offered in North America (Goldstein et al 1992) consisting
often of a six week inpatient intensive training programme
a community based walking programme would be more
sustainable and acceptable to the European population.
Furthermore this type of exercise prescription could be
based at district general hospitals that do not possess
extensive exercise testing equipment. It would be
speculative to suggest that an improvement in shuttle test
performance would result from training.
If a patient manifests a true ventilatory limit to
exercise performance it is well documented that to2Imk
rarely improves (Neiderman et al 1991, Simpson et al 1992),
unlike training a healthy population. Therefore, in theory
the performance on the shuttle test may remain static, this
however requires further study. On the other hand if the
limitation to exercise is not ventilatory (Rampulla et al
1992) but in fact peripheral, a heightened perception of
breathlessness (Belman & Kendregan 1981) or psychological
(motivation) then an improvement in the shuttle test may be
anticipated/observed post training/rehabilitation. It is
reported that the individual assessment of breathlessness
bears little relationship to either the severity of the
airways limitation or the external load (Gottfried et al
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1981). Certainly in the present study the reported Borg
breathlessness ratings post exercise do not relate well to
either the static lung function measurements or
performance. Breathlessness, like pain, has both physical
and emotional components. Unfortunately it is not known
which component is more important in disease (Jones 1992).
Dyspnoea potentially impairs an individual's 'quality of
life' particularly if the perception is inappropriate to
the level of exercise achieved. On the other hand the
perception of dyspnoea can be a useful clinical tool
warning of deterioration.
Despite initial difficulties with the Oxylog system
reported in Chapter 6, their subsequent modification
allowed the Oxylog equipment to be incorporated into the
protocol described in Chapter 7. This study reaffirmed the
assumption of the maximal stimulus to exercise that the
shuttle walking test provides (proposed in Chapter 5). The
patients demonstrated a strong tendency towards a
ventilatory limit. The underestimation of i of the Oxylog
•has been reported in other literature. The respective
relationship between /o2pmk and performance was r=0.88
(treadmill & Douglas bags vs shuttle test performance), r=
0.93 (treadmill & breath by breath computer gas analysis vs
shuttle test performance) and finally r=0.81 (directly
measured shuttle test performance with the Oxylog).
The use of the shuttle walking test has already been
extended into other areas where exercise testing is
appropriate in clinical medicine. Perhaps the most obvious
alternative application of the shuttle walking test is into
the area of cardiac rehabilitation for patients who are
post coronary artery by-pass surgery or post myocardial
infarction. The test is presently under examination for its
reproducibility and suitability in this group of patients.
A further area that the shuttle walking test has been
employed in the assessment of fitness of patients with
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chronic low back pain. Unpublished data suggest that this
is a reproducible measure of exercise tolerance in this
patient group, with pain as the limiting factor to an
improved performance. The shuttle walking test could easily
be incorporated into clinical pharmacological trials. The
test has most recently been employed as a measure of
functional capacity to examine the usefulness of a newly
developed CAL specific quality of life questionnaire.
Scoring on the functionally based questionnaire revealed a
strong relationship with shuttle test performance (Hyland
et al 1993).
In summary, the studies reported in this thesis
consistently demonstrate that the shuttle walking test is
a reproducible exercise test of functional capacity in
patients with CAL. This group of patients have a reduced
exercise tolerance in comparison to a healthy age matched
control group. Overall it would appear that patients
terminate exercise because of a ventilatory limit, ie an
inability of the lungs to match the required levels of
ventilation. The studies reported in Chapters 4, 5, 7 and
9 exclude both a peripheral muscle fatigue and a cardio-
vascular cause for the cessation of exercise. However
motivation and tolerance to dyspnoea must not be overlooked
in this group of patients. Despite this reduced exercise
tolerance the shuttle walking test is sensitive enough to
provide an accurate estimation of an individuals 1:To2 max,
the traditional reference measure of cardio-respiratory
capacity. The shuttle test offers a simple but reliable
exercise test that is acceptable to the patients and
attractive to the operator primarily because of its
inherent standardisation. This allows more valid intra-,
inter-subject and multi-centre comparison of patients than
has previously been possible with simple exercise tests.
The shuttle test can be used in any District General
Hospital as a cheap but effective alternative to a
laboratory exercise test. The shuttle test does not replace
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formal laboratory exercise testing but pfovidg a useful
adjunct to cu	 inrrent practice	 patient4ssessment and
management.
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APPENDIX A
THE SHUTTLE WALKING TEST
INSTRUCTIONS TO THE OPERATOR/PATIENT
Before you start the progressive shuttle walking test it is
important to check that your cassette player is running at
the right speed and that the tape has not stretched. To
help you with this we have put two accurately timed bleeps
60 seconds apart on the tape. Check the timing now.
TIMED MINUTE
The object of the progressive shuttle walking test is to
walk for as long as possible to and fro, along the 10m
course, keeping to the speed indicated by the bleeps on the
cassette. You will hear these bleeps at regular intervals.
You should walk at a steady pace aiming to turn around the
cone at one end of the course when you hear the first bleep
and at the other end when you hear the next.
At first your walking speed will be very slow but you will
need to speed up at the end of each minute. Your aim should
be to follow the set rhythm for as long as you can , each
single bleep signals the end of a shuttle and each triple
bleep signals an increase in walking speed.
You should stop walking only when you become too breathless
to maintain the required speed or can no longer keep up
with the set pace.
The test is maximal and progressive. In other words it is
easy at the start and harder at the end. The walking speed
for the first minute is very slow you have 20 seconds to
complete each 10m shuttle, so don't go too fast.
The test will start in 15 seconds so line up at the start
now.
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Level 1 starts with a triple bleep after the 4 second
countdown.
10M SHUTTLE TEST
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APPENDIX B.
BORG BREATHLESSNESS SCORE
0	 NOTHING AT ALL
0.5 VERY, VERY SLIGHT 	 (JUST NOTICEABLE)
1	 VERY SLIGHT
2	 SLIGHT
3	 MODERATE
4	 SOMEWHAT SEVERE
5	 SEVERE
6
7	 VERY SEVERE
8
9	 VERY, VERY SEVERE (ALMOST MAXIMAL)
10	 MAXIMAL
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APPENDIX B.
BORG PERCEIVED EXERTION SCALE 
6
	
7	 gEM	 VERY, VERY LIGHT
8
	
9	 VERY LIGHT
10
	
11
	 FAIRLY LIGHT
12
	
13	 SOMEWHAT HARD
14
	
15	 HARD
16
	
17	 VERY HARD
18
	
19	 VERY, VERY HARD
20
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APPENDIX C.
CHRONIC RESPIRATORY DISEASE OUESTIONNAIRE
First Administration, 7 Point Scale
INTERVIEWER FORK
This questionnaire is designed to find out how you have
been feeling during the last two weeks. You will be asked
about how short of breath you have been, how tired you have
been feeling and how your mood has been.
1. I would like you to think of the activities that you
have done during the last two weeks that have made you feel
short of breath. These should be activities which you do
frequently and which are important in your day-to-day life.
Please list as many activities as you can that you have
done during the last 2 weeks that have made you feel short
of breath.
(CIRCLE THE NUMBER ON THE ANSWER SHEET LIST ADJACENT TO
EACH ACTIVITY MENTIONED. IF AN ACTIVITY MENTIONED IS NOT
ON THE LIST, WRITE IT IN, IN THE RESPONDENT'S OWN WORDS, IN
THE SPACE PROVIDED).
Can you think of any other activities yea have dons eLuring
the last 2 weeks that have made you feel short of breath?
(RECORD ADDITIONAL ITEMS)
2. I will now read a list of activities which make some
people with lung problems feel short of breath. I will
pause after each item long enough for you to tell me if you
have felt short of breath during that activity during the
last 2 weeks. If you haven't done that activity during the
last 2 weeks, just say "No". The activities are:
(READ ITEMS, OMITTING THOSE WHICH RESPONDENT HAS
VOLUNTEERED SPONTANEOUSLY. PAUSE AFTER EACH ITEM TO GIVE
RESPONDENT A CHANCE TO INDICATE WHETHER HE/SHE HAS BEEN
SHORT OF BREATH WHILE PERFORMING THAT ACTIVITY DURING THE
LAST WEEK. CIRCLE THE NUMBER ADJACENT TO APPROPRIATE ITEMS
ON ANSWER SHEET).
1. BEING ANGRY OR UPSET
2. HAVING A BATH OR SHOWER
3. BENDING
4. CARRYING, SUCH AS CARRYING GROCERIES
5. DRESSING
6. EATING
7. GOING FOR A WALK
8. DOING YOUR HOUSEWORK
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9. HURRYING
10. MAKING A BED
11. MOPPING OR SCRUBBING THE FLOOR
12. MOVING FURNITURE
13. PLAYING WITH CHILDREN OR GRANDCHILDREN
14. PLAYING SPORTS
15. REACHING OVER YOUR HEAD
16. RUNNING, SUCH AS FOR A BUS
17. SHOPPING
18. WHILE TRYING TO SLEEP
19. TALKING
20. VACUUMING
21. WALKING AROUND YOUR OWN HOME
22. WALKING UPHILL
23. WALKING UPSTAIRS
24. WALKING WITH OTHERS ON LEVEL GROUND
25. PREPARING MEALS 
3a) Of the items which you have listed, which is the most
important to you in your day-to-day life? I will read
through the items, and when I am finished, I would like
you to tell me which is the most important.
(READ THROUGH ALL ITEMS SPONTANEOUSLY VOLUNTEERED AND
THOSE FROM THE LIST WHICH PATIENT MENTIONED)
Which of these items is most important to you in your
day-to-day life?
(LIST ITEM ON RESPONSE SHEET)
b) Of the remaining items, which is the most important to
you in your day-to-day life? I will read through the
items, and when I am finished, I would like you to tell me
which is the most important.
(READ THROUGH REMAINING ITEMS)
Which of these items is most important to you in your day-
to-day life?
(LIST ITEM ON RESPONSE SHEET)
C) Of the remaining items, which is most important to you
in your day-to-day life?
(LIST ITEM ON RESPONSE SHEET)
d) Of the remaining items, which is most important to you
in your day-to-day life?
(LIST ITEM ON RESPONSE SHEET)
e) Of the remaining items, which is most important to you
in your day-to-day life?
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(LIST ITEM ON RESPONSE SHEET)
(FOR ALL SUBSEQUENT QUESTIONS, ENSURE RESPONDENT HAS
APPROPRIATE RESPONSE CARD IN FRONT OF THEM BEFORE
STARTING THE QUESTION)
4. I would now like you to describe how much shortness of
breath you have experienced during the last 2 weeks while
doing the 5 most important activities you have selected.
a) Please indicate how much shortness of breath you have
had during the last 2 weeks while (INTERVIEWER: INSERT
ACTIVITY LIST IN 3a) by choosing one of the following
options from the card in front of you: (GREEN CARD)
1. EXTREMELY SHORT OF BREATH
2. VERY SHORT OF BREATH
3. QUITE A BIT SHORT OF BREATH
4. MODERATE SHORTNESS OF BREATH
5. SOME SHORTNESS OF BREATH
6. A LITTLE SHORTNESS OF BREATH
7. NOT AT ALL SHORT OF BREATH
b) Please indicate how much shortness of breath you have
had during the last 2 weeks while (INTERVIEWER: INSERT
ACTIVITY LIST IN 3b) by choosing one of the following
options from the card in front of you: (GREEN CARD)
1. EXTREMELY SHORT OF BREATH
2. VERY SHORT OF BREATH
3. QUITE A BIT SHORT OF BREATH
4. MODERATE SHORTNESS OF BREATH
5. SOME SHORTNESS OF BREATH
6. A LITTLE SHORTNESS OF BREATH
7. NOT AT ALL SHORT OF BREATH
C) Please indicate how much shortness of breath you have
had during the last 2 weeks while (INTERVIEWER: INSERT
ACTIVITY LIST IN 3c) by choosing one of the following
options from the card in front of you: (GREEN CARD)
1. EXTREMELY SHORT OF BREATH
2. VERY SHORT OF BREATH
3. QUITE A BIT SHORT OF BREATH
4. MODERATE SHORTNESS OF BREATH
5. SOME SHORTNESS OF BREATH
6. A LITTLE SHORTNESS OF BREATH
7. NOT AT ALL SHORT OF BREATH
d) Please indicate how much shortness of breath you have
had during the last 2 weeks while (INTERVIEWER: INSERT
ACTIVITY LIST IN 3d) by choosing one of the following
options from the card in front of you: (GREEN CARD)
1. EXTREMELY SHORT OF BREATH
2. VERY SHORT OF BREATH
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3. QUITE A BIT SHORT OF BREATH
4. MODERATE SHORTNESS OF BREATH
5. SOME SHORTNESS OF BREATH
6. A LITTLE SHORTNESS OF BREATH
7. NOT AT ALL SHORT OF BREATH
e) Please indicate how much shortness of breath you have
had during the last 2 weeks while (INTERVIEWER: INSERT
ACTIVITY LIST IN 3e) by choosing one of the following
options from the card in front of you: (GREEN CARD)
1. EXTREMELY SHORT OF BREATH
2. VERY SHORT OF BREATH
3. QUITE A BIT SHORT OF BREATH
4. MODERATE SHORTNESS OF BREATH
5. SOME SHORTNESS OF BREATH
6. A LITTLE SHORTNESS OF BREATH
7. NOT AT ALL SHORT OF BREATH
5. In general, how much of the time during the last 2
weeks have you felt frustrated or impatient? Please
indicate how often during the last 2 weeks you have felt
frustrated or impatient by choosing one of the following
options from the card in front of you: (BLUE CARD)
1. ALL OF THE TIME
2. MOST OF THE TIME
3. A GOOD BIT OF THE TIME
4. SOME OF THE TIME
5. A LITTLE OF THE TIME
6. HARDLY ANY OF THE TIME
7. NONE OF THE TIME
6. How often during the past 2 weeks did you have a
feeling of fear or panic when you had difficulty getting
your breath? please indicate how often you had a feeling of
fear or panic when you had difficulty getting your breath
by choosing one of the following options from the card in
front of you: (BLUE CARD)
1. ALL OF THE TIME
2. MOST OF THE TIME
3. A GOOD BIT OF THE TIME
4. SOME OF THE TIME
5. A LITTLE OF THE TIME
6. HARDLY ANY OF THE TIME
7. NONE OF THE TIME
7. What about fatigue? How tired have you felt over the
last 2 weeks? Please indicate how tired you have felt over
the last 2 weeks by choosing one of the following options
from the card in front of you: (ORANGE CARD)
1. EXTREMELY TIRED
2. VERY TIRED
3. QUITE A BIT OF TIREDNESS
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4. MODERATELY TIRED
5. SOMEWHAT TIRED
6. A LITTLE TIRED
7. NOT AT ALL TIRED
8. How often during the last 2 weeks have you felt
embarrassed by your coughing or heavy breathing? Please
indicate how much of the time you felt embarrassed by your
coughing or heavy breathing by choosing one of the
following options from the card in front of you: (BLUE
CARD)
1. ALL OF THE TIME
2. MOST OF THE TIME
3. A GOOD BIT OF THE TIME
4. SOME OF THE TIME
5. A LITTLE OF THE TIME
6. HARDLY ANY OF THE TIME
7. NONE OF THE TIME
9. In the last 2 weeks, how much of the time did you feel
very confident and sure that you could deal with your
illness? Please indicate how much of the time you felt very
confident and sure that you could deal with your illtness
choosing one of the following options from the card in
front of you: (YELLOW CARD)
1. NONE OF THE TIME
2. A LITTLE OF THE TIME
3. SOME OF THE TIME
4. A GOOD BIT OF THE TIME
5. MOST OF THE TIME
6. ALMOST ALL OF THE TIME
7. ALL OF THE TIME
10. How much energy have you had in the last 2 weeks?
Please indicate how much energy you have had by choosing
one of the following options from the card in front of you:
(PINK CARD)
1. NO ENERGY AT ALL
2. A LITTLE ENERGY
3. SOME ENERGY
4. MODERATELY ENERGETIC
5. QUITE A BIT OF ENERGY
6. VERY ENERGETIC
7. FULL OF ENERGY
11. In general, how much of the time did you feel upset,
worried or depressed during the last 2 weeks? Please
indicate how much of the time you felt upset, worried or
depressed during the past 2 weeks by choosing one of the
following options from the card in front of you: (BLUE
CARD)
1. ALL OF THE TIME
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2. MOST OF THE TIME
3. A GOOD BIT OF THE TIME
4. SOME OF THE TIME
5. A LITTLE OF THE TIME
6. HARDLY ANY OF THE TIME
7. NONE OF THE TIME
12. How often during the last 2 weeks did you feel you had
complete control of your breathing problems? Please
indicate how often you felt you had complete control of
your breathing problems by choosing one of the following
options from the card in front of you: (YELLOW CARD)
1. NONE OF THE TIME
2. A LITTLE OF THE TIME
3. SOME OF THE TIME
4. A GOOD BIT OF THE TIME
5. MOST OF THE TIME
6. ALMOST ALL OF THE TIME
7. ALL OF THE TIME
13. How much of the time during the last 2 weeks did you
feel relaxed and free of tension? Please indicate how much
of the time you felt relaxed and free of tension by
choosing one of the following options from the card in
front of you: (YELLOW CARD)
1. NONE OF THE TIME
2. A LITTLE OF THE TIME
3. SOME OF THE TIME
4. A GOOD BIT OF THE TIME
5. MOST OF THE TIME
6. ALMOST ALL OF THE TIME
7. ALL OF THE TIME
14. How often during the last 2 weeks have you felt low in
energy? Please indicate how often during the last 2 weeks
you have felt low in energy by choosing one of the
following options from the card in front of you: (BLUE
CARD)
1. ALL OF THE TIME
2. MOST OF THE TIME
3. A GOOD BIT OF THE TIME
4. SOME OF THE TIME
5. A LITTLE OF THE TIME
6. HARDLY ANY OF THE TIME
7. NONE OF THE TIME
15. In general, how often during the last 2 weeks have you
felt discouraged or down in the dumps? Please indicate how
often during the last 2 weeks you felt discouraged or down
in the dumps by choosing one of the following options from
the card in front of you: (BLUE CARD)
1. ALL OF THE TIME
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2. MOST OF THE TIME
3. A GOOD BIT OF THE TIME
4. SOME OF THE TIME
5. A LITTLE OF THE TIME
6. HARDLY ANY OF THE TIME
7. NONE OF THE TIME
16. How often during the last 2 weeks have you felt worn
our or sluggish? Please indicate how much of the time you
felt worn out or sluggish by choosing one of the following
options from the card in front of you: (BLUE CARD)
1. ALL OF THE TIME
2. MOST OF THE TIME
3. A GOOD BIT OF THE TIME
4. SOME OF THE TIME
5. A LITTLE OF THE TIME
6. HARDLY ANY OF THE TIME
7. NONE OF THE TIME
17. How happy, satisfied or pleased have you been with your
personal life during the last 2 weeks? Please indicate how
happy, satisfied or please you have been by choosing one of
the following options from the card in front of you: (GREY
CARD)
1. VERY DISSATISFIED, UNHAPPY MOST OF THE TIME
2. GENERALLY DISSATISFIED, UNHAPPY
3. SOMEWHAT DISSATISFIED, UNHAPPY
4. GENERALLY SATISFIED, PLEASED
5. HAPPY MOST OF THE TIME
6. VERY HAPPY MOST OF THE TIME
7. EXTREMELY HAPPY, COULD NOT HAVE BEEN MORE SATISFIED
OR PLEASED
18. How often during the last two weeks did you feel upset
or scared when you had difficulty getting your breath?
Please indicate how often during the last 2 weeks you felt
upset or scared when you had difficulty getting your breath
by choosing one of the following options from the card in
front of you: (BLUE CARD)
1. ALL OF THE TIME
2. MOST OF THE TIME
3. A GOOD BIT OF THE TIME
4. SOME OF THE TIME
5. A LITTLE OF THE TIME
6. HARDLY ANY OF THE TIME
7. NONE OF THE TIME
19. In general, how often during the last 2 weeks have you
felt restless, tense or uptight? Please indicate how oten
you have felt restless, tense or uptight by choosing one of
the following options from the card in front of you: (BLUE
CARD)
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1. ALL OF THE TIME
2. MOST OF THE TIME
3. A GOOD BIT OF THE TIME
4. SOME OF THE TIME
5. A LITTLE OF THE TIME
6. HARDLY ANY OF THE TIME
7. NONE OF THE TIME
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APPENDIX D. 
CALIBRATION PROCEDURES 
D.i. Gas analysers
The equipment was calibrated immediately prior to
expired air analysis and if necessary re-calibrated every
hour. The Taylor Servomex oxygen analyser and the Lira
Infra-red carbon dioxide were both calibrated initially
with oxygen free nitrogen (a null gas) and then with a gas
mixture of a known concentration.
D.ii The Oxylog
The oxygen analysers of the Oxylog was calibrated at the
start of each individual study to zero p0 2 . Oxygen free
nitrogen was passed over the two sampling tubes until a
stable zero reading is obtained. Prior to each use of the
Oxylog the oxygen sensors were calibrated to atmospheric P02
at barometric pressure.
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APPENDIX E. 
GAS ANALYSIS 
E.i The determination of the oxygen and carbon dioxide
content, volume and temperature of the expired air :-
the Douglas bag.
The collection of expired air was well mixed immediately
prior to analysis. A small sample of air was extracted from
the Douglas bag via a sample tube connected to a Hy-flow
pump (Metcalf Industries Ltd.). The rate of sampling was
measured by a gap flow meter. The expired air was directed
into the carbon dioxide analyser for 120 seconds, during
this time the rate of flow was recorded. After 120 seconds
the flow was directed to the 0 2 analyser for 60 seconds.
During which time the deflection of the CO 2 meter needle was
recorded and the flow rate to the 02 noted. At the end of
the 60 seconds the flow was stopped and the digital display
was recorded once stabilised.
The volume of remaining expired air in the Douglas bag was
measured by evacuation through a dry gas meter. The total
volume of ventilation required the addition of this volume
to the volume of air passed through the gas analysers. The
temperature was measured as the expired air passed over a
thermistor placed in the outlet tube of the dry gas meter.
E.ii The determination of oxygen content and ventilation:-
Oxylog
The volume of inspired air is measured through a turbine
type flow meter and is displayed digitally each minute to
the nearest 1 litre. 1:To2 is displayed digitally having a
resolution of 0.01 1.min4 . The calculations of the equipment
make the assumptions
1. The volume of inspired air is corrected to 0°C dry at the
pressure of the experiment, temperature is measured with a
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thermistor at the flow meter.
2. The 1.7E is only correct if the R value is equal to 1.
The error in oxygen consumption measurements are
% error in volume
0.7
-5.3
0.8
-3.5
0.9
-1.8
1.0 0
1.1 1.8
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APPENDIX F. 
BLOOD LACTATE ASSAY 
Blood lactate assays were performed using the fluorometric
enzymatic method described by Maughan (1982). It is
dependent upon the release of NADH by the following
reaction;
LDH
Lactate 	 > Pyruvate
NAD4"/--W NADH
In the conversion of lactate to pyruvate (catalysed by LDH)
the co-factor NAD I' is reduced to NADH. NADH has a natural
fluorescence which is measured as an indication of the
concentration of lactate. Excess LDH and NAD + were used to
ensure the complete conversion of all lactate present.
Fluorometric analysis of the resulting reaction mixture
measures the fluorescence of NADH, which varies according
to the initial lactate concentration. The actual values
were established by relating each sample to a regression
equation computed from a series of lactate standards of
known concentration.
The process of analysis was carried out as follows:
SOLUTIONS.
a) 2.5% Perchloric acid.
b) Hydrazine buffer (1.1 mmo1.14 , pH 9.4): (1.3g hydrazine
sulphate, 5.0g hydrazine hydrate and 0.2g ethylenediamino
tetra-acetic acid disodium salt (EDTA) in 100 ml of
distilled water).
C) Reaction mixture: 2 mg NAD+ and 10 gl LDH per ml of
hydrazine buffer, prepared immediately prior to use.
STANDARDS.
Standard of 1, 2, 3, 4 and 5 mmol 1 4 conncentration were
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prepared from 1.0 M sodium L-Lactate solution for the
analysis of the results presented in Chapter 7. For the
samples described in Chapter 8 standards of 1, 2, 4, 6, 8
and 10 mmo1.14 were prepared.
DEPROTINISATION
20 Al of blood was deproteinised by adding 200 Al of
perchloric acid. It was then mixed thoroughly and stored at
-20°C before analysis.
PROCEDURE
1. Samples were removed from the freezer and allowed to
thaw at room temperature.
2. Once defrosted the samples were mixed thoroughly using
the fwhirlimix' and the precipitate was separated by
spinning in the centrifuge (Eppendorf, model 5412) for 4
minutes.
3. From each sample, in duplicate, 20 Al of supernatant was
pipetted into a test tube (washed in nitric acid). A clean
pipette was used for each sample.
4. A corresponding volume of each of the standard solution
was pipetted into four test tubes and subjected to the same
procedure.
5. 200 Al of reaction mixture was added to all the test
tubes.
6. All the test tubes were mixed again, covered and left to
incubate for 30 minutes.
7. After incubation 1 ml of lactate diluent 0.07 M HC1 was
added to halt the reaction, and the tubes mixed.
8. The samples were read against the blanks and standards
with a fluorimeter (Perkin Elmer 1000M).
9. The lactate concentration was established from the
regression equation of the standards using a BBC micro-
computer with software developed in the department
(Loughborough).
The r value of the regression equations for the standard
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solutions was >0.99 for each of the 4 batches.
DETERMINATION OF THE COEFFICIENT OF VARIATION
Four repeated measures were made on five standard
solutions for the determination of the coefficient of
variation for the assay.
Standard mean C of V
1 mmo1.14 61.0 4.2%
2 mmo1.14 85.7 0.5%
3 mmo1.14 107.0 0.6%
4 mmo1.14 127.1 1.5%
5 mmo1.14 165.7 0.1%
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